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Summary 
Engineered microchannels for vascularization in bone 
tissue engineering 
 
Tissue engineering is an always-evolving field, which aims to restore the 
physiological functions of damages tissues and organs. It uses the most advanced 
techniques and methodologies to develop always-new biomaterials and engineered 
tissues with unique properties and characteristics. This challenging goal can be 
achieved through the combination of cells, biological factors, and biomaterial 
scaffolds. Those last do not work uniquely as supportive elements for the cells but 
thanks to their physicochemical properties they can drive the cell into adhesion, 
migration, morphology change, differentiation and so on, to develop the new tissue. 
In this fundamental context of biomaterial development, the surface has to be 
optimized to increase the interaction of the biological components with the cells to 
favor the growth of the new tissue. 
A very important limiting factor in the development of large and complexes 
tissues is the impossibility to develop a rapid, stable, and organized micro-vascular 
network. This network is normally present in almost all the tissues and allows the 
exchange of oxygen and nutrient with the discarding metabolite products and 
carbon dioxide in each cell of the human body. Herein, we designed and developed 
micro-structured channels that, once biofunctionalized to mimic the physiological 
extracellular matrix, drive the development of capillary vessels in vitro. 
We first created micro-channels bioactive surfaces by combining hot-embossing 
technique and surface functionalization technique. Those micro-channels were 
transferred on to a polycarbonate film using silicon line mold as the template (Figure 
i).  
Summary 
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Figure i – Schematic of the imprinting process. On the upper part, in gray, the silicon mold 
(SiM) with the pattern line. On the bottom, in light blue, the polycarbonate micro-channels 
(PC-µCh). In red the two plates, on which the pressure is applied during the hot-embossing 
process. 
An initial step of layer-by-layer (LbL) deposition of natural polysaccharides of 
chitosan and hyaluronic acid is used to develop a favorable environment for the 
endothelial cells, and at the same time, provide a rich surface for peptides 
immobilization. We characterize the micro-channels development using a 
combination of scanning electron microscopy and profilometry. Later, LbL deposition 
was investigated with ellipsometry and confocal laser scanning microscopy (CLSM). 
Finally, the immobilization of the adhesive peptide RGD and the angiogenic peptides 
SVV and QK were characterized with fluorescence microscopy to quantify the 
number of each type of peptides present on the material's surface and localize their 
penetration into the layer-by-layer cushion. 
Next, we studied human umbilical vein endothelial cells (HUVECs) behavior on 
the biofunctionalized surfaces, identifying which combination of LbL and peptide 
would promote cellular adhesion and increased metabolic activity. The combination 
of adhesive and angiogenic peptide represents a good support for HUVECs to adhere 
and grow. The aim was to develop capillary vessels inside the functionalized micro-
 x 
channels (Figure ii). For this reason, we studied HUVECs behavior on the 
functionalized micro-channels using a combination of time-lapse CLSM and fixed-
time CLSM. We found how the combination of micro-channels, LbL, RGD, and QK or 
SVV peptides provide the best conditions for the development of capillary-like 
structures already after 2 hours of incubation. In the case of RGD+QK combination, 
the capillary-like structures were observed also for the next two hours of the 
experiment. 
 
Figure ii – Schematic of the tubular structure of the capillary vessel. In red the capillary vessel 
seen from inside composed of HUVECs. 
Finally, we investigated a co-culture system using HUVECs combined with human 
pericytes derived from placenta (hPC-PL) to assess the stabilization of the capillary-
like structures in the micro-channels (Figure iii) with LbL, RGD, and SVV peptides. For 
this, we used CLSM and different markers to identify and localize both cells at the 
same time in the biofunctionalized material. We found how the presence of hPC-PL 
influence positively the stability of the capillary-like structures, showing a clear 
formation of the empty-lumen structure for two hours longer than the control with 
HUVECs monoculture.  
Summary 
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To summarize, the combination of micro-channels and surface functionalization 
is a unique way of capillary development after only two hours in both monocultures 
of HUVECs or co-culture of HUVECs with hPC-PL. 
 
Figure iii – Schematic of the pericytes stabilization. Pericytes (in blue) wrapping the HUVECs 
(in red) as one possible mechanism of stabilization. All of this, inside the micro-channels of 
the biofunctionalized material (violet). 
Keywords: hot-embossing, surface functionalization, micro-channels, layer-by-
layer, bioactivity, human umbilical vein endothelial cells, human pericytes, peptides, 
capillary structure. 
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Résumé (long) 
Synthèse de microcanaux bioactifs pour la vascularization 
 
L'ingénierie tissulaire est un domaine en constante évolution qui vise à restaurer 
les fonctions physiologiques des tissus et organes endommagés. Il utilise les 
techniques et les méthodologies les plus avancées pour développer des 
biomatériaux toujours nouveaux et des tissus techniques dotés de propriétés et de 
caractéristiques uniques. Cet objectif ambitieux peut être atteint en combinant des 
cellules, des facteurs biologiques et des échafaudages de biomatériaux. Ceux-ci ne 
fonctionnent pas uniquement comme éléments de soutien pour les cellules, mais 
grâce à leurs propriétés physico-chimiques, ils peuvent conduire à l'adhésion, la 
migration, le changement de morphologie, la différenciation, etc., et au 
développement du nouveau tissu. Dans ce contexte fondamental du développement 
des biomatériaux, la surface doit être optimisée pour augmenter l'interaction des 
composants biologiques avec les cellules afin de favoriser la croissance du nouveau 
tissu. 
Un facteur limitant très important dans le développement de tissus volumineux 
et complexes est l'impossibilité de développer un réseau micro-vasculaire rapide, 
stable et organisé. Ce réseau est normalement présent dans presque tous les tissus 
et permet l’échange d’oxygène et de nutriments avec les produits métabolites et le 
dioxyde de carbone rejetés dans chaque cellule du corps humain. Dans le present 
travail de recherche, nous avons conçu et développé des canaux micro-structurés 
qui, une fois biofonctionnalisés pour imiter la matrice extracellulaire physiologique, 
entraînent le développement de vaisseaux capillaires in vitro. 
Nous avons d'abord créé des surfaces bioactives micro-structurées en combinant 
la technique d’estampage à chaud et des techniques de fonctionnalisation de 
surface. Les microcanaux ont été transférés sur un film de polycarbonate en utilisant 
un moule en silicium comme gabarit (Figure iv). 
Résumé (long) 
 xiii 
 
Figure iv - Schéma du processus d'impression. Sur la partie supérieure, en gris, le moule en 
silicium (SiM) avec la ligne de motif. En bas, en bleu clair, les micro-canaux en polycarbonate 
(PC-µCh). En rouge, les deux plaques sur lesquelles la pression est appliquée pendant le 
processus de gaufrage à chaud. 
Une première étape de dépôt couche par couche (LbL) de polysaccharides 
naturels de chitosane et d'acide hyaluronique est utilisée pour développer un 
environnement favorable aux cellules endothéliales, tout en fournissant une surface 
riche pour l'immobilisation des peptides. Les dimensions des micro-canaux ont été 
caractérisés en combinant la microscopie électronique à balayage et la profilométrie. 
Dans un second temps, la croissance du dépôt LbL a été étudié par ellipsométrie et 
microscopie confocale à balayage laser (CLSM). Enfin, l'immobilisation du peptide 
adhésif RGD et des peptides angiogéniques SVV et QK a été caractérisée par 
microscopie à fluorescence afin de quantifier le nombre de chaque type de peptides 
présents sur la surface du matériau et localiser leur pénétration dans le coussin LbL. 
Ensuite, nous avons étudié le comportement des cellules endothéliales de la 
veine ombilicale humaine (HUVEC) sur les surfaces biofonctionnalisées, en 
identifiant la combinaison de peptides qui favoriserait l'adhésion cellulaire et 
augmenterait l'activité métabolique. La combinaison du peptide adhésif et du 
peptide angiogénique représente un bon support pour que les HUVEC adhèrent et 
se développent. L'objectif était de développer des vaisseaux capillaires à l'intérieur 
 xiv 
des micro-canaux fonctionnalisés (Figure v). Le comportement des HUVECs sur les 
micro-canaux fonctionnalisés a ensuite été étudié à l'aide d'une combinaison de 
CLSM time-lapse et de CLSM à temps fixe. Nous avons montré comment la 
combinaison de micro-canaux, LbL, RGD, et les peptides QK ou SVV fournissent les 
meilleures conditions pour le développement de structures de type capillaire déjà 
après 2 heures d'incubation. Dans le cas d'une combinaison RGD + QK, les structures 
de type capillaire ont également été observées pendant les deux heures suivantes 
de l'expérience. 
 
Figure v - Schéma de la structure tubulaire du vaisseau capillaire. En rouge, le vaisseau 
capillaire, vu de l'intérieur, composé de HUVEC. 
 
Enfin, nous avons étudié un système de co-culture utilisant des HUVEC 
combinées à des péricytes humains dérivés du placenta (hPC-PL) pour évaluer la 
stabilisation des structures capillaires dans les microcanaux (Figure vi) avec les 
peptides LbL, RGD et SVV. Pour cela, le CLSM et différents marqueurs pour identifier 
et localiser les deux types cellulaires simultanément dans le matériel 
biofonctionnalisé ont été utilisé. Nous avons trouvé comment la présence de hPC-PL 
influençait positivement la stabilité des structures de type capillaire, montrant une 
Résumé (long) 
 xv 
nette formation de la structure à lumière vide pendant deux heures de plus que la 
monoculture de HUVEC. 
En résumé, la combinaison de micro-canaux et de fonctionnalisation de surface 
est un moyen unique de développement de capillaires après seulement deux heures 
de monocultures de cellules HUVEC ou de co-culture de cellules HUVEC avec le hPC-
PL. 
 
Figure vi - Schéma de la stabilisation des péricytes. Les péricytes (en bleu) enveloppent les 
HUVEC (en rouge) comme possible mécanisme de stabilisation. Tout cela dans les micro-
canaux du matériau biofonctionnalisé (violet). 
Mots-clés: estampage à chaud, fonctionnalisation de surface, microcanaux, 
dépôt couche par couche, bioactivité, cellules endothéliales de la veine ombilicale 
humaine, péricytes humains, peptides, structure capillaire. 
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Résumé (bref) 
Titre: Synthèse de microcanaux bioactifs pour la vascularization 
Résumé: In vitro, la formation de structures de type tubulaire avec des 
cellules endothéliales de veine ombilicale humaine (HUVEC) a été étudiée en 
combinant la fonctionnalisation de la chimie des matériaux et le développement de 
la géométrie tridimensionnelle. Le polycarbonate (PC) a été utilisé comme modèle 
pour le développement de l'échafaud. Le film de polysaccharide naturel, basé sur un 
dépôt alternatif couche par couche (LbL) d’acide hyaluronique (HA) et de chitosane 
(CHI), a d’abord été appliqué sur une surface PC et caractérisé en termes de 
croissance d’épaisseur microscopie à balayage lascar (CLSM). Cette première 
fonctionnalisation se traduit par un revêtement complet de la couche PC. Une 
biofonctionnalisation supplémentaire avec un peptide adhésif (RGD) et deux 
peptides angiogénétiques (SVV et QK) a été étudiée, immobilisant ces peptides sur 
le groupe carboxylique de HA précédemment déposé, en utilisant la chimie bien 
connue du carbodiimide. La version marquée de chaque peptide a été utilisée pour 
caractériser l’immobilisation et la pénétration des peptides dans les couches de 
polyélectrolytes, aboutissant à une greffe réussie avec une pénétration complète 
dans toute l’épaisseur du LbL. Des tests in vitro ont été effectués à l'aide de cellules 
HUVEC pour évaluer leur efficacité d'adhésion et leur activité métabolique sur la LbL 
avec et sans immobilisation de peptides, ce qui a permis d'améliorer l'activité 
préliminaire lorsque des combinaisons de peptides sont utilisées. Enfin, les micro-
canaux PC (µCh) ont été développés et caractérisés pour la première fois, et les 
autres expériences ont été réalisées sur un micromètre de 25 µm de largeur, 
fonctionnalisé avec une architecture (HA / CHI) 12,5 (PC-LbL) avec des peptides RGD 
et QK -RGD + QK) ou avec des peptides RGD et SVV (PC-RGD + SVV). Notre première 
expérience de tubulogénèse a montré de manière surprenante la formation de 
structures de type tubulaire déjà après 2h d'incubation en utilisant la combinaison 
double-peptides, mais uniquement avec PC-RGD + QK. Les tubes étaient également 
présents après 3 et 4 heures de culture. L'expérience de co-culture avec des péricytes 
humains dérivés du placenta (hPC-PL) montre comment la stabilisation des tubes a 
Résumé (bref) 
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été améliorée après 3 et 4 heures également pour l'échantillon de PC-RGD + SVV. 
Globalement, notre matériel bio-fonctionnel avec les peptides PC-RGD + QK et PC-
RGD + SVV permet la formation d'une structure de type tubulaire à la fois dans une 
expérience de monoculture et de co-culture. 
Mots-clés: estampage à chaud, fonctionnalisation de surface, microcanaux, 
dépôt couche par couche, bioactivité, cellules endothéliales de la veine ombilicale 
humaine, péricytes humains, peptides, structure capillaire. 
Abstract 
Title: Engineered microchannels for vascularization in bone tissue 
engineering 
Abstract: In vitro, tubular-like structures formation with human umbilical 
vein endothelial cells (HUVECs) was investigated by combining material chemistry 
functionalization and three-dimensional geometry development. Polycarbonate (PC) 
was used as a template for the development of the scaffold. Natural polysaccharide’s 
film based on alternate layer-by-layer (LbL) deposition of hyaluronic acid (HA) and 
chitosan (CHI), was first applied to PC surface and characterized in terms of thickness 
growth both, in dry conditions using ellipsometry, and confocal lascar scanning 
microscopy (CLSM). This first functionalization results in a complete coating of the 
PC layer. Further biofunctionalization with one adhesive peptide (RGD) and two 
angiogenetic peptides (SVV and QK) was investigated, immobilizing those peptides 
on the carboxylic group of HA previously deposited, using the well-known 
carbodiimide chemistry. The labeled version of each peptide was used to 
characterize the peptides’ immobilization and penetration into the polyelectrolytes 
layers, resulting in a successful grafting with complete penetration through the 
entire thickness of the LbL. In vitro tests were performed using HUVECs to assess 
their adhesion efficiency and their metabolic activity on the LbL with and without 
peptide immobilization, resulting in a preliminary improved activity when peptide-
combinations is used. Finally, PC micro-channels (µCh) were first developed and 
characterized, and the rest of the experiments were performed on µCh of 25µm 
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width, functionalized with (HA/CHI)12.5 architecture (PC-LbL) with RGD and QK 
peptides (PC-RGD+QK) or with RGD and SVV peptides (PC-RGD+SVV). Our first 
tubulogenesis experiment surprisingly showed the formation of tubular-like 
structures already after 2h of incubation using the double-peptides combination but 
only using PC-RGD+QK the tubes were present also after 3 and 4 hours of culture. 
The co-culture experiment with human pericytes derived from placenta (hPC-PL) 
demonstrates how the stabilization of the tubes was improved after 3 and 4 hours 
also for the PC-RGD+SVV sample. Globally our bio-functional material with PC-
RGD+QK and PC-RGD+SVV peptides allow the formation of tubular-like structure in 
both mono and co-culture experiment. 
 
Keywords: hot-embossing, surface functionalization, micro-channels, layer-
by-layer, bioactivity, human umbilical vein endothelial cells, human pericytes, 
peptides, capillary structure. 
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1. Needs for tissue replacement: The gold standards 
Traumas, injuries, and diseases can lead to the failure of our vital organs, leading 
to death unless properly replaced or regenerated. The always increasing population 
and aging lead inevitably to face an increasing number of traumas, degenerative 
diseases, and congenital abnormalities and disorders. Before encounter organ failure 
and death, the human body tries to find a solution to restore the architecture and 
the function of the damaged tissue/organ [1, 2]. This restoration is generally named 
tissue repair and it can follow two different mechanisms: regeneration or 
replacement (Figure I.1). Briefly, regeneration is the process in which the damaged 
tissue undergoes healing through the formation of newly-growth tissue which 
restores the damaged portion of the tissue until it returns to a physiological healthy 
state (Figure I.1) [2]. Instead, replacement is the process in which severely damaged, 
or largely damaged tissues are repaired by the formation of connective tissue, a 
process named scarring (Figure I.1) [2]. The type of mechanisms which body will use 
to heal the damaged tissue depends mostly on the size and severity of the damage, 
as well as the type of tissue. In fact, each tissue responds differently to damaged 
caused by trauma and injuries and certain tissues of the body contain a subset of cell 
population more active and capable of proliferation (which lead intrinsically to 
regeneration) than other tissues [3]. According to this difference in cellular 
proliferation capability, tissues can be divided into three categories: continuously 
dividing tissues, quiescent tissues and non-dividing tissues [2]. 
I. Literature Review 
 3 
 
Figure I.1 – Regeneration vs. repair: Schematic representation of the two processes of 
regeneration (left part) or repair (right part) depending on the severity of the occurred 
injury. 
Continuously dividing tissues contain a subpopulation of cells which are 
constantly proliferating to replace dead cells, termed as stem cells (Figure I.2). This 
peculiar type of cells has the capability to self-renew or differentiate. Self-renew 
mean that during the cell division, the originated daughter cell is identical to the 
mother cell under all aspects (genetic content, morphology, gene expression, and 
more). Differentiation is the process in which mother cell originate daughter which 
are different, generating multiple type of cells’ types (Figure I.2) [3]. According to the 
definition of stem cells, is now quite clear how the regenerative potential of a tissue 
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is directly linked to the proliferative capacity of those stem cells, as well as the variety 
of cells which they are able to generate from a single starting cell. Thinking about 
everyday life, there are few clear examples of those continuously dividing tissues 
such as skin tissue, in which dead cells of the skin are completely replaced every two 
weeks, or also the gastrointestinal epithelium [2]. 
 
Figure I.2 – What is a stem cell?:Schematic representation of the replicative potential of a 
stem cells. In fact a stem cell can replicate itself an undefined number of time, originating 
an identical daughter cell, or originate a different cell type after a process named 
differentiation. 
Quiescent tissues contain a subpopulation of cells which normally exist in a non-
dividing state, quiescent, but when certain stimuli are applied such as an injury or a 
trauma, the stem cells may enter the cell cycle again in order to regenerate the 
damage. Few examples of this type of tissues are liver, kidney, and pancreas. 
Thinking about liver tissue is well-known how the resection of a part of the liver, for 
donation purpose, for example, is capable of regrowth thanks to the massive 
proliferation rate of the remaining liver cells [2, 3]. 
Non-dividing tissues are composed uniquely of cells which permanently left the 
cell cycle process, and so unable to proliferate. An example of this tissue, with 
dramatic effect in case of injuries, is the cardiac and skeletal muscles. The only 
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mechanism in which these tissues will be normally healed is by the formation of a 
scar tissue, thus replacement mechanism [2], [4]. 
Even if some tissues preserve a good capability to self-regenerate themselves 
through the proliferation and differentiation of stem cells, this potential is very 
limited and all the tissues/organs once seriously damaged, or with severe 
pathological dysfunctions, will undergo to tissue/organ dysfunctions with 
devastating effects which can lead to death [5].  
One critical and largely studied tissue for regenerative capability improvement is 
the bone tissue [6]. Patients with defects in the bone structure, or with osteoporosis, 
or with arthritis, or with a bone infection, or with spinal fusion, or with a metabolic 
bone disease, or with osseous-related tumors like osteosarcoma are unable to use 
the self-regenerative properties of the bone itself to properly heal [7]. The bone loss 
and repairs have, still nowadays, a great impact on both clinical and economic 
importance. The non-union cases in the USA arrive at 100’000 fractures and the 
average cost of treatments is about 11’333 US dollars. In addition, the bone becomes 
more fragile and with reduced regenerative capability while aging, rising the senile 
osteoporosis up to 50% for women and 25% of men with more than 50 years [7].  
When the two mechanisms of repair are not sufficient to avoid tissue/organ 
collapse, in order to preserve the tissue/organ function, transplantation is one of the 
few possible solutions. Transplantation can be considered as the gold standard for 
organs substitution, especially in the case of bone, and the procedure consists in the 
replacement of a damaged organ or tissue with the same organ or tissue, provided 
by a donor. Transplantation is currently used as the first line of action to overcome 
this ever-increasing number of patients (Figure I.3) [1] [5]. 
Depending on the nature of the donor, three main categories can be identified: 
autograft transplant, allograft transplant, and xenograft transplant (Figure I.3). The 
difference between those approaches derives from the source of the organ or tissue 
to transplant [1] [7]. For the single case of bone transplantation, 2.2 million surgeries 
occur worldwide per year, mostly done by using autografts or allografts. This very 
large number of patients increases the complexity and the time required to have 
availability of such grafts and the medical care at the hospital [7]. 
 6 
 
Figure I.3 – Sources for tissues transplants: Schematic of the possible sources for 
transplantation indicating the autograft, isograft, allograft and xenograft.  
1.1. Autografts 
Autograft, named also autologous tissue graft, was the first approach used to 
successfully replace an organ or tissue. It consists of the extraction of a tissue or 
organ from one site to another, within the same individual [1]. Nowadays it is still 
considered the best approach for the reconstruction of most tissues or organs 
defects and is still used as the main control to compare the efficiency of other 
implantable biomaterials since autografts retain large masses of living cells and have 
all the required properties for new tissue development and structural reconstruction 
[5, 8]. Additionally to their success in tissue and organs reconstruction, autograft 
does not present any antigenicity since it comes from the patient’s own body.  
The use of autograft transplant, for bone tissue applications are largely 
investigated and practiced in regular base. In fact, as the first line of action for a bone 
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transplant, autograft present a success rate over 90% compared to other clinically-
available substitutes [5]. This high rate of autograft-transplant success is linked to 
the peculiar properties of the autograft tissue itself, which retains superior 
osteoinductive and osteoconductive properties [5]. Osteoinduction is a physiological 
phenomenon which implies the recruitment of immature cells which differentiating 
in osteoblast would induce osteogenesis (formation of new bone) [9]. 
Osteoconduction is the process in which new bone growth on the surface of a 
material, for example, a newly implanted bone substitute [9]. 
However, even if autograft presents a series of clinical benefits, the approach 
suffers from drawbacks such as unpredictable graft resorption which can be too fast 
or slow, limited availability, short-term viability because of stressful cellular 
conditions during and after transplantation, and most important a second surgery 
[5]. In fact, the harvesting procedure in order to collect the bone tissue from another 
site of the donor can induce pain, morbidity, and risk of postoperative complications 
such as infections [5]. Another important aspect, neglected in the past, is the 
importance of a vascular tissue in large graft surgery, in fact, in the best material 
conditions such as cancellous graft, the vascular response after the surgery can take 
weeks to completely revascularized the implanted bone in large animals model [5, 
10]. 
1.2. Allografts 
Allograft, named also allogenic tissue graft, was investigated as a potential 
solution to avoid the disadvantages of autografts in terms of morbidity and tissue 
availability of the donor/host [5]. Contrarily to autograft, the origins of those tissues 
or organs comes from another individual of the same species but with different 
genotype [1]. This important difference is, unfortunately, at the base of the tissue or 
organs rejection, which is the main risk and drawback for allograft transplantations. 
The rejection is mostly due to the response of the host’s immunity system against 
the allogeneic tissue graft, which plays a pivotal role in the tissue/organ integration, 
or rejection (Figure I. 4) [5]. However, the allografts transplants are always followed 
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by immunosuppressive medication to avoid an extensive immune rejection of the 
new tissue, and in addition to this, human leukocyte antigen (HLA) matching 
between donors and recipients is fundamental [5]. 
 
Figure I. 4 – Allografts and immune system: Schematic of the immune rejection between (1) 
the antibodies of the host and the cells of the donor which trigger (2) the classical pathways 
of complement activation which (3) lead to cellular-mediated cytotoxicity. From [11]. 
In the special case of bone allograft, the allogenic bone tissue grafts are cadaveric 
in origin and available from commercial vendors such as bone banks. Those type of 
grafts has been largely used in the field of reconstructive surgery when the autograft 
was not possible or available [5]. This approach removes completely the drawbacks 
of a second surgery and limitations of tissue availability in quantity and size. In 
addition, the product is ready-to-use and, theoretically, always available in the 
required sizes and shapes, matching the recipient constitutional elements and 
architecture of the original bone. Although, the complete absence of living cells into 
the tissue, to reduce the immune response of the host, provide a poor 
osteoinductive and osteoconductive properties. In addition to those problems, 
another one concern about potential infectious agents transmission, which can be 
minimized by strategies of tissues processing, sterilization and freezing that, 
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unfortunately, decrease even more the already poor osteogenic properties of the 
graft and reduce the mechanical strength of the original tissue [5]. To regulate the 
commercial of this allograft bone tissue, the food, and drug administration (FDA) of 
the United States develops a series of tissues process and medical screening that 
each material has to perform before the approach on the market. The medical 
screening concerns mostly about infectious diseases such as HIV-1, HIV-2, hepatitis 
B, and hepatitis C, while the tissue process applied are blood removal, freeze drying 
or gamma irradiations [5]. Using bone allograft, in comparison to bone autograft, the 
remodeling and revascularization are slow and inefficient, another drawback for a 
quick and rapid integration of the graft with the host’s tissue [5]. In this case, the 
bone transplant failure rate approaching 25%, mostly due to an inadequate 
revascularization and mineralization of the bone graft.[12] [13]. 
1.3. Xenografts 
Xenograft named also xenogeneic tissue graft consists in the use of tissues or 
organs acquired from another species than the final host. This procedure is the less 
common and less practice, however, it is possible to find few applications in which is 
currently used in clinics [14]. When the component to replace is small, and the 
transplant could decide the life of the patient, a xenograft can be used as the last 
option. From ancient Greek, Xeno indicates “foreign, alien”, and in this case, 
represents a tissue from an animal donor, to be implanted into a human patient. This 
approach presents severe implications for immune compatibility due to inter-species 
transplant but could save the life of the patient, which cannot wait any longer other 
donor-sources and would encounter death due to organ failure [14]. A major 
concern with animal-derived graft is the potential transmission of zoonotic diseases 
and prions infections which can lead to a more aggressive form of rejection and 
increase the morbidity of the patients [14].  
Similarly to allografts, xenografts lose partially their osteoinductive properties 
during the processing to counteract the strong antigenic properties, therefore 
xenografts produce poor clinical outcomes [14].
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2. Tissue engineering: the future of organs regeneration 
Even if the potential of the three described graft could save countless lives, the 
enormous imbalance between grafts availability and graft need, together with 
tissues/organ compatibility, push numerous patients in a waiting list, leading often 
to their death. 
Tissue engineering (TE) is the research field that aims to create biological 
substitutes which can restore, repair and replace damaged or diseased tissues and 
organs, resolving the problems related to availability and potentially being applied 
without compatibility or immune rejection issues. The term was first introduced back 
in 1988 at the national science foundation meeting at the Massachusetts Institute of 
Technology (MIT) during the keynote. Four years later, Vacanti J.P. and Langer R. 
published a work containing the first definition of TE: “Tissue engineering is an 
interdisciplinary field that applies the principles of engineering and the life science 
toward the development of biological substitutes that restore, maintain or improve 
tissue functions” [15 J.P. “Tissue Engineering.” Science (1993): 260, 920]. Figure I. 5 
show the TE cycle which corresponds in 5 different phases: first cells are extracted 
from the patients, expanded in culture conditions and seeded into a scaffold in the 
presence of growth factor and other small molecules to generate a tissue. Later the 
newly developed engineered tissue is extracted and implanted into the patients’ 
body. 
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Figure I. 5 - The cycle of tissue engineering:  Cells are extracted from the patient and 
expanded in culture. Later, cells are implanted into a scaffold with (or without) other growth 
factors to generate a tissue. Last the engineered tissue is extracted and implanted into the 
patients’ body. 
Most of the living tissues are composed of repeating parts, assembled together 
in a hierarchical way with a precise three-dimensional architecture and micro-
architecture. The possibility to reproduce those micro-architecture features and 
tissues functionalities have a huge interest in the fast-growing TE field [5]. Although 
the technology and knowledge nowadays do not allow us to develop complex organs 
de novo, more and more studies suggest that is possible to trigger the body’s innate 
(even if limited) capacity of regeneration, increasing the potential of tissues and 
organs regenerative cascade [5]. The potential of TE is not limited at only one type 
of tissue or organ but it could potentially lead to the regeneration of each tissue in 
the human body, however, even if in the modern medicine multitude of studies were 
performed in several tissues’ type, there is not easy access to achieving regeneration 
in clinics [5]. 
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Thanks to technological and knowledge progress and achievements, the original 
definition of TE nowadays can be defined as “a substance that is able, or has been 
engineered, to take a form which, alone or as part of a complex system, is used to 
direct, by control of interactions with components of living systems, the course of 
any therapeutic or diagnostic procedure, in humans or veterinary medicine”[5, 16] 
[17]. 
Biomaterials in TE play a fundamental role for a successful tissue integration and 
regeneration by the creation of a neo-tissue in vitro with similar or identical 
properties of the native body tissue. In addition to the structural properties, 
biomaterials are often used as a template/scaffold for cellular guidance, growth, 
differentiation, etc. together with in situ release of specific molecules, growth 
factors, chemokines, etc. to improve the regenerative potential of the scaffold in the 
damaged tissue. 
2.1. Biomaterial grafts and biocompatibility 
Biomaterial grafts differ from autograft, allograft, and xenograft since they are 
artificially or manufactured materials. In the past, but still, nowadays, the problem 
of a severe and persistent shortage of tissue and organs for worldwide 
transplantation persists. An innovative solution must be considered in order to 
decrease the number of people which populate the waiting list, which is ever 
growing due to population expansion and increased aging [5]. The goal of 
biomaterial design for tissue engineering application is to develop an engineered 
construct capable of both provide a three-dimensional microenvironment for 
cellular functions and guide the formation of the new tissue.  
Biomaterials must possess biocompatible surfaces to reduce or eliminate host 
responses. The definition of this term remains ambiguous in literature, with different 
possible interpretations and definitions. However, I will refer to the definition of 
Williams D.F. which for me better represents the complexes requirements that a 
biomaterial should possess: Biocompatible “refers to the ability of a biomaterial to 
perform the desired function with respect to a medical therapy, without eliciting any 
I. Literature Review 
 13 
undesirable local or systemic effects in the recipient or beneficiary of that therapy, 
but generating the most appropriate beneficial cellular or tissue response in that 
specific situation, and optimizing the clinically relevant performance of that 
therapy”[18]. Therefore, the materials used should provide a structural support for 
a predictable period of time (according to the tissues’ need) in order to ensure the 
formation and the maturation of the new tissue, even under stress conditions, like 
in the case of bone constructs constantly loaded by the body weight [5]. In addition 
to structure, the design of biomaterials should approximate the many critical 
features of the extracellular matrices of the healthy tissue counterpart, mimicking 
the myriad of cellular and molecular events and signaling which are involved in the 
regeneration of the tissue/organ. For this purpose, the combination of supporting 
materials, adequate cells and bioactive factors must be in harmony in order to 
promote the, natively limited, regeneration of the damaged tissues [5]. 
2.2. Limitation of large-size graft: vasculature 
importance 
Even if enormous steps have been made from the origins of tissue engineering 
until nowadays, many of those engineered tissues do not fully match the chemical, 
functional and structural properties of their native counterparts. This failure is 
certainly due to the complexity of the living organisms with their organs and tissues, 
and in addition to that, our knowledge and understanding of this complexity are far 
from being sufficient to understand the mechanisms behind tissues growth, 
remodeling and healing [5]. 
What is missing in all the previously presented procedure is an integration 
between the biomaterial developed and a functional vasculature network, pre-
installed into the device and ready to be linked to the patient’s circulatory system 
[10]. 
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3. Vascular network: physiological architecture and 
function 
In this chapter, we are providing a quick preview of the fundamental components 
of the complex circulatory system focusing on capillaries architecture, role, and 
physiology. The main differences between the three types of capillaries, the 
mechanism of oxygen exchange and the intimate connection between bone and 
blood vessels will be presented. 
3.1. Function and physiology of blood vessels 
The main function of blood vessels is to transport blood around the entire body, 
to properly supply each cell in the human body with oxygen and nutrients, removing 
at the same time the discarding products such as carbon dioxide and metabolite 
waste (Figure I. 6) [19]. 
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Figure I. 6 – Tissue-capillaries diffusion: Schematic representation of molecules exchange 
between the capillary vessels and the surrounding tissues with a particular focus in the 
maximum distance between two capillaries found in healthy tissues in order to avoid 
hypoxic conditions. From [20] 
As the general overview the blood is pumped from the heart to the lungs, through 
the pulmonary vein, to release the carbon dioxide and recharge with new oxygen, 
then it returns to the heart, through the pulmonary artery. From the heart, 
oxygenated blood is pumped in the rest of the body, through the aorta, other 
arteries and arterioles until it reaches capillaries. At the level of capillaries, the blood 
exchanges oxygen with the surrounding tissue and it collects CO2 and waste products 
which will be driven back to the heart through venules and finally veins (Figure I 7) 
[19]. From this general overview, it is possible to identify two distinct circuits: the 
pulmonary circuit and the systemic circuit.  
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Figure I. 7 – Vascular system in the human body: The blood is pumped from the heart to the 
lungs in which the gas exchange occur enriching the quantity of oxygen. Then the 
oxygenated blood travel back to the heart to be pumped to the system circulation through 
the intricate system of arteries. Later gas exchange occurs in the capillaries releasing the 
oxygen present in the blood and enriching it in carbon dioxide. Finally exhausted blood 
travel back to the heart through the intricated system of veins. From [19]. 
 
The different vessels type in the body differ for composition, but they share some 
structural features. For example, each blood vessel has a lumen, a hollow passage 
through the length of the vessel which allows the passage of blood, and in addition, 
almost all the vessels are composed of three layers: tunica intima, tunica media, and 
tunica externa. The tunica intima is located most internally, at the level of the lumen, 
and is made of a continuous layer of endothelial cells present in all the vessel’s type 
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in the entire cardiovascular system (Figure I. 8) [19]. The tunica media is located 
around the tunica intima and consists mostly of smooth muscle cells and connective 
tissues. Especially in arteries, but also arterioles, this layer plays a fundamental role 
in sustaining the high blood pressure pumped from the heart through an expansion-
contraction mechanism which regulates the blood flow, avoiding a pressure drop. 
Venules and veins preserve the tunica media but in reduced thickness and 
importance, since there are no variations in the blood pressure at this level (Figure I. 
8) [19]. Last, the tunica externa is a sheath of connective tissue made of collagenous 
fibers which plays two important functions in providing nutrients through the vasa-
vasorum and maintaining the vessels in their relative position thanks to the 
connection with surrounding connective tissue. Arteries and arterioles present a 
thinner tunica externa, compared to venules and veins (Figure I. 8) [19].  
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Figure I. 8 – Summary of artery and veins tunica: Detail of the three tunica layers on artery 
(A) and on vein (B). Histological sample of artery and vein (C). From [19]. 
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3.1.1. Capillaries 
Compared to the previously described architecture or larger vessels, capillaries 
are microscopy channels composed uniquely of the tunica intima and play the 
fundamental function of supply oxygen and nutrients to all the tissues in the body 
through an exchange process of gases and other substances between blood and 
surrounding cells, and interstitial fluid, a process called perfusion. Lumen diameter 
for capillaries is the smallest in the body and range from 5 to 10 µm making 
erythrocyte to squeeze during passage through. Globally the flow through capillaries 
takes the name of microcirculation. Depending on the size of capillaries, there might 
be some occasional smooth muscle cells, but mostly capillaries are composed of 
endothelial cells arranged to form the endothelium, surrounded by the basement 
membrane. In capillaries, the lumen can be formed by several cells bounded to each 
other and wrapped with a cylindrical orientation, or even formed by a single cell layer 
that wraps around and bound itself. Due to their fundamental perfusion function, 
the wall of capillaries must be leaky to allow gases and molecules to cross the 
endothelium and diffuse outside. According to their leaking characteristic, three 
types of capillaries can be identified: continuous, fenestrated and sinusoid (Figure I. 
9). 
 
Figure I. 9 – Differences between capillaries: Schematic representation of the three types of 
capillaries, indicating the peculiarity of each like the continuous basement membrane for 
continuous capillaries (left), the presence of fenestrations in the fenestrated capillaries 
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(center) and the intracellular gap with incomplete basement membrane in the sinusoid 
capillaries (right). From [19]. 
Continuous capillaries represent the most common type of capillaries present in 
the body tissues, characterized by a continuous and complete endothelial lining with 
tight junctions between endothelial cells. Those tight junctions normally would not 
allow passage of molecules, making an almost impermeable layer, however, in 
capillaries, those junctions are often incomplete, leaving some intracellular clefts 
which allow small molecules such as metabolic products, glucose, water, and 
hormones to freely be exchanged with the surrounding tissue. An exception of this 
leaking capacity is given by capillaries forming the blood-brain barrier, in fact, those 
capillaries do not present intracellular clefts and show a thicker basement 
membrane to prevent the exchange of nearly all substances (Figure I. 9). 
 
Fenestrated capillaries, in addition to the tight junctions and intracellular clefts, 
show pores that make them permeable to large molecules. Those type of capillaries 
is more common in the small intestine for nutrient absorption and kidneys for blood 
filtration. In those capillaries, the basement membrane is preserved as a continuous 
layer which surrounds entirely the endothelial cells (Figure I. 9). 
 
Sinusoid capillaries are the least common type of capillaries. They present the 
same characteristics of intracellular clefts and fenestration as the fenestrated 
capillaries, but in addition, they show large intracellular gaps and an incomplete 
basement membrane (Figure I. 9). Those large passages allow the passage of very 
large molecules such as plasma proteins and even cells. For example, after the 
formation of new blood cells from the bone marrow, those cells enter in the 
bloodstream through the large opening in those sinusoid capillaries, otherwise, the 
small pore of the fenestrated capillaries would not be sufficient to allow the passage. 
Another important organ that requires sinusoid capillaries is the liver. Large 
materials from the digestive tract and the sleep reach the spleen and are later 
processed. 
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3.2. Blood circulation, a combination of flow, pressure 
and resistance 
The movement of the blood through the vessels of the circulatory system is 
defined as blood flow and it is expressed in volume of blood per time. The blood flow 
is originated from the ventricles of the heart that, after contraction, eject the blood 
to the major arteries increasing the pressure. When the blood needs to cross all the 
small vessels of the body such as arterioles, capillaries, and venules it encounters a 
physiological resistance and the flow is slow down, phenomenon defined as 
resistance. Blood pressure is the hydrostatic pressure which blood exerted on the 
walls of blood vessels. [19] 
In order to maximize the nutrient and oxygen exchange, microvessels divide into 
numerous smaller branches increasing the total available area. The stasis of the 
blood flow, in those particularly small vessels with reduced pressure, is prevented by 
the Fahraeus-Lindqvist effect. In particular, the combination of repulsive charges 
between the blood cells and the wall in the capillary vessels, together with a thin 
layer of glycocalyx present on the endothelial layer [19]. 
3.3. Capillaries exchange 
The cardiovascular system is responsible for the circulation of gases, nutrients, 
wastes, and other substances. Depending on the size of those elements they can 
diffuse directly through the membrane of endothelial cells in the continuous or 
fenestrated capillaries, such as gases, lipids, amino acids, sugars, and ions (Figure I. 
10). Larger molecules like proteins in the blood plasma can exit through the great 
gaps of the sinusoids capillaries. Water, thanks to its properties can diffuse by 
osmosis in all the tissues [19]. The overall exchange between capillaries and 
surrounding tissue requires an efficient transport mechanism which is defined as 
bulk flow [21].  
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This important exchange exploits two pressures: the capillary hydrostatic 
pressure and the blood colloidal osmotic pressure. The first one represents the force 
that blood, confined within the blood vessels, exerts on the capillaries’ tunica intima. 
The second one represents the force that a different osmotic gradient exerts. Briefly, 
the high concentration of plasma proteins into the capillaries (which cannot cross 
the tunica intima due of their large size) attracts water by osmosis from the 
surrounding tissue as compensation mechanism [21]. Therefore those two forces 
play together to drive the two exchange mechanisms present in capillaries:  
-filtration occurs when the fluids move from the higher pressure in the 
capillaries to the lower pressure inside the tissues. 
-reabsorption occurring when the fluids move from the higher pressure in 
the surrounding tissues to the lower pressure inside the capillaries [21]. 
 
 
Figure I. 10 – Filtration and reabsorption in capillaries: Schematic representation of the 
effect of the pressure on the fluid homeostasis depending on the type of vessel, which 
regulate the capillary exchange in the tissues. From [19]. 
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3.4. Development of blood vessels: vasculogenesis, 
angiogenesis and vascular remodeling 
In human embryogenesis, heart began beating after 21 days post-fertilization and 
by the fourth week of development, the circulatory pattern is already established to 
allow an immediate supplement of nutrients, gases and remove the waste products. 
During the few weeks of vascular network development the blood vessels start their 
formation from the embryonic mesoderm, the cells’ precursors are termed 
hemangioblast and they later differentiate into angioblasts. This cell type originates 
both the blood vessels and the pluripotent stem cells responsible, later one, for the 
differentiation in elements which compose the blood. Those cells groups together to 
form the blood islands which later open up to develop the vessel lumen (Figure I. 11) 
[19, 22]. Endothelium generates directly from the angioblast of the blood islands 
while surrounding mesenchymal cells will differentiate into smooth muscle and 
connective tissues. This initial formation of de novo vessels is termed vasculogenesis 
and after, based on guidance molecules in the extracellular matrix, the specific 
differentiation in arteries or veins begin [23, 24]. As soon as the blood vessels start 
to develop, pluripotent stem cells begin to produce the blood components. Those 
spare blood islands generate, each, a vascular tube which later merges to the 
neighbors to generate the vascular network (Figure I. 11) [19]. The formation of the 
complex system of vessels thus does not start from one vascular tube which 
elongates to form all the network but starts from several different vascular tubes 
which merge together to create one network, complex and ramified. The formation 
of new blood vessels from the existing one formally termed angiogenesis, continues 
during the whole life of the human being, during the grow and develop [19]. In this 
case, the coordinated migration of endothelial progenitor cells (EPC) and pericytes 
(PCs), from the existing vascular bed, lead to their maturation and stabilization 
creating new vascular network [25]. Two are the purposed models for angiogenesis: 
capillary sprouting is the first one, and involve the migration of endothelial cells from 
the existing vessel to a new region without vessels in order to develop the new one. 
Intussusception is the second one, and consist in the split of a vessel into two smaller 
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vessels which now can remodel and develop independently [26-28]. Micro-vascular 
remodeling is a different process which occurs during the entire life of a person in 
the skeletal muscle after exercise activities, in the female menstrual cycle or in the 
pathological situation like inflammation, wound healing and tumors, responding to 
hypoxia conditions [29]. 
The important role is played by the umbilical vein, which carries blood rich in 
oxygen from the mother to the developing fetus directly into the fetus heart which 
has the function to pump it in its circulatory system. 
 
Figure I. 11 – Blood vessels development. Vasculogenesis occurring through the fusion of 
the blood island to develop the primary capillary plexus (left). Angiogenesis with the 
formation of new branches of an existing artery (right). From [30] 
3.5. The bone tissue: an example of intimate vessel 
integration 
3.5.1. The structure of the bone 
In the bone, arteries enter through the compact bone using a natural cavity called 
nutrient foramen to properly supply oxygen and nutrients to the spongy bone and 
the medullary cavity. Once blood is inside the spongy bone in the bone marrow 
cavities is later collected by veins, and those veins exit from the bone using the same 
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nutrient foramina as arteries used to enter (Figure I. 12) [19]. The marrow cavity 
presents a range of vascular niches which play the important role of bone growth, 
differentiation and the development of hematopoietic lineage depending also on a 
gradient of oxygen tension [31]. The vascular supply in the bone tissue enables 
efficient growth and regulate bone remodeling, which are not possible in the 
avascular cartilage [31]. In fact, direct impairment of blood supply is linked with 
reduced bone growth and problems in the repair mechanisms of the bone, with 
consequent bone loss and, at last, necrosis [31]. The intimate connection between 
bone and vessels can be appreciated also considering the hematopoiesis process, 
which briefly is the development of new blood cells components. In fact, the marrow 
in the bone is the responsible site where hematopoiesis occurs, thanks to 
mechanisms which are also regulated by the pressure of oxygen in the tissue [31]. 
Moreover, as soon as the new cells’ components of the blood are produced, they 
need to be perfused into the circulatory system through the sinusoidal capillaries. 
The vasculature in the bone tissue also provides an important role in the 
regeneration and healing process. A bone fracture, in fact, damages also the blood 
supply, resulting in a drop of oxygen level, and consequently hypoxia state, which 
triggers many signaling events for cells such as the inflammation process, prior to 
healing [31]. Last, the quality of vascular supply in bone tends to decrease during the 
aging, leading to pathological settings such as anemia, immobility, and bone loss 
[31]. 
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Figure I. 12 – Blood vessels and bone: Schematic of the intimate relationship between blood 
vessels on bone tissue with particular attention of the localization of the vessels. From [19]. 
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4. Microvascular tissue engineering 
The aim of this chapter is to review the most advanced (state-of-the-art) 
approaches and methodologies used to develop capillary-vessel structures. The 
focus will be given to the cellular component and the possibility to combine different 
cells, later in this chapter will discuss the different possible materials and 
composition which can be used to develop a properly defined and engineered 
supporting biomaterial. In addition, small molecules and factors will be reviewed to 
underline their potential to trigger cellular signals in the development of capillary 
vessels. Finally, the chapter will conclude with the two main procedures to develop 
capillaries using in vivo or in vitro approaches. 
4.1. Key-role of pre-vascularization: the future of large 
tissue creation 
Current status of vascular tissue engineering focuses mostly on the development 
of large diameters graft, to overcome death for cardiovascular disease (CVD)[32 
2016, 33, 34] Despite those prostheses for vascular bypass grafts are currently used 
clinically, the absence of capillary network remains a missing part of the vascular 
tissue engineering [10, 35] [29, 36].  
The importance of developing a functional capillary network into the engineered 
construct is fundamental when the size of such scaffolds is larger than a few mm3 in 
volume. Although largely ignored during the initial studies of tissue engineering, a 
major limitation for cell survival is the accessibility to oxygen and nutrients in order 
to properly perform the necessary metabolic activities [29, 37]. It is nowadays 
globally accepted that cells will encounter hypoxia and death when the closest 
capillary is further than 200 µm, which is the oxygen diffusion limit in living tissue 
[10] [29, 37],[38] [39]. As a consequence, the most successful engineered tissues 
produced nowadays, which can find a valid application in clinics, are based on the 
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constructions of thin layers such as skin, urinary tract, avascular cartilage and heart 
valves [40, 41] [42] [43] [44].  
Only recently, engineered tissues start to implement microvascular capillary bed 
in order to achieve a better integration after implantation in the body of the host, 
however, there is no a well-defined procedure which can be used to obtain reliable 
results widely applied for a large variety of tissues [10] [35]. 
In adults’ mammals, the body is physiologically capable to develop new 
capillaries, where required, within the tissues, regulating constantly the quantity of 
oxygen provided to each cell which is forming tissues and organs. Unfortunately, we 
are currently limited by technology, knowledge, and techniques for the development 
of complex and large scaffold, which would help the global health in replacing, 
repairing and restoring damaged tissue and organs.  
Before discussing more in deep about cellular, material and growth factors 
importance, we need to define some terminology which is largely used, but often 
with a small difference between definitions. The terminology linked to capillary 
vessels remodeling or regression is not well-defined in the literature (Figure I. 13), 
and each research group defines their personal definition about it. In my study, I will 
refer to the definition reported by Lokmic et al.: 
“ 
-Vascular remodeling is a process of reorganization of the engineered vascular 
network to achieve tissue homeostasis and maintain a fully functional construct. This 
process encompasses recruitment of pericytes and smooth muscle cells (SMCs) to 
the abluminal surface of the endothelial tubes (maturation) and at later stages a loss 
of individual blood vessels (pruning) of the microcirculatory network.  
-Vascular regression is a process of complete loss of all cellular and structural 
components of a microcirculatory network through programmed cell death 
(apoptosis) resulting in the death of all of the construct’s cellular components and 
loss of construct function.  
“ 
[45]. 
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Figure I. 13 – Capillaries remodeling: Schematic of mature vessel, immature vessel, 
angiogenesis and vascular regression. [46] 
Vascularization, applied for large tissue engineering constructs is an always-
improving field and the interest of the scientific community is growing every year 
more [47 Heinz Redl, 2019]. 
4.2. Cellular importance: the players 
4.2.1. Molecular perspective of cell signaling: cell 
adhesion 
In this part, the most important cell signaling pathways for the development of 
capillary networks are investigated. The first cell signaling event is the cellular 
adhesion, which always occurs between cells and the surrounding environment [48].  
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Adhesion can be briefly described as the capability of the cells to be stable in 
contact with the surrounding ECM through the cell’s receptor binding of the protein 
of the ECM (Figure I. 14). It has been demonstrated how cell adhesion is involved in 
the stimulation of other signals that regulate cell cycle, cell migration, cell 
differentiation, and cell survival [49]. The affinity between cell and substrate is 
fundamental in order to design and develop an optimal biomaterial for tissue 
engineering. In addition, cell adhesion plays a key role in cell communication and 
regulation, becoming essential for the development and the maintenance of a tissue 
[49]. 
 
Figure I. 14 – Focal adhesion in cells: Schematic representation of the main components and 
architecture of focal adhesion such as integrins, actin, vinculin, and talin. From [48]. 
To properly trigger cellular signals, extracellular or intracellular forces are 
transmitted through localized sites at which cells adhered to other cells or the ECM 
[49]. In eukaryotic cells, this adhesion is occurring through a list of possible receptors 
such as integrins family, immunoglobulins, non-integrin collagen, glycolipids, 
glycosaminoglycans, and glycosylphosphatidylinositol-linked [48]. The integrin 
family covers a very important role in cellular adhesion, and their interaction with 
ECM is the most investigated. Integrins are capable of bind the main component of 
ECM proteins which are collagen, fibronectin, and laminin. Once the binding occurs, 
integrins are activated and cluster together into a nascent adhesion. Integrins are 
attached to actin filaments, which are the tensile members of the cytoskeleton, 
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through focal adhesion (FA) complex; a highly organized cluster of molecules. The 
cytoskeleton has the structural role to hold the nucleus and preserve the shape of 
the cell. Integrins, responsible for the transmission of forces to the cytoskeleton, are 
capable of mechanotransduction through the FA proteins, connecting the integrins 
to the actin filaments forming the adhesion complex. The FA complex formation is 
important not only for the cell adhesion but also for cell migration, proliferation, 
differentiation and for tissue organization, maintenance, and repair (Figure I. 15) 
[49]. 
 
Figure I. 15 – Integrins activation during focal adhesion: Schematic representation of the 
intracellular receptors and the integrin connection. From the inactivated integrins, until the 
active form which would feel the extra-cellular forces and transfer the signal to the 
intracellular domain From [49] 
Two main mechanisms are reported to explain the cell adhesion, the first one 
describes the in vitro cell adhesion defined as passive adhesion, the second one 
describes the in vivo cell adhesion defined as dynamic adhesion [49]. 
During in vitro condition in static medium cultures such as the culture flask or the 
Petri dishes, cells adhere through a mechanism defined as passive adhesion. Cells 
undergo attachment and spreading with a morphological alteration of their structure 
driven by passive deformation and active reorganization of the cytoskeleton (Figure 
I. 16) [49]. When integrins bind to ECM proteins, Rho GTPase proteins are activated 
such as Rho, Rac, and Cdc42. This activation is later responsible for cytoskeleton 
regulation which induces cells to spread, migrate and control the formation of stress 
fibers which assemble in focal adhesion complex [49]. Three stages can be identified 
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during the process of static in vitro cell adhesion: cell body attachment to the 
substrate (Figure I. 16 phase I), cell body flattening and spreading (Figure I. 16 phase 
II), reorganization of actin skeleton and focal adhesion formation (Figure I. 16phase 
III) [49]. During phase I, the interactions between cell and substrate are mostly 
electrostatic, thus weak interaction. The force which regulates the contact between 
cell and substrate is due to sedimentation effect and the morphology of the cell 
retain the round shape typical of cells in solution. During phase II, there is a change 
in morphology with a decrement in cell height and increment of the contact area 
spreading beyond the projected area of the spherical-cell contact. In this case, the 
contacts became stronger via adhesive interaction mediated by integrins. During 
phase III, the spreading process is continuous and evolving together with the 
reorganization and distribution of actin skeleton of the cell body. At this stage, the 
cellular spread reaches its maximum and the adhesive forces are the strongest via 
formation of focal adhesion (Figure I. 16) [49]. 
 
Figure I. 16 – Cell adhesion phases in vitro conditions: Evaluation of passive in vitro cell 
adhesion intervention and stages. Phase I represent the initial attachment, phase II 
represents the flattening of the cells with initial integrins bounding and last, phase III 
represents the strongest interaction with focal adhesion formation and spread cell-
morphology. From [49] 
During in vivo conditions, the adhesion of cells to extracellular matrix is an 
extremely dynamic process because involves fluid flow such as in the blood 
circulation, when migrating cells from the bloodstream need to pass through the 
endothelial layer and penetrate into the surrounding tissue, in response to 
environmental cues such as tissue remodeling [49]. Also in this model, the cell 
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adhesion cascade and signaling involve three basic steps: selectin-mediated rolling, 
chemokine-triggered activation, and integrin-dependent arrest (Figure I. 17). Those 
three-phased together, from the rolling of cells to the endothelial surface until cell 
arrest, are generally named docking phase [49]. Molecules responsible during this 
stage of adhesion are cell-surface conjugates selectins, chemokines, and 
immunoglobulins. The signal cascade for adhesion is triggered from the moment in 
which the cell starts to roll on the vessel’s wall; molecular bonding between adhesion 
molecules must form rapidly, as well as break rapidly for cells to roll. The rolling cell 
are able to transduce those adhesive-braking signals from the receptors’ surface to 
the cell nucleus in order to induce morphological changes which would slow down 
the rolling speed of the cell until its complete arrest, a fundamental prerequisite for 
cell migration through the vascular endothelium to reach the underlying tissue 
(Figure I. 17) [49]. 
The second part of the overall process to allow cells penetrating through the 
endothelium to reach the surrounding tissue takes the name of locking phase (Figure 
I. 17). This phase occurs after the ex-rolling cell established stable bonds with the 
endothelial cells mediated by integrins bonds. During this phase cell adhesion 
became stronger and spreading occurs in a similar approach to the static conditions, 
followed by cellular crawling to migrate into the endothelial lumen. Once the cell 
reaches the designed place, transmigration occurs, which is the process in which the 
cell emigrate out of the vasculature penetrating between two endothelial cells, 
paracellular transmigration, or through one endothelial cell, transcellular 
transmigration (Figure I. 17) [49]. 
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Figure I. 17 – Cell adhesion in vivo conditions: Schematic of the two steps docking and locking 
of cell adhesion when flowing in the blood circulatory system. From [49] 
4.2.2. Molecular perspective of cell signaling: 
angiogenesis 
The second cell signaling event is specifically involved in the formation of vessels 
structure, named angiogenesis or tubulogenesis [35]. 
 
Angiogenesis is a complex process in which tissues or organs involve multiple 
cells, from the same type or from different types, which guide the development of a 
new vessel from the angiogenetic sprout formation until the vessel stabilization [35] 
[50-53].  
In the human body, blood vessels differ from each other depending on their 
cellular composition, their diameter size and the functions they need to perform. 
Regardless of those differences, all blood vessels share a common characteristic 
which is the presence of a hollow center region, named lumen. The process which 
induces the formation of this lumen is extremely efficient and allows endothelial cells 
to cope with the force applied by the shear stress of the turbulent blood flow [54]. 
During the initial part of the process, when supporting cells are not yet bonded to 
the external surface of the endothelial cells, the cell-cell interaction of endothelial 
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cells are capable of supporting the physical forces exercised. While the size of the 
diameter of the vessels seems to be determined genetically, the blood flow is 
essential for the regulation and the maintenance of this lumen diameter [55]. 
Depending on the inner diameter of the blood vessels, the impact falls on the overall 
blood pressure and the perfusion of nutrients [54]. 
It has been already investigated the potential mechanisms by which lumen and 
tubular structure could be formed in epithelial cells, in the specific, five mechanisms 
were purposed: wrapping, budding, cavitation, cord hollowing, and cell hollowing 
(Figure I. 18) [54]. 
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Figure I. 18 - Five mechanism of epithelial tubulogenesis. Wrapping, budding, cavitation, 
cord hollowing and cell hollowing. From [56] 
Wrapping consists of planar cells sheet which wraps to form a tubular structure. 
Budding in which a vessel sprout from a pre-existing tube. Cavitation where space is 
created by the elimination of the central part of the cells from cell-cell aggregates in 
spheres or cylinder. Cord hollowing where a cord or cylinder of packed cells creates 
a central space by changing the cellular shape. Cell hollowing in which individual cells 
create an intracellular space within them to create a luminal structure (Figure I. 18) 
[54]. Number studies suggest how three out of five mechanisms purposed are used 
I. Literature Review 
 37 
by endothelial cells during developmental or postnatal angiogenic events: budding 
cord hollowing and cell hollowing. A common feature among those mechanisms is 
the necessity of the EC to create a physical space within the three-dimensional ECM 
to invade it and form lumen and tube networks [54]. EC can assume their 
characteristic cobblestone shape along the walls of the generate space into the ECM, 
to later create a tight connection with the adjacent cells through intercellular 
junctional adhesion. Matrix metalloproteinases (MMPs) are proteins secreted by EC, 
able to cleave proteins of the ECM to locally degrade the environment. Those MMPs 
play a key role during the formation of the empty space in the ECM where after EC 
will migrate to develop later one a new vessel. The physical space created by MMPs 
before the EC migration have been termed vascular guidance tunnels and influence 
both EC motility and vascular remodeling [54]. 
Previous studies in culture using three-dimensional ECM, as well as zebrafish and 
knockout mice, shown how integrins-ECM interactions play a critical role during 
vascular formation especially in the regulation of cellular sprouting, lumen 
development and tube stabilization [54]. Among the integrins identified to be 
responsible for the formation of new vessels, it is possible to identify α1β1, α2β1, 
α4β1, α5β1, αvβ3, and αvβ5. The binding of those integrins activates a downstream 
signaling which induces phosphorylation of Src and FAK kinases, which contributes 
to the process for the formation of the lumen and it’s stabilization (Figure I. 19). 
Another important downstream path regulated by integrins is the Rho GTPases such 
as Cdc42 and Rac1, which regulate the endothelial cells’ cytoskeleton activity, 
resulting in a morphogenic response for lumen development [54]. Already from its 
early formation during embryogenesis process, the vascular lumen has to sustain a 
large variety of physical forces such as plasma and blood cells circulation. In 
vertebrates, the heart starts to beat before the vasculature network is fully 
remodeled, thus endothelial tubes must be enough stable to sustain the pressure of 
the pumped flow [54]. These forces, from the moment they are applied to the 
vasculature network, will trigger morphological changes in the EC for the 
cytoskeleton orientation and the cell-cell junctional complexes formation and 
stabilization. In fact, in absence of flow perfusion, vessels naturally regress and, on 
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the contrary, when the pressure applied is higher than physiological, vessels 
undergoes an enlargement [54]. 
 
Figure I. 19 – Intracellular cascade of cell migration: Schematic representation of the 
intracellular cascade triggered by ECM-integrin link which lead to cellular migration. From 
[57] 
Once the vasculature is newly-developed, a fundamental process takes place: 
vessel maturation. In this process, different cell types such as pericytes and vascular 
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smooth muscle cells are recruited to catalyze further remodeling events. 
Interestingly, some data suggest that during the maturation phase and the mural cell 
recruitment, genes involved in tube regression events are activated, without 
showing a visible regression in the morphology of the tubular structure [54]. 
4.2.3. Cell mono-culture: capillary formation 
The oldest and most used cells for in vitro testing regarding vascularization is the 
endothelial cell extracted from the umbilical vein in humans since their isolation and 
characterization in 1973 [58 1973]. Human umbilical vein endothelial cells (HUVECs) 
have been extensively studied and used in research, both alone or with other 
supporting cells, to achieve vascularization in vitro and in vivo conditions [59]. 
HUVECs show an average lifespan about 10 passages and in vitro culture conditions 
for about 5 months [58], after which cells enter in a senescence stage: their 
proliferation stop and they develop giant multinucleated cells to undergoes death as 
the final stage [60]. HUVECs isolation in the clinic is a laborious process and, as most 
of the primary cells, there are differences between the donor-to-donor batch. 
Nevertheless, HUVECs becomes one of the most used sources for vascular studies in 
the field of tissue engineering for both large vascular scaffolds development and 
micro-vascularization studies since they preserve nearly all of the native-vascular 
endothelium features, normally found in physiological condition [59] [61]. After 
decades of studies, since their first isolation, HUVECs played a critical role in the 
development of in vitro model which help the understanding of mechanisms related 
to angiogenesis and neovascularization, inflammation and hypoxia response in 
tumors and embryogenesis [62-64]. HUVECs monolayer has been used also with 
microfluidic chambers to mimic shear stress and blood flow in vitro, in order to 
reproduce the physiological conditions and study cellular signaling, gene expression 
and cellular behavior [61]. Both in vivo and in vitro conditions, HUVECs express 
specific endothelial markers such as von Willebrand factor and CD31, making 
possible their identification and isolation. In addition, HUVECs are capable to bind a 
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large set of growth factor including VEGF, FGF, TNF-alpha, and angiopoietins, thanks 
to the abundance of specific cellular receptors [61]. 
Raghvan et al. introduce a novel method to combine three-dimensional structure 
micro-channels with collagen matrix and endothelial cells in order to promote de 
novo endothelial tubulogenesis in vitro (Figure I. 20) [65]. They seeded endothelial 
cells into the micro-patterned channels previously filled with unpolymerized 
collagen, applying a centrifugation step in order to drive the cells into the channels. 
After, gelling of collagen was performed with incubation at 37˚C. 
 
Figure I. 20 – Endothelial cell seeding in micro-channels: Schematic of the method used to 
seed endothelial cells into the micro-channels previously filled with collagen. From [65]. 
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In their study, Raghavan et al. prove the self-assembled formation of tubular 
structure over 24h incubation with bFGF and VEGF, with the possibility to regulate 
the tube dimension using a combination of collagen concentration, channel width, 
and template pattern (Figure I. 21). Collagen was used at 1.3 mg/ml, 2.4 mg/ml, and 
3.3 mg/ml, while channel width was ranging from 50 to 244 µm with a height 
between 50 and 100 µm. In addition, their approach also allows removing the 
developed tubes embedded into collagen, retaining spatial organization to be, 
possibly, further used as a component for more complex composite three-
dimensional scaffolds for in vivo implantation [65]. Their studies investigated also 
the more complexes structure with a “T” or “Y” branch structure, showing after 48h 
incubation, a bifurcation of the endothelial cells to follow the channel design, and 
forming a lumen per each branch [65]. 
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Figure I. 21 – Single endothelial tube formation. (A) phase contrast images after 24h 
HUVECs-collagen seeding in 50µm width channel. (B) Fluorescence images of HUVECs (red) 
and BAMEC (green) cultured in 50µm width and 50µm tall channels. From [65] 
Sivarapatna A et al. established a microvascular platform based on PDMS to seed 
endothelial cells using microfluidic approach, studying the cellular gene expression 
change in response to shear stress to mimic in vivo physiological conditions [66]. The 
researchers were able to seed and growth HUVECs cells into the microfluidic 
platform up to 7 days of incubation, in micro-channels if about 200 µm in diameter 
developing intact microvessels in vitro (Figure I. 22) [66]. 
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Figure I. 22 – Capillary network development: Immunofluorescence analysis of micro vessels 
generated using HUVECs after 4 days of culture under regular flow, marked with endothelial 
markers like vWF (left) and VE-cadherin (right). Adapted from [66]. 
Since HUVECs shows a great potential for the scientific community, several 
studies were done to transfect those cells with viruses carrying specific plasmids, to 
modify the original genetic content of HUVECs and develop a prolonged life-span cell 
line [60, 67]. Afterward, immortalized cell line, developed through the fusion 
between HUVECs and other cancer cells, was developed to generate a stable cell line 
which could mimic the characteristics of the original endothelial cells, without the 
drawback of the limited expansion [60]. In a previous study of Zheng et al, HUVECs 
were cultured into a spatial-defined microchannels network within matrices of type 
I collagen (Figure I. 23). After 1-2 weeks, endothelial morphology and barrier function 
were investigated as well as the behavioral change of HUVECs when exposed to flow 
stress [68]. 
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Figure I. 23 – Continuous curved capillary structure: CLSM of endothelialized micro-fluidic 
vessels. (i) General overview of the network, (ii) detail of the corner of the network in three 
different view sections. (iii) 3D reconstruction of the branching section. From [68] 
The above-mentioned studies provide a more detailed understanding of the 
effort involved in the development of micro-vessels structures using an in vitro 
approach. However, according to the diameter size of each micro-vessel investigated 
so far, they cannot be classified as normal capillaries, but they can be defined as 
“giant” capillaries [69-71]. 
 
In a more recent publication Tsvirkun D. et al. developed micro-channels of 30-
40 µm height from PDMS, creating a microfluidic device which approaches closer the 
size of capillaries in the human body. Once the device was developed, micro-
channels were coated with fibronectin and later HUVECs were injected into the 
microchannel network in a pulse-wave manner for two consecutive days and 
cultured for two weeks, developing a continuous tubular structure inside the micro-
channels (Figure I. 24) [72]. 
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Figure I. 24 – Endothelial micro-tubular structure formation: Confocal images of HUVECs 
(green) from the top-, side, cross-section views and the 3D reconstruction. From [72]. 
4.2.4. Cell co-culture: vascular stability 
In physiological In vivo conditions, blood vessels and especially capillary vessels, 
are surrounded by perivascular cells which aim to stabilize and maturate the vascular 
structure. Pericytes (PCs) are perivascular cells already largely used in vascular tissue 
engineering and they present multipotential differentiation capacity (chondrogenic, 
myogenic, osteogenic, and adipogenic differentiation) expressing cell surface 
markers such as CD73, CD90, and CD105 [73] [74]. According to their characteristics 
in differentiation potential and cellular markers, Crisan et al. showed that PCs are 
the in vivo equivalent of cultured mesenchymal stem cells (MSCs) [75]. Therefore in 
my thesis, I will focus on the interest in PCs and their usage in literature for vascular 
tissue engineering applications. For more detailed information about the properties 
and functions of PCs in terms of cell isolation, culture and characterization methods, 
please refer to the review of Gökçinar-Yagci et al. [76]. Pericytes (also named as 
Rouget cells or mural cells) are perivascular cells that wrap around endothelial cells 
in capillaries and microvessels (Figure I. 25) [75]. 
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Figure I. 25 – Endothelial cells and pericytes in vivo spatial organization: Immunostaining 
image of Endothelial cells (CD34 +) forming a skeletal muscle small vessel (transverse 
section). Pericytes (CD 146 +) surround the structure. From [75]. 
Rouget described them in 1873 giving their initial name, and later in 1923 a 
German anatomist Zimmermann rename them as “pericytes” [77] [78]. In vivo 
physiological conditions, Pericytes can be found in capillaries, arterioles, venules, 
and also at the subendothelial region of large vessels [79]. Small blood vessels like 
capillaries are composed of endothelial cells surrounded by basal membrane, and 
PCs [76]. 
The newly developed vascular structures require a stabilization and perfusion in 
order to maturate. Stabilization occurs by the application of flow-mediated shear 
forces, mimicking the physiological conditions, in addition, the basement membrane 
is produced and PCs are recruited [76]. The precise order of sequences of those 
events is not clear and can vary according to different conditions but in mature 
vessels, pericytes are embedded within the endothelial basement membrane [26]. 
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In the field of micro-vascular tissue engineering pericytes are largely used since they 
are one of the main residents of small blood vessels and provide vessel stability [76]. 
The mechanism in which PCs are capable of stabilizing endothelial cells, like 
HUVECs, is not limited to a physical interaction between the two cells’ type but 
involves as well as several signaling pathways [76]. Important pathways involved in 
the interaction between those two cell types are Transforming growth factor β (TGF-
β) / activin-like kinase receptor (ALK5) [80], angiopoietin 1 (Ang1) / receptor tyrosine 
kinase of the Tie family (Tie2) [81, 82], and platelet-derived growth factor b (PDGF-
B) / PDGF receptor beta (PDGFR-β) [83]. Zheng at al. studied the interactions 
between endothelial cells and pericytes when added to collagen bulk to form a long 
and stable vessel sprout [68]. Studies demonstrate how, during the angiogenetic 
process, the absence of those cell-cell interactions due to the absence of supporting 
cells like pericytes leads to EC tube instability and regression [84]. An elegant 
experiment was performed developing a co-culture system between HUVEC and 
supportive cells grown in Matrigel, with and without direct contact between the two 
cell types. In both conditions, cells were able to communicate through soluble 
factors, but only in one case, the physical cell-cell interaction was involved. It was 
shown how the sample co-cultured without the physical cell-cell interaction was 
much less developed in term of capillary-like network formation [85]. The 
achievement of a stable co-culture system which would improve angiogenesis is not 
yet an easy task and the possible supporting cells such as pericytes, SMC not always 
lead to capillary network formation [86]. Co-culture experiments were performed 
trying to mimic the different type of tissues, such as in the case of engineered skin 
graft in which capillary network was introduced by co-culturing keratinocytes, 
dermal fibroblast and HUVEC on a 3D porous scaffold made of chitosan and collagen 
[51]. 
In the human body, the ratio between PCs and ECs differ from tissues to tissue 
ranging from 1:1 in the brain and retina, lower to 1:10 in skin and lung, and as low as 
1:100 in striated muscle [76] [87]. PCs gained with the years more and more 
attention because it was demonstrated their role in regulators of vascular 
development, stabilization, maturation, and remodeling such as stabilization of 
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blood vessels permeability, blood pressure control, vasculogenesis and angiogenesis, 
contractility of vessels tone, and repair processes [76]. 
Tourovskaia A et al. developed an in vitro model for brain blood barriers using a 
combination of HUVECs and PCs seeded into microtubular channels made of PDMS 
(Figure I. 26 A-C) [88]. They report a successful angiogenesis in which PCs were 
recruited to the ECs vessels in presence of VEGF gradient with increasing sprout 
length (Figure I. 26 D) [88]. 
 
Figure I. 26 - Angiogenetic studies on co-culture of HUVECs and PCs: (A) Immunofluorescence 
of HUVECs and (B) PCs with (C) merge of fluorescent signals. (D) determination of sprout 
length in presence or absence of VEGF for the co-culture system. From [88] 
Morin KT et al. developed microvessels in fibrin gels to study the fundamental 
interactions between cells and matrix as well as align the microvessels for tissue 
engineering purpose [89]. The results reported in their work demonstrated the 
ability of HUVECs and PCs to form fully interconnected microvascular networks in 
fibrin gel developing longer structures with longer average length. In addition, the 
type of media used influence significantly the recruitment of PCs (Figure I. 27). 
I. Literature Review 
 49 
 
Figure I. 27 - Immune fluorescent studies for co-culture: (A, B) of HUVECs (red) and PCs 
(green) co-culture and (C, D) monoculture of HUVECs in two different media compositions 
indicating recruited PCs (white arrow-head). (E) confocal z-stack of construct. Scale bars = 
30 µm. (F-H) quantification of micro vessels network properties in presence or absence of 
PCs. * p < 0.05. From [89]. 
Sudong Kim et al. developed a co-culture system into a single stromal cell culture 
channel filled with fibrin solution. Firstly, HUVECs were seeded using the microfluidic 
approach in endothelial growth medium-2, later PCs were mixed in fibrinogen 
solution and injected in the central channel. The incorporation of pericytes was then 
followed in the angiogenic sprout (Figure I. 28) [90]. They reported how after 4 days 
of co-culture, PCs were frequently found adjacent to the capillaries vessels with 
 50 
stretched morphology to cover the abluminal surface of endothelium. The particular 
detail of the pericyte’s adhesion to the endothelial-derived collagen IV basement 
membrane (Figure I. 28). 
 
Figure I. 28 – Co-culture immunofluorescence images: HUVECs (red) and PCs (green) 
developing microvascular network. Scale bar 50µm. (B) Confocal sections of pericytes-
decorated capillaries. Scale bar 20µm. From [90]. 
Moon et al. performed an experiment using a long time-lapse acquisition to 
follow the formation and the regression of capillary structure in PEG-hydrogels [91]. 
They investigated a monoculture of HUVECs and a co-culture of HUVECs with 10T1/2 
(4:1 ratio) in PEG-hydrogels (Figure I. 29) [91]. 10T1/2 is a clonal mouse embryo cell 
line with multipotential [92]. For the monoculture investigation, they found how 
HUVECs were forming large clusters after 5 hours, then organizing in the primitive 
tubule-like structure after 21hour stable up to 50 hours. At later time-points 
between 53 and 69 hours, however, the structure lost their tubular morphology and 
rapidly regressed to form again the initial cluster (Figure I. 29). Contrarily, the co-
culture experiment reported a rapid organization of tubule-like structure between 
21 and 37 hours which were maintained stably even at later time-points of 52-69 
hours (Figure I. 29) [91]. 
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Figure I. 29 – Time-lapse confocal microscope HUVECsCellular interactions in hydrogels 
encapsulated with either A) HUVECs only or B) HUVECs and 10T1/2 cells were visualized over 
about 70 hours with time-lapse confocal video-microscopy. A) In HUVECs mono-culture 
conditions, tubule-like structures initially formed by cells failed to maintain their networks 
and quickly regressed after about 50 hours of encapsulation in hydrogels. B) Tubule-like 
structures formed in co-culture conditions maintained their morphologies throughout the 
time-lapse experiments. From [91] 
 
Andries D. van der Meer et al. developed microfluidic channels in PDMS to 
demonstrate the potential of blood-vessels-on-chip [93]. In their studies, they 
developed a three-dimensional construct inside a microchannel by injecting a 
mixture of HUVECs and PCs with collagen type I into PDMS channel of 500µm width, 
120 µm height and 1 cm length (Figure I. 30). After 12 hours cells were capable to 
organize themselves into a single tubular structure with a bifurcation. In addition, 
they demonstrate how the inhibition of the TGF-B pathway lead to disruption of 
normal vascular development with defective angiogenesis (Figure I. 31) [93]. 
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Figure I. 30 – Microfluidic structure for endothelial seeding: (A) Schematic representation of 
the microfluidic device with indicated measures. (B) Bright field image of cell suspension 
inside the microchannel after 1h of seeding. From [93] 
 
Figure I. 31 - Organization of PCs and HUVECs in presence of inhibitors: (A) brightfield 
microscopy and in (B) confocal microscopy in the presence of TGF-B inhibitors and the 
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control sample. Scale bar 100 µm, dashed lines denote the sections in the respective planes, 
arrow denotes lumen in control structure. From [93]. 
More recently Zhang et al. Investigate a coculture system using a home-made 
scaffold which they term AngioChip. This AngioChip presents a symmetrical 
bifurcation of micro-channels which can be connected to a pump to provide a regular 
flow (Figure I. 32). The micro-channels were firstly seeded with EC using microfluidic 
approach, and later supportive cells were seeded on top of the micro-channels. The 
smart approach consists in the fabrication of micro-pores in the micro-channels, 
which allow the two cells type to communicate through specific factors (Figure I. 32). 
Later the chamber is sealed using a biodegradable gel system. The authors report 
how this approach provided no delay for the tissue endothelialization since the 
endothelial coverage was achieved within one day after perfusion. In addition, 
paracrine signaling between the two cells type can be sustained thanks to the 10-
20µm pores present on the micro-channels (Figure I. 32). In summary, the AngioChip 
was successfully used for in vitro and in vivo studies to generate a hepatic tissue 
model with a precise three-dimensional structure allowing a direct anastomosis to 
the host vasculature [94]. 
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Figure I. 32 – AngioChip microfluidic studies: (Top left) Schematic of a part of an AngioChip 
tissue with particular attention on the co-culture system without direct contact but micro-
holes connections. (Top right) Schematic of the assembly of the bioreactor and the assembly 
of vascularized tissue. (a-d) Immunostaining HUVECs (red) of the internal vasculature after 
2 days of culture. (a) a view of the entire network (b) a view of a corner and (c) a straight 
segment and (d) a branch. Scale bar 100 µm. Adjusted from [94]. 
4.3. Biomaterials: more than just a supportive element 
The basement membrane produced by endothelial cells (EC), in physiological 
conditions in the human body, is composed of several molecules such as laminins’ 
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family, collagen IV, heparin-sulfate proteoglycans and nidogen. Altogether, these 
molecules play the important role of communication with the EC to induce 
proliferation, migration, differentiation, maturation, and adhesion [95]. Migration of 
EC during angiogenesis is driven by a well-known peptide motif sequence: arginine-
glycine-aspartate (RGD). The binding of this motif sequence through integrin 
receptors, present on the EC membrane, results in modification of cellular shape and 
behavior [96]. In addition, some ECM proteins are able to interact and bind 
angiogenetic factors such as VEGF-A and FGF-2, providing a signaling-reservoir which 
trigger angiogenesis in the migrating EC [97, 98]. 
In tissue engineering field, the biological substitutes, which aim to support the 
seeded cells and guide them through biological function, are generally termed 
scaffolds or biomaterials [45]. Biomaterials play a key role in the engineered tissues 
constructs, in fact they serve as scaffolding to support the cells but also the 
mechanical properties of the tissue/organ to replace, they serve as reservoir for 
molecular signaling thanks to growth factors absorption or grafting, they serve to 
trigger signals to the cells in order to guide them through one intracellular pathway, 
or another.  
In this sub-chapter, we will investigate the different materials largely used in 
vascular tissue engineering and the importance of their microscopical structures. 
4.3.1. Naturally derived biomaterials 
Natural biomaterials present the peculiar characteristic to resemble the native 
extracellular matrices of tissues, such as good bioactivity, biocompatibility and, 
tunable biodegradation. In order to preserve their original characteristics of natural 
biopolymers, they are often processed using aqueous solutions and environmental-
friendly methods [5]. It is critical to avoid any release of cytotoxic products which 
could alter the delicate equilibrium of cellular and molecular signaling. Upon the real 
application in the complex biological systems, those biopolymers and their 
degradation by-products must be tested to verify the absence of harmful products 
and signaling [5]. Since natural biomaterials contain epitopes which can be 
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recognized and bounded by cells during their activity, they possess the innate ability 
to promote biological recognition which improves radically the functionality and 
regenerative properties of the final implantable device [5]. This class of biomaterials 
can be further divided into two larger groups, according to shared common 
properties: protein-based biomaterials and polysaccharide-based biomaterials. 
 Among the naturally derived biomaterials, and specifically in the polysaccharide-
based biomaterials, it is common to find polyelectrolytes which are a macromolecule 
containing both cationic and anionic groups. Some of those polyelectrolytes are 
directly extracted from animals or derived from animals’ components as reported by 
those two important examples of polyelectrolytes largely used in TE field: chitosan 
(CHI) and hyaluronic acid (HA). 
Chitosan (CHI) is a natural-derived copolymer, originated from chitin (poly(N-
acetyl-D-Glucosamine) by partial de-acetylation of the D-glucosamide groups (Figure 
I. 33). Chitin, the precursor of chitosan, is widely distributed in nature and it is the 
most abundant polysaccharide in nature, after cellulose. It was firstly isolated from 
fungi and later from beetle insects. However, nowadays the main sources of chitin 
are the crustaceans wastes of the fishing industry [99]. Chitin is not naturally present 
in the human body, nevertheless, it was proved how this would induce only a 
minimal immune response when implanted in other animals [100]. 
The biological properties of Chitosan are associated to its solubility in water and 
other solvents. Above pH 7 chitosan remains insoluble in aqueous solutions [101]. 
However, in the presence of a little amount of acid, the amino groups are 
protonated, facilitating the solubility of the macromolecule [101]. The pKa of its 
primary amino groups depends on the deacetylation degree, as well as its solubility 
[101]. 
It was investigated in several studies, how the two monomers of the CHI 
copolymer behave differently in terms of biodegradability. In fact, while the de-
acetylated residues of CHI are non-degradable, the acetylated residues can be slowly 
degraded by the action of lysozyme and other catabolic enzymes (Figure I. 33) [102]. 
The secretion from the body, via the kidney, works when the resultant fragments are 
smaller than 30 kDa, and thus soluble [103]. Previous studies demonstrate how a 
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change of deacetylation degrees from 60 % to 70 % can drastically change the 
leftover of implanted CHI film from < 5 % to > 90% respectively, after 12 weeks 
implantation in vivo by a subcutaneous implant in the back of rats [102]. This 
suggests that using a batch of CHI with de-acetylation degrees <60 % would allow a 
complete clearance of the degraded chains of CHI from the body [103]. 
 
Figure I. 33 - Chitosan chemical structure. Notice the acetylated monomer on the left, and 
the deacetylated monomer on the right, in which an acetyl group was removed. From [104]. 
Hyaluronic acid (HA) is a copolymer, which alternates glucuronic acid and N-
acetyl-D-glucosamine and is a major constituent of the extracellular matrix, present 
in many tissues in the body such as vitreous humor and synovial joint fluid (Figure I. 
34) [105]. The pKa of its carboxyl groups are around 3-4 and, therefore, at 
physiological pH (± 7) these groups are negatively charged [106]. HA is known to be 
non-adhesive for most proteins and so, represent an ideal material to be used 
natively or chemically modified [103]. Those characteristics make HA extremely 
attractive for various technologies concerned with body repairs such as wound 
healing [107], drug delivery [108] and visco-supplementation [109]. HA presents 
several advantages for tissue engineering applications such as biodegradability, 
biocompatibility, and bioresorbability and, moreover, HA is involved in the wound 
healing process, providing faster healing [105].  
The appealing properties of HA, makes it largely used in tissue engineering, 
especially after chemical modification, easily performed thanks to the alcohol and 
carboxyl group present in each monomer. Several routes of chemical modification 
 58 
are possible, such as esterification, hydrazide modifications, glutaraldehyde 
crosslinking, auto-crosslinking, and carbodiimides chemistry. In this last case, the 
crosslinking occurs via formation of anhydride on the polysaccharide through 
reaction with neighboring carboxyl groups, and this anhydride then reacts with 
nearby hydroxyls to give both inter- and intramolecular cross-links. In some studies, 
HA was crosslinked using EDC to enhance mechanical stability [110 Watson, & 
Cameron, 2010, 111]. Even when physicochemical properties of the new HA-based 
scaffold change, depending on the chemical change, most of the resulting derivate, 
retain the biocompatibility and biodegradability of the native HA [105]. 
 
Figure I. 34 – Hyaluronic acid monomeric structure. 
Those two polyelectrolytes can be used, not exclusively alone, but also in 
combination with each other and thanks to the electrostatic charges present on 
those two polyelectrolytes, is possible to deposit them in alternate way, in a process 
generally termed layer-by-layer deposition (LbL) to functionalize surfaces and make 
them (more) biocompatible [112-116]. Briefly, the technique involves the initial 
deposition of the polyanion, negatively charged species and, after several rinsing 
steps, the deposition of polycation, positively charged species [117]. The 
electrostatic interaction between those two species can be controlled and tuned 
thanks to the salt concentration used to dissolve them, the pH, the temperature and 
the deposition time [118, 119]. Polyelectrolytes growth in mass and thickness was 
found to follow either a linear equation [120, 121] or an exponential equation [122, 
123] depending on the nature of the polyanion and polycation (Figure I. 35). 
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Figure I. 35 – Studies on polyelectrolytes LbL growth: (A) Evolution of the polyelectrolytes 
film thickness (dA) for PEI-(PSS/PAH)i or PEI-(PGA/PLL)i. PEI: polyethylenimide, PSS: 
poly(styrenesulfonate), PAH: poly(allylamine hydrochloride), PGA: by poly(L-glutamic acid), 
PLL: poly(L-lysine). From [124]. (B) From Polyelectrolytes LbL film growth in linear or 
exponential manner, depending on the strength of interaction between the 
polyelectrolytes. From [125]. 
The combination of HA/CHI can be found in several biomedical applications such 
as guided tissues regeneration in periodontal applications [126], drug delivery [127], 
protein adsorption [128], cartilage tissue engineering [129], bone tissue engineering 
[130], or also microchip reactor for enzyme immobilization [131]. It was shown that 
HA/CHI deposition of about 20 cycles can reach the thickness of 10µm or more [119]. 
The deposition of the two alternate polyelectrolytes can be performed in an 
automatic manner using a dipping machine (Figure I. 36). Briefly, the preselected 
material is firstly dipped into the first polyelectrolyte solution and automatically 
rinsed several times, before the application of the second polyelectrolyte. 
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Figure I. 36 – Layer-by-layer assembly: Schematic representation of the LbL assembly 
through an automatic dipping machine, divided in 4 main parts. Part 1, deposition of the 
first polyelectrolyte in this case Chitosan. Part 2, rinsing in NaCl solution to remove the 
excess. Part 3, deposition of the second polyelectrolyte in this case hyaluronic acid. Part 4, 
rinsing in NaCl solution to remove the excess. Gently provided from [126 and João F. Mano. 
"Biomimetic polysaccharide/bioactive glass nanoparticles multilayer membranes for guided 
tissue regeneration." RSC Advances 6.79 (2016): 75988-75999.] 
4.3.2. Synthetic biomaterials 
On the other hand, synthetic scaffolds can be tuned to provide the desired 
biological functions such as vessels ingrowth, depending on chemistry, pore size, 
density, and interconnectivity [132, 133]. A disadvantage of some of those scaffolds 
is given by the degradation rate and the formation of toxic by-products during the 
break down of the polymeric chains [134]. It was shown how the fast degradation of 
poly d, l-lactic-glycolic acid copolymer (PLGA) negatively affects cell viability and 
migration due to significant acidification of the local environment during to polymer 
degradation [134].  
Synthetic biomaterials can trigger a biological response, defined as the foreign 
body reaction. During this process, macrophages and foreign body giant cells 
develop a fibrotic tissue which surrounds the implanted material, negatively 
influencing its functionality in patients, with the undesired outcome, in some cases, 
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of device failure [135]. The foreign body reaction represents the end-stage of the 
inflammatory wound dealing process, occurring after implantation of medical 
devices, prosthesis or materials [135]. The interactions between macrophages and 
foreign body giant cells with the synthetic material’s surface play a role in modulating 
this inflammatory event [135]. The formation of fibrotic tissue all around the 
implanted material can, therefore, impair microvasculature formation and further 
development of the tissue [136-138]. Polytetrafluoroethylene (PTFE) membranes of 
various pore sizes were tested and implanted subcutaneously in rats resulting in the 
development of thick fibrotic tissue, typical of a foreign-body response when the 
pores size were below 5 µm in diameter [138]. 
Thermoplastic polymers were developed more than 80 years ago, and their usage 
nowadays became part of the routine life. Those materials start to be used also in 
the tissue engineering field as a template or scaffold materials, such as Polyethylene 
terephthalate, Polycaprolactone, and Polycarbonate. This last polycarbonate 
polymer was firstly synthesized at the beginning of 50's from the union of a carbonic 
acid with symmetrical aromatic 4,4 dihydroxy diphenyl (Figure I. 37) [139]. 
 
Figure I. 37 - Chemical structure of Polycarbonate: the two units which compose the polymer 
are represented; bisphenol A and carbonate.  
This polymer is not soluble in aqueous solutions, but it is highly soluble in organic 
solvents such as dichloromethane. Key-characteristics of this material is the optical 
transparency to possibly work with cells and visualize them. In addition, it is resistant 
to reagents, it is mechanically and thermally stable and moreover, it can be used 
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easily for molding process like hot embossing. The glass transition temperature of 
this polymer is around 140-150˚C and its capacity to absorb water is nearly zero 
[139]. Thanks to its transparency, resistivity, durability, and plasticity during the 
molding process, PC acquired an immediate interest for different applications. One 
example is the capability to transform the PC into a micro-reactor. Their small size 
and high control over parameters such as temperature, pH, salt solution and flow 
speed allow those micro-reactors to develop an efficiently biochemical reaction, 
otherwise impossible in the normal industrial processes. PC during the years was 
successfully functionalized with proteins [140] and nucleic acids [141]. In the work 
of Ogonczyk D et al., alkaline phosphatase enzyme (ALP) was immobilized into the 
capillaries of polycarbonate, and enzymatic reaction was followed for several days 
to evaluate the stability of the immobilized enzyme over time at different flow rate 
speed (Figure I. 38) [140]. The recorded absorbance shower how the enzyme was 
successfully immobilized onto a polyethyleneimine (PEI) layer through carbodiimide 
chemistry and stable up to 27 days (Figure I. 38). For more detailed works about the 
use of microfluidics for cell isolation and other biomedical application please refer to 
this review [142]. 
 
Figure I. 38 – Stabilization of immobilized proteins: Characterization of stability of ALP 
enzyme when immobilized in PC capillaries under constant flow rate. From [140]. 
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4.3.3. Hybrid materials 
To ameliorate the cellular function and improve the control over the material 
degradation, hybrid scaffolds composed of both natural and synthetic materials 
were developed. Those materials often incorporate angiogenetic proteins [143] or 
peptide sequences [144-146]. Incorporating those factors results in a bio-recognition 
of the material from the body, avoiding the foreign body reaction effect and 
improving cell migration and growth [45]. Recent studies were done combining 
synthetic Polydimethylsiloxane (PDMS) and natural Collagen to develop 
microchannels [147, 148]. In the study of Alimperti S. et al., they fabricated micro-
channels of 160µm diameter, made of PDMS coated with collagen type I to study the 
endothelial cells barrier integrity. Combination of HUVECs and human kidney 
pericytes was used or HUVECs with human bone marrow stromal cells (HBMSCs) 
[147]. Costa PF et al. developed instead one micro-channel of 700-800 µm diameter 
with a narrow constriction in the middle, to study arterial thrombosis. Channel made 
of PDMS was later coated with rat tail collagen type-I and finally, HUVECs were 
perfused in the microfluidic system for two days to ensure confluent monolayer 
[148]. Another study for atherosclerotic plaque formation was done using a 
combination of PDMS and vWF/fibrinogen [93]. In this study, they developed 
microfluidic chips from PDMS using parallel micro-channels of 300µm width and 
52µm height and later immobilized vWF/fibrinogen. In addition, HUVECs were 
seeded into the precoated micro-channels and stenosis formation was investigated 
[93]. 
4.3.4. Surface chemistry: biochemical and physical 
modifications 
Besides bulk properties, the control of the properties of the biomaterial surface 
used for medical applications is a key point. So, biomaterial surface is often modified 
with biomolecules that can stimulate different intracellular pathways in the cell, such 
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as adhesion, migration, growth, differentiation, angiogenesis and much more. The 
activation of these pathways depends not only on the type of biomolecules that is 
adsorbed or grafted on the surface of the biomaterial but is also strongly related to 
the quantity and density present on the surface.  
The native extracellular matrix is a mixture of macromolecules self-assembled 
together, mostly composed of collagen proteins, glycoproteins, hyaluronan, and 
proteoglycans [149]. Like the ideal biomaterial should be, the ECM serves as a 
scaffold for cells, reservoir of growth factors and cytokines, and provide structural 
strength to tissues maintaining the intricate architecture around the cell and the 
shape of organs. The aim of the tissue engineering filed is to transfer the 
characteristics of the physiological ECM into the biomaterials, controlling the 
environment for cells in a precise way [150-152]. 
 In order to mimic the ECM environment, biomaterials’ surface has been modified 
with a large variety of substances from the inorganic molecules to short peptides or 
complex proteins, tuning the cellular behavior. Coating of the biomaterials’ surface 
before introducing the cellular component can increase significantly cellular 
adhesion, increasing the biocompatibility of the material [152]. Usage of natural 
proteins extracted from the ECM is a smart approach for the biomaterials’ surface 
coating. However, sometimes the use of large proteins can be complicated due to 
the laborious and long procedure for their extraction from the ECM and purification 
with the high risk to alter the native conformational state of the protein itself [153, 
154]. In fact, proteins are macromolecules with a defined three-dimensional 
structure which is fundamental for cellular-receptors recognition and binding. When 
the three-dimensional structure of a protein changes from its native state to an 
aberrant state, the process is defined as denaturation [153, 154]. Denaturated 
proteins lose their capability to bind cellular-receptors and thus to perform any 
biological function for the cell. When instead the sequence of the protein is altered 
due to sequence breakage, the process is named degradation [155, 156]. Proteins 
denaturation and degradations are an important drawback to consider during the 
development of a biomaterial, in fact, the process of integration of those 
macromolecules into the biomaterial, maintaining the native proteins’ structure can 
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be challenging. In addition to this point, when a protein is covalently bonded to the 
biomaterials’ surface is fundamental to provide the proper orientation, which would 
not affect the functionality of the protein in binding the cellular-receptor. As results, 
a precise control over protein dynamics can be extremely difficult. 
A valid alternative solution to large macromolecules like proteins can be the 
usage of small and stable oligomers, named peptides. A peptide is a small molecule 
which reproduces the binding site, defined epitope, of larger proteins [157-159]. This 
allows scientist to use more stable molecules than the proteins, without affecting 
the biological recognition between epitopes and cellular-receptors. In addition to 
their stability during the biomaterials’ surface functionalization, peptides can be 
easily synthesized with a moderate cost, can be easily characterized, present a slow 
enzymatic degradation, and in lyophilized conditions are extremely stable for 
transport and storage purposes.  
In order to biofunctionalize the biomaterial’s surface to enhance the overall 
material properties, several techniques are commonly used. The most simple but 
also least stable is the physical adsorption of biomolecules, such as peptides. In this 
case, the surface functionalization is performed by dipping the material into a 
peptide solution in order to allow a physical interaction between the materials’ 
surface and the biomolecules in solution and allow their deposition [160, 161]. Since 
the forces of interaction in this technique are weak, environmental conditions such 
as temperature, pressure, pH, ionic strength and concentration must be stable and 
properly adjusted. Any change of those conditions might easily cause a molecules 
desorption and system instability.  
When molecules are covalently immobilized to a surface they acquire the 
advantages to be more stable to environmental modifications and they are more 
stable over a longer period of time [161]. Several routes are possible in order to 
create a covalent bond between the molecule of interest and the biomaterials’ 
surface. However, a common route, largely used for peptides grafting, consists in the 
use of carbodiimide chemistry (Figure I. 39).  
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Figure I. 39 – Carbodiimide chemistry for peptides immobilization: General representation 
of the chemical reactions which occur between the molecule-presenting carboxylic group 
“1” and EDC to generate an unstable product. Later Sulfo-NHS will react with this unstable 
form to generate a stable ester that can react with the amine group of the molecule “2” in 
order to create a newly and stable amine bond linking molecule “1” and molecule “2”. From 
[162]. 
This route involves two chemicals: 1-Ethyl-3-(3-
dimethylaminopropyl)carbodiimide (EDC) combined with N-Hydroxysuccinimide 
(NHS) or N-hydroxysulfosuccinimide (sulfo-NHS). In the specific, the carboxyl group 
on the materials’ surface reacts with EDC to form an unstable intermediate (Figure I. 
39). Upon reacting with NHS (or sulfo-NHS), a more stable amine-reactive 
intermediate is formed (Figure I. 39). Finally, this intermediate is coupled to the 
amine groups found on the peptide group, finalizing the immobilization process 
(Figure I. 39). Previously in our group, carbodiimide chemistry was largely used to 
covalently graft peptides on to polyethylene terephthalate (PET) surface after a 
hydrolytic/oxidative step to increase the number of carboxylic groups [163-169, 170 
2013. 3, 171 2009., 172 2010]. 
Many other methods of immobilizing biomolecules on materials’ surfaces are 
reported in the literature, and each of them, according to the conditions of reaction 
or the reactive group used, present advantages and drawbacks [173] [174]. Methods 
used include the biotin-avidin system, click chemistry and 3-
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aminopropyltriethoxysilane (APTES). For a larger list of biomolecules immobilization 
methods, please refer to more detailed publications [173, 175] [176]. 
4.4. Small molecules: the signaling messengers 
4.4.1. Growth factors 
Growth factors are an important category of small molecules with a powerful 
effect. They can play the important role of initiators of vascularization process, and 
so, they have been largely used both in vitro and in vivo [177, 178]. In the body, they 
are able to activate endothelial progenitor cells (EPC) and guide their migration 
through gradient effect, based on the modulation of their concentration in the 
tissues. In addition, growth factors can guide cell assembly, the formation of new 
vessels and finally the stabilization of the tubular structure to preserve the shape 
and the function over the time, in a process termed vessel maturation [20]. 
To solve the instability problem of growth factors, due to their short-life, new 
materials were designed in order to preserve the growth factor functionality and at 
the same time allowing a slow-rate delivery strategy. Biomaterials with a different 
rate of biodegradability, thanks to natural or synthetic polymers characteristics, can 
be used to entrap the growth factors protein within the scaffold, and release them 
in a time-dependent manner, according to the biodegradability of the material [179-
181]. Examples of those slow-rate-release materials are the encapsulation of growth 
factors in poly(lactic-co-glycolic acid) (PLGA) [182, 183]. Another innovative 
approach to constantly supply growth factor to the system, is the usage of 
transfected cells which overexpress angiogenic factors, like in the work of Geiger et 
al. in which mesenchymal stem cells (MSCs) transfected with VEGF plasmid, can 
provide significantly enhanced vascularization and osteogenesis [184] or the work of 
Yang et al. in which transfected MSCs improved heart function after myocardial 
infarction [185]. 
A key point in this growth factors strategies is not simply their production or 
release, but probably even more important is to control their dose. In fact, a high 
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level of growth factors in tissue might lead to vessel destabilization [186], endothelial 
hyperplasia [187] and even cancer development [188]. Therefore, to control the 
dose present on the material, their spatial localization and their stability, the focus 
of tissue engineering shifted to immobilization approaches in which growth factors 
(or derivatives) are covalently bonded to the scaffold and accessible to bind cells-
receptors to trigger intracellular signals [189]. 
Successful vascularization was achieved using a group of well-known growth 
factors used to upregulate the endothelial cells signaling: vascular endothelial 
growth factor (VEGF), basic fibroblast growth factor (bFGF) and platelet-derived 
growth factor-β (PDGF-β) [35, 190-198].  
VEGF is a family of homodimer glycoproteins which bind heparin, and the 
founding member of this family of polypeptides is named VEGF-A which present 
complex role both in vitro and in vivo for angiogenesis and vasculogenesis (Figure I. 
40) [199, 200].  
 
Figure I. 40 - Model of VEGF protein and receptor interaction: identifying the different 
classes of VEGF protein from A to D and of receptors from R1 to R3. From [201]. 
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The gene encoding for VEGF-A is located in human on the chromosome 6 and 
encode for 8 exons [202] which undergoes different exon splicing, generating up to 
four different protein-variants: VEGF-A121, VEGF-A165, VEGF-A189 and VEGF-A209 
[203]. Besides the type of spliced-variant of the VEGF-A protein, a key-role factor is 
a proper concentration to use within a body tissue to avoid hypertension, 
atherosclerotic plaque development [204], inappropriate vessels growth [205] and 
neovascularization in tumors [206]. In fact, the angiogenetic properties of this 
protein are strictly dependent on the dose applied in the tissue, and therefore the 
determination of the proper concentration to be used is crucial before applying it 
within engineered tissues [45]. In addition, this protein presents a short half-life (the 
time after which the protein is not functional anymore) and so, novel studies of 
encapsulation and controlled release have been examined [207]. 
During the process of angiogenesis, the concentration of the VEGF-A protein 
influences the rate and amount of new vessels development [208]. When the 
capillaries are formed, the migration of pericytes around the tubular structure is 
recognized as the synonym of vessel maturation, while the absence of pericytes 
often leads to capillary regression [209]. VEGF-A and pericytes cells work in 
collaboration to promote vessel remodeling and maturation, in fact, it was shown 
how the presence of pericytes in absence of VEGF-A do not prevent capillary vessels 
regression in vivo [210]. The mechanisms which drive the capillary vessels regression, 
as well as the EC shedding into the vessel lumen are unknown, however, there is a 
two-steps hypothesis: firstly, a quick cessation of blood flow and EC apoptosis with 
consequent destruction of the vessel wall, secondly, the degradation of the 
basement membrane [210]. Capillary vessels remodeling occurring within 
engineered tissues cannot be avoided either in vitro and in vivo. However, the 
capillary vessels regression can be prevented to obtain a functional scaffold that can 
benefit from the pre-vascularized network developed inside [45]. The VEGF protein 
is nowadays largely used in order to guide angiogenesis in bone tissue when 
combined with hydroxyapatite microspheres [211], or encapsulated into injectable 
cell macroaggregates [212], or again encapsulated into hydrogels [213]. 
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FGF is a large protein family, composed of 23 members. The main actor for our 
studies is the FGF-2, which play an active role in angiogenesis [214]. Similarly to 
VEGF-A, also this factor, when overexpressed, is associated with dangerous side 
effects such as hyperplasia [215], atherosclerosis formation [216] and hypertension 
[217]. The half-life of FGF-2 is about 9 hours [218] and thus, development of 
controlled-release delivery systems is required for tissue engineering showing how 
slow-release system of FGF-2 in PLGA beads can improve up to 4 times the capillary 
penetration in rats [219]. FGF-2 has been also recently used to develop three-
dimensional scaffolds to enhance skin regeneration and dermal neovascularization 
using a composite material of gelatin and silk fibroin [220] or to induce osteoblastic 
differentiation of bone marrow mesenchymal stem cells using up-regulated gene 
expression [211]. 
Platelet-derived growth factor-β was discovered back in 1974 when it was 
observed how the released material from platelets was able, alone, to induce cell 
growth of many cells which are serum-dependent [221, 222]. PDGF in human is 
normally a heterodimer of two subunits with related sequences, the two chains have 
been termed simply “A” and “B” [223]. In normal conditions, the human plasma 
contains a very low level of PDGF, and intravenous injection of it, is rapidly cleared 
from the body, indicating that the effect of this growth factor is most probably linked 
to a locally increased signal, then a systemic increase in the blood flow [224]. About 
its potential, PDGF is able to induce a cell migration of fibroblast and smooth muscle 
cells, through a chemotactic response [225, 226] This important property might be 
linked to the important role of wound healing process. It was also shown how PDGF 
is able to modulate cell growth in a direct way, by cellular-receptor binding, on 
specific cells sensitive to it such as chondrocytes, vascular smooth muscle cells, glial 
cells dermal and tendon fibroblasts [227]. In addition, PDGF works as potent 
vasoconstrictor showing a concentration-dependent mechanism of aorta 
contraction [228]. 
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Figure I. 41 - Dose-response curve for PDGF and angiotensin-2 in aortic contraction: From 
[228] 
4.4.2. Peptides 
Even if the use of growth factors became a common approach to induce 
vascularization, some drawback has to be solved, such as the high instability and 
short active-life form in vivo [20]. This limitation requires several bolus injections 
over the time, to preserve the functionality of those expensive factors, resulting in 
inefficient approach [229].  
Generally, the name of a peptide is indicated with the single-letter-code of the 
amino acid of which it is composed. The most well-known and largely used peptide 
sequence to improve cellular adhesion is a derivative from fibronectin, a protein 
which composes the extracellular matrix, and takes the name of “RGD” which 
represent the three mains amino-acids of the binding site of the protein: Arginine-
Glycine-Aspartate (Arg-Gly-Asp for three-letter code or RGD for single-letter 
code)[152, 159, 166, 167, 230-235]. Cell adhesion is the process in which integrins 
form a cluster when bounded to both (which are intra-membrane cellular receptors) 
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the actin cytoskeleton of the cells (microfilament of cells) and proteins of the 
extracellular matrix [230].  
In addition to cellular adhesion, as for RGD peptide, other sequences can be used 
to specifically target different cell functions, thanks to specific cell-receptor 
interaction, like in the case of “SVVYGLR” peptide. This sequence derived from 
osteopontin [236-238] and bind the integrins α4β1[239], α4β7[240], and α9β1[241]. 
It has been shown how this sequence has the potential to enhance endothelial cells 
adhesion, proliferation, migration, and tube formation both in vitro and in vivo [238, 
241, 242] [243, 244]. Thanks to those characteristics of a potent angiogenetic factor, 
this small peptide might be expected to stimulate angiogenesis when grafted on a 
surface.  
Another more recent peptide sequence, to induce angiogenesis, is named “QK” 
peptide [245]. This peptide was designed to reproduce the vascular endothelial 
growth factor (VEGF) 17-25 helix region, which is responsible for the binding with 
the cell receptor (Figure I. 42). This peptide was developed de novo by mutagenesis 
of the sequence of amino acid, in order to find the best structural conformation 
which would provide stability maintaining its activity in terms of cell-receptor 
interaction and angiogenesis [245-248].  
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Figure I. 42 - Nuclear magnetic resonance of QK structure: (a) backbone representation of 
QK structure. (b) backbone superposition (yellow) with VEGF protein. Gently provided from 
[245] 
It was shown how QK peptide, in vitro, is able to bind cell receptor-like KDR and 
Flt-1, which normally recognize and bind the complex VEGF protein [245] [246]. In 
addition, D’andrea proved how QK competes with VEGF for binding the endothelial 
cell's receptor, triggering the downstream intracellular signaling pathway such as 
ERK1/2 [245]. The novel peptide sequence was also tested in vivo, to ensure that the 
biological activity and the angiogenic potential was still triggered in animal models, 
comparable with the VEGF protein (Figure I. 43). Encouraging results indicate how 
QK peptide was able to increase capillaries density on the tibialis anterior muscle of 
rat model, accelerate healing by enhancing angiogenesis in the granulation tissues 
after wound formation and greater peripheral capillaries infiltration (Figure I. 43) 
[249]. 
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Figure I. 43 – In vivo studies on QK peptide: (A) QK and VEGF165 accelerate the closure of 
wound in mice, compared to the negative control VEGF15. (B) Quantification of micro-
vessels infiltrating Matrigel plugs. Adapted from [249]. 
4.5. Surface topography and micro patterning: advance 
mimicking of natural ECM 
Scaffolds on tissue engineering provide primarily the needed three-dimensional 
structure specific for tissues, supporting tissues regeneration through adhesion, 
proliferation, cellular interaction, and communication [250]. Scaffolds can be 
fabricated using various techniques such as heat, light, and molding (or their 
combination) in order to develop a desired three-dimensional structure. Their design 
should be in all the three-dimensions, ranging from the centimeter to the 
micrometer sizes, in order to mimic not only the tissues features but also the micro-
environment of the extracellular matrix (ECM) [250, 251]. Originally, micro-pattern 
technology was used for microelectronics industries, combining the knowledge of 
material science and surface chemistry, but nowadays those techniques can be 
applied in tissue engineering applications in order to mimic in a better way the ECM 
environment [252] [250]. 
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4.5.1. Photolithography 
Photolithography is a well-established method, largely used to fabricate 
semiconductors, which currently found useful applications in biomedical and tissue 
engineering fields for cells, proteins and peptides patterning [165-167, 253]. In brief, 
photolithography is used to transfer geometrical shape from a mask to a special 
surface, using exposition to light or ultraviolet wavelength (Figure I. 44) [254]. Firstly, 
a layer of photoresist is applied to the material surface (Figure I. 44). This photoresist 
is an organic solvent which has the characteristic to be sensitive to light exposition 
and thus change its characteristics and chemical bonding. Photoresists can be 
classified into two categories: positive and negative. Positive photoresists react 
positively to light exposition, breaking some chemical boundaries and becoming 
more soluble in the developer solution, a specific solution designed to wash away 
and remove the soluble form of the photoresists. In this case, photoresists positively 
exposed to light, are removed from the surface, generating a new pattern (Figure I. 
44). Negative photoresists work in the opposite way, they react negatively to light 
exposure, becoming insoluble in the developer solution. This means that the 
photoresists exposed to light will not be removed by the developer solution, while 
all the rest of the photoresists will be efficiently washed away from the surface of 
the material [254]. Those newly developed patterns can now be used to specifically 
graft bioactive molecules with the desired spatial distribution (Figure I. 44). 
Regardless of the type of photoresist selected, the last step termed lift-off, involves 
the removal of the leftover of the photoresists, by dissolution in an organic solvent 
(Figure I. 44). 
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Figure I. 44 – Photolithography for peptides immobilization: (a) Schematic of 
photolithography approach to immobilize peptides on a polymeric substrate. First polymer 
is covered by photoresist and then exposed to light through a mask with a specific pattern. 
Then after the pattern transfer, peptides are grafted where the light remove the 
photoresist, and finally the leftover of the photoresist is removed, leaving immobilized 
peptides in a pattern-design. Gently provided by [167]. 
Possible applications in tissue engineering of this technique were investigated by 
several groups of research using different biomolecules and cells, such as the work 
of Moon et al. in which PEG-RGDS was patterned on poly(ethylene glycol)-diacrylate 
(PEGDA) hydrogels [253]. Endothelial cells, in this case, were seeded on the materials 
with a different linear pattern from 50 µm to 200 µm width (Figure I. 45). It was 
shown how ECs were able to develop capillary-like structure only in the smaller 
pattern-type while the larger show a continuous monolayer of spread cells (Figure I. 
45). As well as the pattern condition, also biomolecules concentration play an 
important role. In the same work, researchers investigate RGD peptide 
concentrations ranging from <10 µg/cm2 up to >100 µg/cm2. They proved how lower 
concentration is not sufficient to reproduce the tubular-like structures as well as the 
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higher peptide concentration, only an intermediate concentration of about 20 
µg/cm2 was able to reproduce tubular structures in the patterned material [253]. 
 
Figure I. 45 – Development of pattern-line on PEGDA hydrogels: designed strips (A) from 50 
to 200 µm. (B) Fluorescence image of pattern on the hydrogel and (C) HUVECs adhesion on 
such patterns. Scale bars = 200 mm. From [253] 
Photolithography technique has a great potential for micro-patterning but it 
shows some limitations and drawbacks, such as the incompatibility to develop three-
dimensional structures, or a poor patterning on a not-planar surface and last the 
organic solvents used to remove the photoresist, typically acetone can be harmful to 
proteins [255]. 
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4.5.2. Soft lithography 
To improve the micro-fabrication process, several non-photolithographic 
techniques have been developed to create high-quality micro- and nanostructures 
[256]. Those techniques are generally termed soft-lithography since each of them 
involve an elastomeric stamp or mold where the pattern is transferred. The main 
techniques under the definition of soft-lithography are the following: microcontact 
printing, replica molding, micro-transfer molding, micro molding in capillaries and 
solvent-assisted micro molding [256]. Those techniques collectively are cheap to 
process and simple to perform with a high reproducibility. In this session, among the 
possible soft lithography techniques, we will focus on the microcontact printing 
technique which allows reproducing three-dimensional structures. 
4.5.3. Hot embossing 
Hot embossing is a simple and highly reproducible process in which a polymeric 
material can be molded according to an initial master (most of the time made in 
silicon). Firstly, the design of the microstructure of the master is performed using 
photolithography. Then silicon can be used directly as an embossing tool reducing 
the cost of material production (no intermediate steps required), high reproducibility 
and aspect ratio in the developed structures and the possibility to deep dry etch the 
material [257, 258]. After the master preparation, the silicon master is mounted in 
the embossing machine and a combination of pressure and temperature will be 
applied to reach the temperature above the glass transition temperature of the 
selected polymer in order to penetrate within the master, into the polymer, to 
transfer the pattern shape. At the end of the process, when the pressure is still 
applied on the polymeric material, the temperature is decreased below the glass 
transition to allow the stabilization of the microstructure of the material, before the 
master removal [258]. 
Hot embossing is a promising process to transfer micro- or nanostructures 
pattern from a master mold onto a polymeric substrate with high precision and 
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quality features (Figure I. 46). This technology was developed more than 40 years 
ago and has been used for research applications, as well as industrial production. 
[259]. 
 
Figure I. 46 – Hot-embossing process: Schematic representation of an hot-embossing 
process which detailed the four main steps involved: the heating, the molding or embossing, 
the cooling, and the demolding. Reused from [260]. 
Four main steps characterize the hot embossing process (Figure I. 46):  
Heating the mold and the substrate up to the molding temperature (usually close 
to the glass transition temperature of the polymer). 
Embossing the microstructure patterns using pressure at the molding 
temperature. 
Cooling the mold and the substrate to the demolding temperature, without 
releasing the pressure applied. 
Demolding the component by opening the tools and removing the polymer from 
the mold. 
During the process, two deformation stages occur: the first one is a stress 
concentration and strain hardening during heating and embossing steps. The second 
one is the stress relaxation and deformation recovery during the cooling and 
demolding steps. The main parameters for the hot embossing are the glass 
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transitions temperature (Tg), the pressure applied and the holding time (during 
embossing) [259]. 
Depending on the polymer used for the process, different sizes were exploited 
ranging from 6 mm down to 0.02 µm, as summarized by this review [259]. In 
addition, a wide variety of feature geometries were created and tested such as 
cuboids, channels, cavities, pyramid arrays, microlenses, pin arrays, and other more 
[259]. 
Table I. 1 - Summary of features, sizes and polymers used for hot embossing process: 
References per each work can be found on the work of Peng L. et al. [259]. PMMA = 
polymethyl-methacrylate, PC = polycarbonate, PS = polystyrene, COC = cyclic-olefin-
copolymer, PVC = Polyvinyl chloride. 
Feature geometry Lateral (μm) Height (μm) Aspect ratio Materials 
Cuboids 0.5 and 20 1 and 25 2 and 1.25 PVC and PS 
Channels 70 40 0.57 PMMA 
Cavities 0.071–0.98 0.296 0.30–4.17 PMMA 
Channels 50 30 0.60 PMMA 
Line features 100 71 0.71 PMMA 
Pyramid arrays 50 35.3 0.71 PMMA 
Channels 100 37 0.37 COC 
Channels 100 100 1.00 PMMA 
Channels 100 50 0.50 PMMA 
Channels 50 100 2.00 COC 
Pyramids 100–530 260 0.49–2.60 PMMA 
Microlens 150 35.88 0.24 PC 
Nano-columns 0.1 0.26 2.60 PC 
Microlens 150 25.15 0.17 PC 
Line features 1.6 1 0.63 PS 
Microlens 145 10.8 0.07 PC 
Pin array 0.11 0.37 3.7 PMMA 
Nano-columns 0.48 4.7 9.79 PMMA 
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Saha, Biswajit et al. developed complex micro-capillaries size using hot-
embossing process in polymethyl-methacrylate (PMMA). They were capable to 
transfer the pattern from a silicon mold to PMMA material using the combination of 
the high temperature of the 130˚C and constant force of 25 mN (Figure I. 47). 
 
Figure I. 47 - SEM images of micro-channels molded on PMMA:(e) curve region, (f) straight 
region, and (g) cross-section of the micro-channel. From [261]. 
4.6. Vascular tissue engineering approached 
Collecting all those precious details and knowledge about cell type, material 
properties, and growth factor potential is possible to combine the different expertise 
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to develop an engineered tissue with a desired pre-vascularized network within it. In 
order to develop this tissue, two main approaches are used: 
 -In vivo approach. The first approach involves a preliminary implantation under 
the skin of the patient, to induce the ingrowth of the capillaries. After some weeks, 
the pre-vascularized scaffold is surgically removed to be newly implanted in the 
desired region. This implies a double surgery procedure which carries pain, 
morbidity, and possibility to develop infections. 
-In vitro approach. The second approach consists in the formation of CVN using 
in-vitro techniques to guide endothelial cells through the development of this 
network. This approach is more challenging since we need to mimic the complexes 
signals and environment existing in vivo. 
4.6.1. In vivo approach 
Two techniques are used in vivo to create new vascular network into the 
implanted scaffold.  
The first one termed extrinsic vascularization consists in the development of a 
micro-circulatory system through the capillaries ingrowth of the surrounding tissue 
in the host [35] [45, 262, 263]. In the human body, this process occurs every time 
there is an avascular region in physiological, pathological or surgical situations [45, 
264]. The technique involves the initial implantation of the scaffold (without cells 
seeded) into highly vascularized tissues on the host, such as intermuscular tissue 
[265], adipose tissue, kidney capsule and subdermal areas [219, 266-273]. This first 
implantation, into an ectopic position of the host, will induce a de novo 
vascularization mediated by the host vessels which would migrate and infiltrate 
through the scaffold to build this vascular network [274-276]. 
Due to a slow capillaries ingrowth, a delay normally occurs between the 
implantation time and the full perfusion of oxygen and nutrients within the scaffold, 
resulting in inadequate for thick engineered construct larger than 3 mm [45]. It was 
proved that capillary ingrowth into an engineered tissue via extrinsic vascularization 
takes up to several weeks and depends on the size of the construct, leaving cells in 
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hypoxic conditions for several days if dimensions are larger than 400 µm3 [35] [277]. 
The nowadays technology integration depends initially on the diffusion, and later on 
extrinsic vascularization making impossible to avoid fibro-vascular ingrowth and 
formation of scar tissue. In addition, once the extrinsic vascularization is complete, 
the scaffold is surgically removed from the patient and newly implanted into the 
required target site. This triple-surgery requirement is the biggest drawback of this 
approach which would cause pain and morbidity to the patient [262] [177]. 
The second one, termed intrinsic vascularization, uses a similar approach as the 
extrinsic one, but exploit the intrinsic potential of a blood vessel to sprout and create 
new capillaries network [10, 262] [278, 279]. This approach can be divided into three 
phases:  
-First, joint of a macrovascular component with a scaffold 
-Second, implantation of the scaffold within an ectopic body part and surgically 
anastomosis 
-Third, extraction of the vascularized scaffold and implantation in the region of 
interest  
The most used macrovascular component for this type of approach, in order to 
generate intrinsic vascularization, is named arteriovenous loop (AVL) [280] [10]. In 
this case, an artery and a vein are connected together via a pedicle (which can be an 
autologous vein or another synthetic substitute) to create a loop in the blood flow, 
and placed inside a protected silicon chamber. This loop presents interesting 
characteristics of increased share stress and wall tension due to blood perfusion of 
the host when the micro-surgical anastomosis is performed during the first 
implantation [280] [281]. Those characteristics induce a spontaneous formation of 
angiogenetic sprouts from the pedicle which allow the formation of a capillary 
network both inside the silicon chamber and in the surrounding tissue. This 
preliminary network has been proven to remodel with the time to create arterioles, 
postcapillary venules and venules [279]. Similarly to the extrinsic vascularization 
approach, at least three surgeries are also required in this case. The first one would 
implant the scaffold in an ectopic region of the host, rich in vasculature where the 
surgical anastomosis can be performed. Once the scaffold would be vascularized 
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thanks to intrinsic vascularization process, a second surgery is needed to remove the 
implanted scaffold, while the third one would be needed to finally implant the 
scaffold in the designed region of interest [280]. 
 
Figure I. 48 – Extrinsic and intrinsic vascularization models: Schematic representation of (b) 
Extrinsic Vascularization and (c) Intrinsic vascularization used for TE pre-vascularization 
approach. From [45]. 
This method was largely used and investigated using different tissue materials 
[282-284], using artificial ECM such as Matrigel, collagen, gelatin, fibronectin and 
fibrin [20, 279, 285, 286] or even in the absence of additional ECM [278].  
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Despite the high potential of AVL method, the concerns related to multiple 
surgeries make this technique more complex and problematic. 
4.6.2. In vitro approach 
The efficient, rapid and sufficient vascularization for the large tissues and 
biomaterials remain the main obstacle for the wide implementation of TE into 
clinical practices. Even if nowadays is possible to vascularize some constructs by 
stimulation ingrowth of the host’s vasculature, these approaches showed a slow 
development and a laborious surgical process [280]. The research field is trying to 
investigate in parallel another approach which is the pre-vascularization which aims 
to induce the formation of a sufficient vasculature within the engineered tissues 
before its implantation into the host. Such engineered tissue should allow the 
connection to the host’s vasculature at the moment of the implant and provide an 
immediate perfusion through all the scaffold. However, the development of such 
functional vascular tree with hierarchical structures remains a long-lasting challenge 
[280]. 
Pre-vascularization in vitro consists in the seeding of endothelial cells (alone or 
with other vascular supportive cells) into a scaffold or gels before the implantation 
in vivo, in order to recreate a three-dimensional vascular network [10]. Human 
umbilical vein endothelial cells (HUVECs) are commonly used as a cell source to 
develop capillary-like structures [287]. This approach is a successful strategy to 
facilitate the survival of cells into engineered constructs after in vivo implantation. 
The efficiency of this approach does not only depend on the formation of capillary-
like structures but also involves the functional join between the capillaries into the 
scaffold and one of the patients, a process called anastomosis or inosculation [10]. 
After the implantation, due to the formation of a wound to implant the material, 
oxygen and nutrients which are contained in the blood will diffuse into the scaffold 
as the initial step. Within 48h after the surgery, a close alignment and joining of 
capillaries of the graft with the patient’s one occurs, facilitating blood perfusion. 
Later on, the blood flow is consolidated by extrinsic vascularization, the angiogenic 
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ingrowth of the patient’s capillaries into the implanted scaffold. An example of the 
potential of this technique is provided by Trembley at al. in which they developed an 
endothelial-reconstructed skin with capillary-like structures, which after 
implantation in nude mice, anastomose after only 4 days, compared to the 14-days 
period to achieve a similar result without a pre-vascularized network structure [274]. 
The main drawback of the in vitro approach is the impossibility to surgically connect 
the small capillary network of the pre-vascularized scaffold, to the host vasculature, 
slowing down the perfusion of the nutrients and oxygen after implantation [20]. The 
possible strategies to induce the formation of a capillary network into a scaffold 
broad from the use of special cells type, to the use of small molecules such as growth 
factors, cytokines or the immobilization of molecules such as proteins or peptides. 
4.6.3. Micro engineering technique: the use of micro 
scale pattern or structures 
Development of a stable vascular network, with a designed pattern which can be 
integrated into engineered tissues, is of significant interest. In fact, endothelial cells 
cultured without a designed pattern will grow according to a random architecture, 
making more complex to integrate this network with the designed tissue of interest 
[65]. 
The highly structured microenvironment made of ECM guide and influence cells 
under a lot of aspects such as adhesion, morphology, and mechanical stimuli [288]. 
The cellular adhesion is driven by receptor-ligand interaction, which transfers the 
localized signal to the cytoskeleton of the cells, changing its entire architecture [289-
291]. Those particular conditions differ largely from the culture-conditions in a petri 
dish and even if those artificial conditions can be practical for cell expansion, they 
would not mimic the more complex microstructure present in complex tissues. This 
leads to the development of new strategies and techniques to recreate a micro-scale 
environment which could lead cells into the desired fate [288]. Micro-patterning 
methods are now becoming more popular in the field of tissue engineering and 
biomedicine and three-dimensional micropatterning mimic better the physiological 
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environment than two-dimensional micropatterning, because cell behaves 
differently in those two conditions [292, 293]. 
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II. Objectives and strategy
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Tissue engineering is an emerging field with a great potential for the therapeutic 
goal of tissues and organs regeneration [294, 295]. The combined work of scientists, 
engineers, and physicians enable the development of very complex, sophisticated 
and innovative products, which can be implanted into the patients to heal the 
damaged tissue or replace some of their functions [296]. However, the enormous 
technological progress of materials, techniques, and analysis face the biological 
limitations of long cell culture time, reduced cell-source availability and especially 
low (or even absent) oxygen-nutrients perfusion. Especially, this last limitation 
impairs enormously the fabrication of large tissues or organs since the cells which 
compose those tissue/organ depend primarily on the proper level of oxygen and 
nutrient to accurately reproduce the physiological condition of such tissues/organs 
[297-299]. A particular tissue in which the interaction of blood vessels is 
exceptionally important is the bone tissue. In fact, inside the bone marrow, the 
blood-components are produced and have to be introduced immediately in the 
vascular system. Therefore it exists a close spatial relationship between the two 
tissues with a continuous interaction and remodeling to ensure a perfect function 
over the lifespan of the human being [19, 300]. 
In this context, the present Ph.D. research work focuses on an innovative 
approach to develop tubular-like capillaries micro-vessels using a combination of 
cellular component, biochemical factors, natural polysaccharides, and three-
dimensional patterns. The overall goal is to guide human umbilical vein endothelial 
cells (HUVECs) to develop capillary vessels into a specific pattern structure in order 
to improve the basic knowledge about capillary development for future clinical 
applications such as the development of large pre-vascularized bone scaffolds.  
HUVECs have been largely investigated for development of large vascular tissues, 
as well as basic studies of angiogenesis in 2D conditions or encapsulated into 
hydrogels [10, 301]. Nevertheless, there is no emerging definitive solution ready to 
be used at the clinic, and our study will investigate the potential of a novel approach 
aiming at developing capillaries with the smallest possible size. 
The research work detailed in this thesis manuscript aims to determine the 
specific impact that polyelectrolytes, peptides, and geometrical cues can have on 
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HUVECs for the development of capillary vessels. In order to minimize the variable 
present in this work, a defined culture media without supplemented factors was 
chosen. This choice would prove how only the tested conditions can lead to the 
development of capillaries structures, without the influence of supplemented 
factors. Specifically, the effect of the surface’s functionalization with hyaluronic acid 
(HA) and chitosan (CH), the impact of the adhesive peptide (RGD) and angiogenic 
peptides (SVV, QK) and the three-dimensional pattern of micro-channels on the 
HUVECs adhesion and tubulogenesis was investigated. We hypothesized that the 
interaction between the HUVECs with the surrounding artificial extracellular matrix 
(ECM) combined to the potency of peptides in the three-dimensional space would 
be sufficient to guide those cells into the development of capillary vessels. 
1. Objective #1: Fabrication of PC microchannels 
The first objective of this work is the development of a stable three-dimensional 
network. The native structure of capillary vessels is a tubular geometry ranging from 
10 to 15 µm with the empty lumen in the middle.  
In the present work micro-channels (µCh) with the width in the range of 25 µm 
were developed, and cells were seeded and grown to develop tubular-like 
structures. The fabrication technique must be reproducible, easy to perform, rapid 
and allow the fabrication of relatively large scale sample. Among the potential micro-
fabrication techniques, hot-embossing was chosen which is a template-based 
fabrication that involves a mold in silicon (SiM) containing line-pattern that are 
transferred to PC using a combination of pressure and temperature to develop µCh. 
The characterization of the patterned structures is performed using scanning 
electron microscopy (SEM) and profilometry to determine the dimensions of the 
pattern features. 
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2. Objective #2: Biofunctionalization 
The second objective of this study is to functionalize the supporting material 
using natural polysaccharides. The supporting substrate should present a surface’s 
charge, it should be transparent to facilitate cell observations, it should be molded 
in a fast, accurate and reproducible manner, and it should be cheap and available 
without limits in the production. As it presents all these characteristics, 
polycarbonate (PC) appeared as a very good candidate’s material and was therefore 
selected as supporting material. In addition to its peculiar characteristics, the current 
studies were possible thanks to a collaboration with it4ip, a company expert on the 
development of PC films and membranes with the defined thickness. PC surface can 
be functionalized thanks to its negative net charge on the surface and it is compatible 
with a number of common microfabrication techniques such as hot embossing.  
Our second objective includes two parts. The first one consists of the deposition 
of natural polysaccharides using the layer-by-layer (LbL) deposition approach, in 
order to develop a homogeneous ‘cushion’ on the PC surface, aiming at improving 
cellular adhesion and biorecognition. Biorecognition is possible thanks to the 
interactions between cell’s receptors and the binding motifs present in natural 
polysaccharides like hyaluronic acid (HA) and chitosan (CHI). In addition to this, with 
the LbL approach, the thickness of the final cushion can be finely controlled 
depending on the number of deposited bilayers, as well as the degree of crosslinking 
performed. The final crosslinking density, in fact, influences not only the stability of 
the LbL cushion but also its mechanical properties, which can be tuned to properly 
mimic a more suitable substrate for endothelial cells to grow, proliferate and 
develop tube-like structures. 
The second part of this first specific objective is the immobilization of bioactive 
molecules onto and into the LbL cushion. Two type of peptides; the cell-adhesive 
sequence arginine-glycine-aspartic acid (RGD) and two angiogenic sequences known 
as SVV and QK were chosen for this work. The RGD sequence is globally known to 
have a potent effect on improving cellular adhesion on material thanks to the 
presence of an integrin-binding-site in its sequence. HUVECs cells present the 
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integrin receptors on the surface of the cells’ surface and therefore the binding 
between the integrin receptor with the RGD binding-motif would trigger an 
intracellular signaling that leads to adhesion of the cells. SVV peptide is known to 
contain the binding-site of osteopontin protein, and it was already demonstrated 
how the presence of this peptide immobilized on the surface of a material can induce 
the development of capillary vessels, especially in bone tissues where osteopontin 
normally is highly expressed. The last peptide, QK, was designed to mimic the binding 
site of the more complex Vascular endothelial growth factor (VEGF). This protein is 
known as a potent angiogenetic factor and is currently used in a lot of studies to 
induce pre-vascularization into engineered constructs.  
Regardless of the peptide sequence, all of them share some common 
characteristics, such as the presence of a terminal amino group, that can be used as 
the functional group to perform the immobilization of the peptides on the material 
surface. 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) and N-
hydroxysulfosuccinimide (sulfo-NHS) was used in order to activate the carboxylic 
groups present on the HA, and later let them react with the amino group present on 
the peptide to form a covalent amide bond. Surface characterization at this step was 
performed using ellipsometry, fluorescence microscopy, and confocal microscopy.  
Last, a preliminary study with HUVECs is performed to check the difference in 
metabolic activity between the different samples’ conditions combining two assays: 
XTT text for metabolic activity and PicoGreen test to quantify the DNA content of 
each sample. 
3. Objective #3: Capillaries development 
The third specific objective of this work is the guidance of HUVECs through the 
development of capillary vessels. Once the objectives #1 and #2 are achieved the 
biological studies with HUVECs are performed. Functionalizing the micro-channels, 
with LbL and peptides combination, is fundamental to provide simultaneously a 
three-dimensional microenvironment and a rich cell-matrix environment where 
endothelial cells can recreate capillary vessels structures.  
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 PC microchannels substrates presenting three types of surface chemistry were 
chosen for the biological investigations: Polycarbonate functionalized only with 
HA/CHI layer-by-layer (abbreviated PC-LbL), PC bio-functionalized with HA/CHI LbL 
layer-by-layer onto which adhesive RGD peptide and angiogenic peptide SVV were 
covalently grafted (abbreviated PC-LbL-RGD+SVV), and polycarbonate bio-
functionalized with HA-CHI LbL onto which adhesive RGD peptide and angiogenic 
peptide QK were covalently grafted (abbreviated PC-LbL-RGD+QK).  
Cellular morphology inside the µCh was observed using confocal laser scanning 
microscopy (CLSM) in order to have a complete acquisition of the whole three-
dimensional structure of HUVECs to determine the formation, or not, of tubular-like 
structures. The images were then elaborated with IMARIS software in order to 
reconstruct the three-dimensional acquisition and identify the presence of the 
lumen in the tubular structures.  
The material’s surface characteristics were investigated in order to evaluate 
which material would lead to a faster development of tubular-like structure and 
which would stabilize for longer such structure over the time. Investigations were 
performed following the evolution of HUVECs at different time-points to answer 
those questions. 
4. Objective #4: Capillaries stabilization 
The last fundamental objective of this work is the stabilization (and maturation) 
of the newly developed capillaries using a second cell line, like human pericytes 
derived from placenta (hPC-PL). Pericytes were selected according to their nature 
capability to stabilize capillary vessels in vivo in the human body, and therefore the 
co-culture composed of HUVECs and hPC-PL would better mimic the proper 
conditions also in vitro.  
HUVECs morphology and hPC-PL localization inside the micro-channels were 
investigated using confocal laser scanning microscopy (CLSM). In specific, capillary 
structure and lumen formation were followed as in the objective 3 of this chapter, 
to determine the formation over the time using Fiji software and IMARIS software. 
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Later, once the capillary structures were formed, hPC-PL were seeded together with 
the HUVECs and followed for a longer time. 
The material condition PC-µCh-RGD+SVV was chosen, with HUVECs:hPC-PL ratio 
of 2:1 and separate time for the seeding approach: first seeding HUVECs and after 2 
hours seeding of hPC-PL. 
5. Strategy and approach 
In order to achieve these objectives, we established the following strategy. The 
most suitable method of biofunctionalization of the polycarbonate substrates was 
first selected. One important requirement was to choose a quite universal technique 
that could easily be transferred for the biofunctionalization of other substrates, 
more adequate for bone tissue engineering transplant. PC substrate used is in the 
present work is therefore only a model template for evaluating the potential of our 
innovative approach in developing small capillary vessels. A versatile technique 
which presents the potential to be used on several substrates is the so-called 
polyelectrolyte layer-by-layer (LbL) deposition. Here, two naturally-derived 
polyelectrolytes with opposite charges were chosen in order to interact with each 
other and build up the LbL cushion. Hyaluronic acid (HA) was chosen as anionic 
polyelectrolyte according to its ubiquitous presence as a component of the ECM and 
its negative net charge at the desired pH thanks to the carboxylic group in its 
sequence. The second polyelectrolyte chosen is Chitosan (CHI) for its 
biocompatibility and because it presents a positive net charge at the pH used for the 
build-up of the LbL layer, thanks to the presence of amino groups in its structure. 
Once the HA/CHI LbL film reached the desired thickness, a stabilizing step is 
performed using carbodiimide chemistry with EDC/sulfo-NHS in order to crosslink 
the LbL film using the amino and carboxylic groups of CHI and HA, respectively. 
After the LbL coating of the PC substrate, a further biofunctionalization is 
performed using small biomolecules to promote cell-material integration. The small 
molecules used in this work are peptides with precise sequences and defined 
structures which mimic larger proteins, without instability and denaturation 
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drawbacks. Regarding the immobilization of the peptides onto the HA/CH layers, we 
chose an already well-known protocol using carbodiimide chemistry allowing to form 
covalent bonds between amino and carboxylic groups, and therefore forming a 
stable immobilization of the peptides on the materials’ surface. The type of peptide 
chosen falls into two categories: adhesive peptide or angiogenic peptide. The 
Arginine-Glycine-Aspartic acid (RGD) peptide sequence was chosen for our 
preliminary studies, as it is a peptide sequence found on many extracellular matrix 
proteins, such as fibronectin, vitronectin, and osteopontin. RGD is the specific region 
on those proteins and is recognized by integrins to facilitate cell-material interaction. 
RGD sequence has been largely investigated to improve cellular adhesion using 
several types of cells combined with several types of materials, and in our work, the 
Penta-sequence GRGDS was used [167]. Additionally, the mimetic peptide of 
osteopontin is chosen according to its angiogenic potential. The used sequence is 
composed of nine amino acids GDSVVYGLR since it was already successfully 
investigated in angiogenetic studies with HUVECs [166]. Last, mimetic peptide of 
vascular endothelial growth factor (VEGR) is used. VEGF is the most known and used 
protein for angiogenetic studies both in vitro and in vivo, and its active binding site 
for cellular receptor has been replicated into the 15-aa sequence 
KLTWQELYQLKYKGI. This sequence mimics the same angiogenic potential of the 
complex VEGF exploiting another mechanism of activation [248].  
The second step was the selection of the micro-fabrication method in order to 
develop µCh. The pattern should be sufficiently large to allow HUVECs cells to grow 
inside, but not too large to lose the micro-environment of a natural capillary 
structure which ranges between 10 and 15 µm. In addition, the µChs should be 
developed uniformly on a large-area surface without consuming a significant amount 
of time. Considering the characteristics of the polycarbonate material such as the 
glass transition temperature of 150˚C, hot-embossing method was selected since 
satisfies all the requirements in terms of large patterning area and fast imprinting 
time. The hot embossing technique and protocols were initially investigated using 
larger micro-channel width and spacing, to conclude on a smaller pattern, closer to 
the final sizes of a capillary vessel but not too small to constrict the cells in terms of 
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migration and morphology change. Once the channels are fabricated, the 
biofunctionalization approach is performed using both LbL and immobilized 
peptides. After that, the LbL film is removed in the space between two channels 
using a metal blade, In order to avoid as much as possible cell adhesion outside the 
microchannels. 
Then, the strategy for carrying out cell culture consists of the seeding on HUVECs 
cells using a centrifugation approach to collect the totality of cells at the bottom of 
the µCh. The used media is free from fetal bovine serum (FBS) and other 
growth/angiogenetic factors in order to evaluate uniquely the effect of geometry 
and biofunctionalization on capillary vessel development. The culture is followed by 
confocal laser scanning microscopy (CLSM) at early time-points from 1h until 5h after 
HUVECs seeding with acquisition time each hour. 
Last, co-culture with HUVECs and hPC-PL is performed to follow the improved 
stability of the capillary vessels structures inside the micro-channels 
biofunctionalized material. Also, in this case, the media used for the study is free of 
FBS and other growth/angiogenetic factors. The culture is followed firstly seeding 
HUVECs during 2 hours, and later seeding hPC-PL in ½ of the HUVECs concentration, 
and investigated with CLSM during two more hours.
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Figure II. 1 – The objectives of my work: Schematic summary of the steps used to achieve 
each objective of my work. First, biofunctionalization with polysaccharides and peptides is 
performed and characterized with ellipsometry and fluorospectrometry (Objective #1). 
Second, 3D-micro pattern is developed and functionalized and further characterized with 
scanning electron microscopy, profilometry and fluorescence microscopy (objective #2). 
HUVECs are seeded into the developed micro-channels to develop capillary-like structures; 
characterized with confocal laser scanner microscopy (CLSM) (objective #3). hPC-PL are 
seeded to stabilize the tube-like structure; HUVECs morphology and hPC-PL localization 
inside the micro-channels are investigated using CLSM (objective #4).
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III. Materials and Methods
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1. Materials 
Polycarbonate (PC) films of 50 µm thickness were gently provided by it4ip, 
Belgium. Polyethyleneimine (PEI) with 25 kDa molecular weight was purchased from 
Aldrich (408727-100ML). Chitosan (CHI) with 50-150 kDa molecular weight was 
purchased from NovaMatrix with a deacetylation degree of >90%w (BP-08016-02, 
CL-114). Hyaluronic acid (HA) with 151-300 kDa molecular weight was purchased 
from Lifecore Biomedical (025841, HA200K-5). N-(3-Dimethylaminopropyl)-N'-ethyl-
carbodiimide hydrochloride (EDC), N-Hydroxysulfosuccinimide sodium salt (Sulfo-
NHS), 4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES), fluor-shield 4′,6-
diamidino-2-phenylindole (DAPI), Cell Proliferation Kit II (XTT), Poly(2-hydroxyethyl 
methacrylate) (poly-HEMA), Rhodamine red, Sodium hydroxide (NaOH), and 
Hydrochloric acid (HCl) were purchased from Sigma-Aldrich (E7750-5G, 56485-1G, 
H3375-500G, F6057-20ML, 11465015001, P3932-10G, 83689-1G, S8045, and 
H1758respectively). Sodium chloride (NaCl) was purchased from Fisher scientific 
(10428420-1KG). Fetal bovine serum (FBS), Trypsin-EDTA, Quant-iT™ PicoGreen™ 
dsDNA Assay Kit, CMTPX cell tracker, CMFDA cell tracker, and AlexaFluor-Phalloidin-
564 were purchased from Thermo Fischer scientific (10500064, 25200072, P11496, 
C34552, C2925, and A22283 respectively). β-(N-Morpholino)ethanesufonic acid 
(MES) was purchased from ACROS (32776-1000). Polycarbonate in powder was 
purchased from Lexan, General Electric (145). Ethanol 96%, 2-propanol, and acetone 
were purchased from VWR (83804.360, 20842.367 and 20066.365 respectively). 
Peptides were purchased from Genecust, with personal customize sequences: 
GRGDS (refer from now on as “RGD”), GDSVVYGLR (refer from now on as “SVV”), Ac-
KLTWQELYQLK(Ac)YK(Ac)GI-amide (refer from now on as “QK”), GRGDSK-
Fluorescein 5-isothiocyanate (refer from now on as “RGD-FITC”), GDSVVYGLRK-
Fluorescein 5-isothiocyanate (refer from now on as “SVV-FITC”), and Ac-
KLTWQELYQLK(Ac)YK(Ac)GIK-Fluorescein 5-isothiocyanate (refer from now on as 
“QK-FITC”). Human umbilical vein endothelial cells (HUVECs), human pericytes 
derived from placental (hPC-PL), endothelial basal medium 2 (EBM-2) with 
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endothelial medium supplements, and pericytes growth medium (PGM) were 
purchased from Promocell (C-12203, C-22111, C-12980, and C-28040 respectively). 
Endothelial growth medium 2 (EGM-2) is created adding the endothelial medium 
supplements to the EBM-2. Silicone was purchased from HEMA (80805014). One-
side-polished (100) silicon wafers were purchased from Wacker (Germany). 
1.1. Molecular structures 
GRGDS peptide (RGD) 
 
GDSVVYGLRK peptide (SVV) 
 
Ac-KLTWQELYQLK(Ac)YK(Ac)GI-amide peptide (QK) 
 
GRGDSK-Fluorescein 5-isothiocyanate conjugate peptide (RGD-FITC) 
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GDSVVYGLRK-Fluorescein 5-isothiocyanate conjugate peptide (SVV-FITC) 
 
Ac-KLTWQELYQLK(Ac)YK(Ac)GIK-Fluorescein 5-isothiocyanate conjugate peptide 
(QK-FITC) 
 
Polyethyleneimine (PEI) 
 
Chitosan (CHI) 
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Hyaluronic acid (HA) 
 
Polycarbonate (PC) 
 
N-(3-Dimethylaminopropyl)-N'-ethyl-carbodiimide hydrochloride (EDC) 
 
N-Hydroxysulfosuccinimide sodium salt (Sulfo-NHS) 
 
CMTPX cell tracker 
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CMFA cell tracker 
 
4′,6-diamidino-2-phenylindole (DAPI) 
 
1.2. Materials preparation 
Hot embossing 
Polycarbonate micro-channels (PC-µCh) were developed using hot embossing 
technique by pattern transfer from a silicon master (SiM) (Figure III. 1). 
PC films were firstly washed by immersion in isopropanol for 10 minutes, and 
then dried blowing nitrogen gas with a pressure pistol. Parameters such as 
temperature, pressure (or force) and time were investigated to allow a complete PC 
mold transfer. Three types of line SiM patterns were used after the optimization 
step:  
-Master with line pattern width (w) of 25 µm, line spacing (s) of 100 µm and line 
height (d) of 28 µm (MICRO-L-25K-125K) represented in Figure III. 1 A. Periodicity is 
represented by the sum of width and spacing (w+s). 
- Master with line pattern width (w) of 25 µm, line spacing (s) of 50 µm and line 
height (d) of 28 µm (MICRO-L-25K-75K) represented in Figure III. 1 B. Periodicity is 
represented by the sum of width and spacing (w+s). 
- Master with line pattern width (w) of 25 µm, line spacing (s) of 25 µm and line 
height (d) of 28 µm (MICRO-L-25K-50K) represented in Figure III. 1 C. Periodicity is 
represented by the sum of width and spacing (w+s). 
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Figure III. 1 – Silicon master with micro-line patten: Schematic representation of the three 
silicon masters used to develop micro-channels in polycarbonate. The line width (w) and 
height (d) is constant in all the masters, 25µm and 28 µm respectively, but the spacing (s) 
between line differs: s = 100 µm (A), s = 50 µm (B) and s = 25 µm (C). The nomenclature of 
the silicon masters represent the micrometric scale pattern (MICRO) the type of pattern as 
line (L), the line width (w) and periodicity (w+s) of the pattern. 
The molds were firstly washed by immersion in ethanol for 10 minutes and blow-
dried using nitrogen gas to remove small particles before the imprinting process. 
Molding was performed using temperature- and pressure- controlled Fontijne 
hydraulic press (TP400, Fontijne, Holland) with the following protocol:  
- Materials were aligned to fit in the embossing machine, according to Figure III. 
2 A 
- The “sandwich” of the components of printing is assembled according to Figure 
III. 2 B 
- Plates were brought in contact without applying force,  
-The temperature was increased from room temperature (RT) until 200˚C  
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-The sample was kept for 2 minutes at 200˚C without force applied to equilibrate 
the system’s temperature homogeneously. 
-Force of 3 kN was applied 
-After 2 minutes, the temperature was cooled down to 30˚C, without reducing 
the applied force 
-Finally, the applied force was removed by opening the plate of the press 
 
Figure III. 2 – Hot-embossing setup: Schematic representation of the setup for imprinting 
the materials. The top view (A) allows to visualize which silicon master was used and where 
is its location, as well as the location of the PC films and the other elements. The cross-
section view (B) represents the type of “sandwich” of each element necessary for an 
homogeneous imprinting process. 
After the hot embossing, the different PC films were gently peeled off from the 
SiM and stored into a fluoroware wafer carrier, while the SiM was washed with 
acetone and blow-dried, as previously described, before each imprinting process. 
Molded PC-µCh are named accordingly with the type of mold used: PC-µCh(25K-125K), 
PC-µCh(25K-75K) and PC-µCh(25K-50K) (Figure III. 3). 
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Figure III. 3 – Imprinted polycarbonate micro-channels: Schematic representation of the 
three polycarbonate micro-channel materials developed with the respective silicon masters 
previously represented. The line width (w) and height (d) of the micro-channels is constant 
in all the samples, 25 µm and 28 µm respectively, but the spacing (s) between line differs: s 
= 100 µm (A), s = 50 µm (B) and s = 25µm (C). The nomenclature of the samples indicates the 
polycarbonate micro-channels (PC-µCh) with the the line width (w) and periodicity (w+s) of 
the pattern. 
1.3. Material functionalization 
1.3.1. Layer-by-layer deposition and crosslinking 
Multilayered structures were built-up using the layer-by-layer (LbL) assembly 
technique, either on flat PC films or on PC-µCh. Hyaluronic acid (HA), chitosan (CHI) 
and polyethylenimine (PEI) were firstly freshly dissolved overnight under stirring 
conditions, at 1 mg/ml in 0.15M NaCl solution and buffered at pH 6.0-6.5 using NaOH 
and HCl 0.1M solutions. PC films or PC-µCh were firstly washed through 10 min 
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immersion in isopropanol followed by blow-drying step with nitrogen gas. Each 
deposition and rinsing steps were performed using a custom-made automatic 
dipping machine, holding the samples in a vertical orientation. Initially, a thin layer 
of PEI was deposited on the PC substrate, followed by three rinsing steps with NaCl 
0.15 M pH 6.0 to coat the materials’ surface with a homogenous positively charged 
layer (Figure III. 4). Afterwards the PC material was dipped alternatively in CHI and 
HA solutions for 5 min, each followed by three rinsing steps in NaCl 0.15 M, pH 6.0 
solution (Figure III. 4). The multilayered films were then crosslinked by immersion of 
the modified PC substrates into freshly prepared EDC/sulfo-NHS (30 mM/50 mM in 
NaCl 0.15M pH 5.0-5.5) solution overnight at 4˚C (Figure III. 4). After 16 h, the 
crosslinking reaction was stopped by performing eight washing steps of 20 min each 
in HEPES (20 mM in NaCl 0.15M pH 7.3-7.6) solution (Figure III. 4). For the initial 
characterization, different architectures of PC-PEI(HA/CHI)n were developed with n 
ranging between 4 and 24. Each of these architectures were freshly crosslinked 
before performing further measurements. Once the characterization of the 
polyelectrolytes growth was performed, the architecture PC-PEI(HA/CH)12.5 was 
chosen as the definitive one, used for all further experiments on 
biofunctionalization, like peptide immobilization, and for the biological 
investigations as well. From now on, this specific architecture is referred to PC-LbL. 
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Figure III. 4 – Layer-by-layer functionalization: Schematic representation of the layer-by-
layer deposition technique showing each step of deposition and rinsing. First, PC sample is 
fixed on the head of the automatic-dipping machine and the initial PEI deposition is 
performed, once. Then, the HA and CHI are deposited repetitively in cycle, each followed by 
three rinsing steps, in order to build up the polyelectrolytes layer-by-layer (LbL) film. Once 
the LbL reached the desired architecture, it was crosslinked at 4˚C overnight and then 
washed extensively to remove the crosslinking solution. The type of solutions used for the 
deposition are indicated with particular attention on the salt concentration and pH. 
1.3.2. Peptide grafting 
PC-LbL was further functionalized by immobilizing six types of peptides on the 
LbL cushion. RGD, SVV, QK, RGD-FITC, SVV-FITC, and QK-FITC sequences alone or in 
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combination were immobilized using carbodiimide chemistry, same concentration 
as for the crosslinking of the LbL. Briefly, a quick activation of the polyelectrolyte LbL 
with EDC/sulfo-NHS was performed for 15 min at RT followed by one rinsing step in 
0.1 M MES buffer (Figure III. 5). Then the activated PC-LbL substrates were immersed 
into a peptide solution (10-4 M in 0.1 M MES buffer at pH 5.0-5.5) overnight at 4˚C. 
After 16 h, only for the PC-µCh-LbL samples, a further step of scratching with a metal 
blade was performed to remove the bioactive coating from the spacing between 
channels (Figure III. 5). Both flat PC-LbL or PC-µCh-LbL were washed eight times for 
20 min each with 0.1 M MES buffer, followed by three rinsing steps of 5 min each in 
ethanol 50% (Figure III. 5). Last, samples underwent a sonication step (30 Hz, 100 W, 
Elmasonic P120H) of 0, 30 or 60 min to investigate the optimal time which allows a 
complete removal of unreacted peptides (Figure III. 5). 
For the immobilization of peptide combination (such as RGD+SVV or RGD+QK) 
the same protocol as previously described was used with the presence of the two 
peptides in the equimolar concentration of 10-4 M each. 
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Figure III. 5 – Peptide immobilization step: Schematic representation of the immobilization 
of peptides on polyelectrolytes LbL. First the LbL is activated and quickly rinsed. Then it is 
immersed in peptide solution overnight and the day after PC-µCh undergoes further 
scratching step. Both PC and PC-µCh undergoes two washing steps with MES buffer and 
ethanol. Last step of sonication, with a different exposition time, is performed to remove 
the unreacted peptides. 
1.3.3. Biofunctionalized material sterilization 
Approach A: Sterilization was performed placing the biofunctionalized materials 
in 48-well plate and immersed in ethanol 70% overnight. The day after, ethanol was 
removed and the samples were left under the laminar flow hood for 1h with the lid 
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open. Then three washed 10 min each was performed with sterile PBS, before the 
cell seeding. 
Approach B: Sterilization was performed placing the biofunctionalized materials 
in 48-well plate and immersed in ethanol 70% for 15 min. After ethanol was removed 
and the samples were left under the laminar flow hood for 45 min with the lid open. 
Then three washed of 2 min each was performed with sterile PBS, before the cell 
seeding. 
1.4. Materials characterization 
1.4.1. Profilometry 
SiM pattern’s height and PC-µCh’s depth were characterized by profilometry 
(Veeco Dektak 150). The scan of both features was performed perpendicularly to the 
direction of the features using the following parameters: Profile HillsAndValleys, 
ScanDuration 100 s, ScanLength 100 µm, scan resolution 0,003 µm, ScanType 
Standard Scan, StylusForce 4 mg, StylusScanRange, 524 µm, StylusType Radius: 0,7 
μm. At least three measurements were acquired per each sample. 
1.4.2. FE-SEM 
PC-µCh were firstly coated with Pt/Pd depositing 10 nm thick layer (Cressington 
208HR, thickness controller MTM-20). Both SiM and PC-µCh samples were observed 
at 15 keV with a Field Emission Scanning Electron Microscope (FE-SEM) (JSM- 7600F, 
Jeol Ltd.) in order to characterize the features’ width and spacing. 
1.4.3. Ellipsometry 
HA/CHI multilayer growth was followed by ellipsometry (Jobin Yvon Horiba) using 
the same material preparation procedure, described in the material 
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functionalization part, with a little modification. Instead of using directly a PC film, 
the PC was firstly spin-coated (Laurell WS-650MZ) at 1 g/L on a 1 cm2 silicon wafer 
surface (speed 4500 rpm, acceleration 2250 rpm and time 60 seconds), in order to 
create a homogeneous thin layer. Psy and Delta of each sample’s architecture from 
4<n<24 was measured. Later, Igor pro (6.3.7.2, Wavemetrics) software was used to 
simulate a curve model using isotropic film on isotropic substrate model and the 
following variables: number of layers = 1, wavelength= 632.8 nm, theta angle = 65.2 
˚C, Start value = 0, step size = 10, end value = 5000, silicon refraction (n1)= 3.882, 
silicon absorption coefficient (k1)= 0.019, air refraction (n2) = 1, air absorption 
coefficient (k2)= 0, silicon oxide refraction (n3)= 1.455, silicon oxide absorption 
coefficient (k3)= 0, PC refraction (n4)= 1.5848, PC absorption coefficient (k4)= 0 [302 
1998.]. This model was used to fit the material’s thickness and obtain the values for 
each measured architecture. 
 
1.4.4. Spectrometry (TBO) 
Free carboxylic groups available on PC-LbL samples were quantified using 
toluidine blue-0 (TBO) test [163]. The TBO method allows a selective dye staining of 
the deprotonated acid groups (COO-), present on the surface of the material, through 
ionic interaction at basic pH. It was already proven how 1 mole of TBO complex 
exactly with 1 mole of COO- [303] and therefore the final concentration of COO- 
groups was calculated. [163]. Briefly, 5 mM TBO solution in NaOH at pH=10 was 
freshly prepared and added to PC-LbL samples overnight. The day after, when the 
TBO has properly interacted with the COO- groups, two quick rinsing steps in NaOH 
pH 10 solution and MilliQ water were performed followed by elution of the dye in 
acid pH condition, using acetic acid solution (50%). Thanks to the new acid 
conditions, the TBO present in the solution is proportional to the TBO linked to the 
COO- groups on the material. 200 µl of the final solution was aliquoted into a 
transparent flat-bottom 96-well plate and absorbance was read at 633 nm (BioTek 
µQuant Gen5). The concentration of TBO was evaluated aliquoting 200 µl of TBO 
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standards from 10-4 to 10-8 M to create a calibration curve, reading the absorbance 
signal at 633 nm. Once the equation absorbance vs. concentration was developed, 
the unknown COO- concentrations were calculated knowing their absorbance 
intensity. 
1.4.5. Fluorospectrometer (peptide grafting) 
In order to quantify the density of the different peptides grafted on the LbL 
multilayer, fluorescent peptides: RGD-FITC, SVV-FITC, and QK-FITC, were grafted 
onto flat PC-LbL using the same procedure than for unlabeled peptides and using as 
control PC and PC-LbL without carbodiimide chemistry. Quantification was then 
performed using spectrofluorometer (CLARIOstar Exitation: 488 nm, Emission: 535 
nm, gain: 600, 30x30 matrix scan method). A calibration curve was plotted reading 
the fluorescence signal of 100 µl FITC-peptides aliquots in solution from 10-4M to 10-
8M concentration range. From the fluorescence intensity of the known peptides’ 
concentration is it possible to obtain the calibration curve. This was then used to 
evaluate the concentration of peptides grafted on the sample and, knowing the area 
of the sample, it was also possible to determine the concentrations reported in 
nmol/cm2, pmol/cm2, pmol/mm2, and molecules/nm2. 
1.4.6. CLSM (LbL swelling) 
PC-LbL-RGD-FITC samples were firstly rinsed in PBS, dipped in rhodamine red 
(Sigma-Aldrich 83689-1G) solution for 5 min and rinsed once in PBS. Then the 
materials were placed upside-down unto a glass slide for CLSM analysis at the 
confocal laser scanning inverted microscope (CLSM, ZEISS LSM 710). Images were 
acquired in green fluorescence (RGD-FITC) and red fluorescence (rhodamine red) 
with exposition time of 20 ms, oil objective 40 X scanning the entire thickness of the 
sample. Later a Z-reconstruction using Fiji (Schindelin J Nature methods 2012) 
software was performed to determine the penetration depth of the two-fluorophore 
used inside the LbL multilayers. 
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1.4.7. Fluorescence microscopy (scratching test) 
PC-µCh-LbL-RGD-FITC samples were treated to remove the upper part of the LbL 
from the µCh spacing region. Removal of the top layer was performed on half of the 
sample, using a metal scalpel scratching in the direction of the channels. Later, 
fluorescence microscopy (LEICA DM5500B) was performed to identify the different 
regions of the partially scratched sample and the images were acquired using 10X 
objective. Images were analyzed using Fiji (Schindelin J Nature methods 2012) 
software and fluorescence signal was recorded.
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2. Cell culture 
2.1. Mono culture (or HUVEC) 
2.1.1. Expansion 
HUVECs were grown in a culture flask using EGM-2. Cells were sub-cultured using 
trypsin-EDTA and maintained in a humidified atmosphere containing 5 % CO2 at 37 
°C. Cells at passages 4–6 were used for experiments. 
2.1.2. Cell detachment and counting 
At the defined time-point of growth, HUVECs were detached using the trypsin-
EDTA protocol which can briefly be summarized as follow: culture media containing 
FBS was removed and HUVECs were rinsed twice with warm PBS without Ca2+ and 
Mg2+. After PBS was removed and warm trypsin-EDTA was added and the sample 
incubated for 2-3 min in the cell incubator at 37˚C and 5% CO2. After that time, an 
aliquot of is collected and placed into the Malassez chamber for counting the 
number of total cells present in each sample under a brightfield microscopy [304]. 
Alternatively to the Malassez chamber, a more precise and reliable method can 
be used, based on the double-stranded DNA (dsDNA) quantification using PicoGreen 
kit (refer to paragraph 3.2 for more detail about PicoGreen method). 
2.1.3. Culture on PC-LbL 
Firstly, the wells of a 48-well plate were coated with anti-cell-adhesive polyHema 
3% solution in ethanol 96% and dried overnight. Later, PC-LbL were placed on the 
coated wells and sterilized with ethanol 70% immersion for 15min, followed by 
ethanol removal and drying for 45 min. After, samples were washed using PBS three 
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times of 10 min each. 0.1 million HUVEC/cm2 were then seeded in EBM-2 for 4 hours 
maintained in a humidified atmosphere containing 5 % CO2 at 37 °C. After that, 
media was replaced with EGM-2 and incubated until the time-point was reached. 
2.1.4. Culture on PC-µCh-LbL 
Firstly, the wells of a 48-well plate were coated with anti-cell-adhesive polyHema 
3% solution in ethanol 96% and dried overnight. Later, PC-LbL were placed on the 
coated wells and sterilized with ethanol 70% immersion for 15min, followed by 
ethanol removal and drying for 45 min. After, samples were washed using PBS three 
times of 10 min each. 0.1 million HUVEC/cm2 were then seeded in EBM-2 and then 
centrifuged (Eppendorf 5810) using a swing-bucket rotor (Eppendorf A-2-DWP) for 2 
min at 900 RPM. After samples were stored in a humidified atmosphere containing 
5 % CO2 at 37 °C until the time-points were reached. 
2.2. Co-culture (or hPC-PL) 
2.2.1. Expansion 
hPC-PL were grown in a culture flask using PGM supplemented with 20% FBS and 
supplement kit. Cells were sub-cultured using trypsin-EDTA and maintained in a 
humidified atmosphere containing 5 % CO2 at 37 °C. Cells at passages 4–6 were used 
for experiments. 
2.2.2. Culture on PC-µCh-LbL 
Firstly, the wells of a 48-well plate were coated with anti-cell-adhesive polyHema 
3% solution in ethanol 96% and dried overnight. Later, PC-LbL were placed on the 
coated wells and sterilized with ethanol 70% immersion for 15min, followed by 
ethanol removal and drying for 45 min. In the meantime, HUVECs growing on the 
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culture flask were treated with CMTPX cell tracker for 45 min following the 
manufacturing instructions, while hPC-PL were treated with CMFDA cell tracker for 
45 min following the manufacturing instructions. After, samples were washed using 
PBS three times of 10 min each. 0.1 million HUVEC/cm2 were then seeded in EBM-2 
and then centrifuged (Eppendorf 5810) using a swing-bucket rotor (Eppendorf A-2-
DWP) for 2 min at 900 RPM. After samples were stored in a humidified atmosphere 
containing 5 % CO2 at 37 °C for 2 hours. Later, 50’000 hPC-PL/cm2 were seeded in 
EBM and placed again in the incubator until the prime-points were reached. 
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3. Biological characterization 
3.1. Metabolic activity (XTT) 
Metabolic activity test was performed after 18h of HUVECs incubation, according 
to manufacturer protocol. Two controls of PC and PC-LbL were tested together with 
the samples RGD, SVV, QK, RGD+SVV, and RGD+QK. Absorbance was read (BioTek 
µQuant Gen5) at 650 and 450 nm after 4 hours incubation with the components of 
the kit. 
3.2. DNA content (Pico green) 
dsDNA content of the same samples from the XTT test were quantified using Pico-
Green assay. Samples were firstly rinsed three times with PBS. Later 400µl of PBS 
were added and cells’ membrane were lysate through 10s ultra-sonication (Micro-
tip, Misomx ultrasonic processor XL) using 3 different power intensities and 
performed keeping the samples on ice. Later, dsDNA was extracted and quantified 
following the manufacturing instructions. Fluorescence signal (CLARIOstar, gain: 
600) was measured at 520 nm and cell number was calculated considering that each 
cell contains on average 6.6 pg of dsDNA [305]. 
3.3. CLSM (tubulogenesis) 
3.3.1. Mono-culture tubulogenesis 
Three-dimensional organization of HUVECs was evaluated using CLSM (ZEISS LSM 
710). At the desired time-points of 1h, 2h, 3h, 4h, and 5h, cells were fixed using 
PFA4% incubation for 15 min. After PBS rinsing, the samples were stained with 
Phalloidin-564 and mounted with Fluor shield DAPI in glass slide for CLSM analysis. 
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Images acquisition was performed with an oil objective at 40X in red and blue 
fluorescence. 
3.3.2. Co-culture stabilization 
Three-dimensional organization of HUVECs and hPC-PL were evaluated using 
CLSM (ZEISS LSM 710). At the desired time-points of 2h, 3h, and 4h cells were fixed 
using PFA4% incubation for 15 min. After PBS rinsing, the samples were mounted 
with Fluor shield DAPI in glass slide for CLSM analysis. Images acquisition was 
performed with an oil objective at 40X in red, green and blue fluorescence. 
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4. Software and statistical analysis 
4.1. ImageJ / Fiji 
Fiji 2.0 (Schindelin J Nature methods 2012) was used for measuring the feature 
pattern in SiM and PC-µCh, the thickness of the LbL after CLSM analysis, adjusting 
and adding scalebar to all the fluorescence microscopy images, and analyze all the 
CLSM of monoculture and co-culture experiment to identify the location of tubular-
like structures. 
4.2. IMARIS 
IMARIS 9.0 (Oxford Instruments, http://www.bitplane.com) was used for the 
three-dimensional (3D) reconstruction of the confocal images and for analysis of the 
tubular structures of HUVECs into micro-channels. 
4.3. PRISM (statistical software) 
4.3.1. µCh development 
A first two-tailed unpaired t-student test was performed between w and w’ 
samples to compare if their mean were different. We assume gaussian distribution 
of the samples. Welch's correction was then performed, assuming not equal SD 
between samples. 95% confidence level was chosen. 
A second two-tailed unpaired t-student test was performed between s and s’ 
samples to compare if their mean were different. We assume gaussian distribution 
of the samples. Welch's correction was then performed, assuming not equal SD 
between samples. 95% confidence level was chosen. 
A third two-tailed unpaired t-student test was performed between d and d’ 
samples to compare if their mean were different. We assume gaussian distribution 
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of the samples. Welch's correction was then performed, assuming not equal SD 
between samples. 95% confidence level was chosen. 
Results were considered to be significantly different starting from p < 0.05. 
Different p values were represented with different symbols: p < 0.05 (*) p < 0.01 (**) 
p < 0.001 (***) p < 0.0001 (****). 
4.3.2. LbL growth 
Non-linear fit with exponential growth was used. The selected fitting method was 
the least squares fit, without comparison or constraints. No weighting was 
considered, minimize the sum-of-squares of the distance of the points from the 
curve choosing when you expect the average distance between point and curve to 
be unrelated to the values of Y. We considered each replicate of Y as an individual 
point. The fit curve was performed for a maximum number of iterations 1000 and 
the goodness-of-fit was quantified using the R square and the sum-of-squares values. 
4.3.3. TBO 
The two-tailed unpaired t-student test was performed between the PC and PC-
LbL samples to compare if their mean were different. We assume gaussian 
distribution of the samples. Welch's correction was then performed, assuming not 
equal SD between samples. 95% confidence level was chosen. Results were 
considered to be significantly different starting from p < 0.05. Different p values were 
represented with different symbols: p < 0.05 (*) p < 0.01 (**) p < 0.001 (***) p < 
0.0001 (****). 
Linear regression was performed on the standards to identify the equation of the 
calibration curve and interpolate the unknown samples from the standard curve. 
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4.3.4. Peptide grafting 
Ordinary two-way ANOVA was performed comparing each cell mean with every 
other cell mean on the same column, as well as compare rows within each column. 
When F values for a given variable were found to be significant, the multiple 
comparison analysis was corrected with the Tukey test. Results were considered to 
be significantly different starting from p < 0.05. Different p values were represented 
with different symbols: p < 0.05 (*) p < 0.01 (**) p < 0.001 (***) p < 0.0001 (****). 
Linear regression was performed on the standards to identify the equation of the 
calibration curve and interpolate the unknown samples from the standard curve. 
4.3.5. Scratching test 
A first two-tailed unpaired t-student test was performed between t and t’ 
samples to compare if their mean were different. We assume gaussian distribution 
of the samples. Welch's correction was then performed, assuming not equal SD 
between samples. 95% confidence level was chosen. 
A second two-tailed unpaired t-student test was performed between w and w’ 
samples to compare if their mean were different. We assume gaussian distribution 
of the samples. Welch's correction was then performed, assuming not equal SD 
between samples. 95% confidence level was chosen. 
A second two-tailed unpaired t-student test was performed between s and s’ 
samples to compare if their mean were different. We assume gaussian distribution 
of the samples. Welch's correction was then performed, assuming not equal SD 
between samples. 95% confidence level was chosen. 
Results were considered to be significantly different starting from p < 0.05. 
Different p values were represented with different symbols: p < 0.05 (*) p < 0.01 (**) 
p < 0.001 (***) p < 0.0001 (****). 
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4.3.6. Metabolic activity (XTT) 
One-way ANOVA without matching or pairing was performed 95% confidence 
interval. We assume a gaussian distribution of the samples, comparing the mean of 
each sample with the mean of every other sample. When F values for a given variable 
were found to be significant, the multiple comparison analysis was corrected with 
the Tukey test. Results were considered to be significantly different starting from p 
< 0.05. Different p values were represented with different symbols: p < 0.05 (*) p < 
0.01 (**) p < 0.001 (***) p < 0.0001 (****). 
Linear regression was performed on the standards to identify the equation of the 
calibration curve and interpolate the unknown samples from the standard curve.  
4.3.7. DNA content (Pico Green) 
One-way ANOVA without matching or pairing was performed 95% confidence 
interval. We assume a gaussian distribution of the samples, comparing the mean of 
each sample with the mean of every other sample. When F values for a given variable 
were found to be significant, the multiple comparison analysis was corrected with 
the Tukey test. Results were considered to be significantly different starting from p 
< 0.05. Different p values were represented with different symbols: p < 0.05 (*) p < 
0.01 (**) p < 0.001 (***) p < 0.0001 (****). 
Linear regression was performed on the standards to identify the equation of the 
calibration curve and interpolate the unknown samples from the standard curve. 
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The studies outlined in this thesis aim to understand the interactions between 
cells and biomaterials for tissue engineering applications focusing on angiogenesis. 
For this purpose, a three-dimensional micro-structured material presenting various 
forms of bioactivity was designed, to mimic the complex and rich extracellular matrix 
environment, naturally present in the human body. The combination of various 
surfaces' properties can influence the cell response in many ways. 
In the first part of the results chapter, the fabrication and characterization of 
various elaborated flat and microstructured surfaces are presented. Three types of 
micro-channels in polycarbonate with different geometries were successfully 
fabricated, and the best among those was later functionalized with adhesive and/or 
angiogenic peptides through a polyelectrolytes cushion deposited in a layer-by-layer 
manner. The peptide sequence chosen to induce the initial cellular adhesion was the 
well-known Arg-Gly-Asp (RGD). Two peptides with angiogenic properties were also 
tested: SVV sequence derived from osteopontin protein, and QK sequence designed 
to mimic the vascular endothelial growth factor (VEGF) protein. Each step of the 
surface functionalization process was monitored through a variety of surface 
characterization techniques to ensure the validity of the used protocol. These 
techniques include profilometry to evaluate the depth of the developed µ-channels, 
scanning electron microscopy (SEM) to evaluate the width and spacing between 
channels, ellipsometry to investigate the polyelectrolytes growth on the PC material, 
absorption spectroscopy to quantify the amount of available carboxylic groups on 
the LbL cushion, fluoro-spectrometry to quantify the number of immobilized 
peptides in the LbL cushion, fluorescence microscopy to investigate the efficiency of 
functional layer removal out of the µCh, and confocal laser scanning microscopy 
(CLSM) to evaluate the thickness and the penetration of the peptides into the LbL 
cushion. 
In the second part of this chapter, results on the evaluation of human umbilical 
vein endothelial cells (HUVECs) behavior on the adhesive and angiogenetic modified-
surfaces with peptides are reported. 
We first determine the cellular behavior on flat surfaces, functionalized to be 
adhesive and angiogenic. After, mono-culture conditions with HUVECs were tested 
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on µCh-functionalized materials to follow the development of tubular-like structures 
and to evaluate the impact of the surface chemistry used to functionalize the 
different samples while maintaining constant the three-dimensional geometry of the 
µCh. Finally, a co-culture experiment with HUVECS and hPC-PL was performed in 
order to assess if a stabilization of those tubular-like structures for a longer period 
of time can be obtained, compared to the monoculture conditions tested. 
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1. PART I: Fabrication of PC microchannels  
In this study, three-dimensional channels with dimensions ranging at the micro-
scale level, are developed in order to favor the formation of capillaries vessels on a 
total surface of 1 cm2. In literature, various techniques are reported to fabricate 
micro-scale pattern on material surfaces such as photolithography, soft lithography, 
and hot embossing as already discussed in chapter I. Among those interesting 
techniques, hot-embossing offers a series of advantages related to its ease of 
processing, rapidity, reproducibility, and versatility depending on the polymeric 
material used. Hot-embossing belongs to the categories of techniques which require 
a template in order to transfer a pre-defined pattern into a multitude of materials’ 
surfaces. In the present study, the template master mold is made of silicon (SiM) and 
the material surface is polycarbonate (PC). This imprinting method allows large areas 
to be patterned on the micro-scale without the need for other time-consuming 
processes. Moreover, surface features of micro-metric scale can be easily 
constructed without limit on geometry. 
Two main types of surfaces were elaborated for biological assays: (1) flat 
polycarbonate films (PC) with and without functionalization, and functionalized 
polycarbonate micro-channels (PC-µCh). The PC materials do not require any 
processing and were thus only cleaned and washed prior to functionalization. 
Instead, the PC-µCh materials require an initial step of micro-fabrication in order to 
develop the three-dimensional geometry. For the micro-patterning of PC materials, 
three types of lines pattern were used, characterized by their width (w), the spacing 
between lines (s) and their depth (d).  
Combination of scanning electron microscopy (SEM) and profilometry are used 
to fully characterize the pattern line on the SiM, used for the hot-embossing, and on 
the imprinted PC-µCh. More precisely SEM is used to characterize the line-channels 
width (w) and spacing (s) (Figure IV. 1 A, B, and C), while profilometry was used to 
characterize the line height or channel depth (d).  
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Three types of SiM were used in this study, with the following nomenclature: 
MICRO-L-25K-125K (Figure IV. 1 A), MICRO-L-25K-75K (Figure IV. 1 B) and MICRO-L-
25K-50K (Figure IV. 1 C) which define their main features. And accordingly, three 
types of PC-µCh are generated from each mold named: PC-µCh25K-125K, PC-µCh25K-75K, 
and PC-µCh25K-50K. 
 
Figure IV. 1 – Silicon Master and Polycarbonate micro-channels geometries.Characterization 
of Silicon masters (SiM) and polycarbonate micro-channels (PC-µCh) using SEM and 
statistical analysis of the SEM and profilometry data for each molding type. (A) SiM MICRO-
L-25K-50K image with marked details of line width (w1) and spacing (s1). (B) SiM MICRO-L-
25K-75K image with marked details of line width (w2) and spacing (s2). (C) SiM MICRO-L-25K-
125K image with marked details of line width (w3) and spacing (s3). (D) PC-µCh25K-50K image 
with marked details of channel width (w1’) and spacing (s1’). (E) PC-µCh25K-75K image with 
marked details of channel width (w2’) and spacing (s2’). (F) PC-µCh25K-125K image with marked 
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details of channel width (w3’) and spacing (s3’). Statistical analysis of the differences in 
features between SiM and PC-µCh for the pattern 25K-50K (G), 25K-75K (H) and 25K-125K 
(I). 
1.1. 25K-125K geometry 
The first SiM type investigated, MICRO-L-25K-125K, presents width (w1) of 24,78 
± 0,07 µm, spacing (s1) of 100,30 ± 0,06 µm and height (d1) of 26,19 ± 0,01 µm (Figure 
IV. 1 A, G). The corresponding imprinted samples generated by this SiM are named 
PC-µCh25K-125K. Those PC-µCh samples present micro-channel width (w1’) of 22,16 ± 
0,03 µm, spacing (s1’) of 99,87 ± 0,05 µm and depth (d1’) of 27,76 ± 0,01 µm (Figure 
IV. 1 D, G). After the measurements of each feature of the two samples, a comparison 
is performed using three independent t-student test with PRISM software. The first 
comparison investigates if there is a statistical difference between the SiM line width 
(w1) and the PC-µCh width (w1’), resulting in a p < 0.0001 (****). The second 
comparison investigates if there is a statistical difference between the SiM line 
spacing (s1) and the PC-µCh spacing (s1’), resulting in a p < 0.0001 (****). The last 
comparison investigates if there is a statistical difference between the SiM line 
height (d1) and the PC-µCh depth (d1’), resulting in a p < 0.0001 (****). In this case, 
all the differences between SiM features and PC-µCh features result to be strongly 
significant (Figure IV. 1 G). To conclude the analysis of this sample, knowing the size 
of the mold, the total number of microchannels in the mold was calculated to be 
equal to 48 channels/mold. 
1.2. 25K-75K geometry 
The second SiM type investigated, MICRO-L-25K-75K, present width (w2) of 24,33 
± 0,07 µm, spacing (s2) of 50,75 ± 0,06 µm and height (d2) of 26,19 ± 0,01 µm (Figure 
IV. 1 B, H),. The corresponding imprinted samples generated by this SiM are named 
PC-µCh25K-75K. Those PC-µCh samples present micro-channel width (w2’) of 22,27 ± 
0,03 µm, spacing (s2’) of 50,57 ± 0,04 µm and depth (d2’) of 27,00 ± 0,03 µm (Figure 
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IV. 1 E, H). After the measurements of each feature of the two samples, a comparison 
was performed using three independent t-student test with PRISM software, 
reporting the results in the same way as for the previous geometry. For this 
investigated sample, width and depth differences between SiM features and PC-µCh 
features result to be strongly significant (****), while the spacing difference 
between SiM line and PC-µCh result to be significant (*) (Figure IV. 1 H). In the 
present case, the total number of microchannels in the mold was estimated to be 80 
channels/mold. 
1.3. 25K-50K geometry 
The last SiM type investigated, MICRO-L-25K-50K, present width (w3) of 25,13 ± 
0,03 µm, spacing (s3) of 24,47 ± 0,04 µm and height (d3) of 26,19 ± 0,01 µm (Figure 
IV. 1 C, I),. The corresponding imprinted samples generate by these SiMs are named 
PC-µCh25K-50K. Those PC-µCh samples present micro-channel width (w3’) of 26,09 ± 
0,07 µm, spacing (s3’) of 22,40 ± 0,07 µm and depth (d3’) of 25,86 ± 0,05 µm (Figure 
IV. 1 F, I). After the measurements of each feature of the two samples, a comparison 
is performed using three independent t-student test with PRISM software reporting 
the results in the same way as for the previous geometry. In this case, all the 
differences between SiM features and PC-µCh features result to be strongly 
significant (****) (Figure IV. 1 I). For this mold, the total number of microchannels 
which is equal to 120 channels. 
 
These data confirm what was already reported in the literature, that hot 
embossing is an easy and highly reproducible procedure capable of transferring a 
pattern from a master to a polymeric material using a combination of temperature 
and pressure [306]. However, this pattern transferring does not result in a perfect 
matching between the features of the initial master and the polymeric material. 
Those little modifications are common in the application of hot embossing and are 
due to the thermal shrinking of the polymer, occurring during the cooling step which 
follows the molding phase [307]. Nevertheless, the reduced size of the micro-
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channels compared with the original line width, would not affect the biological 
experiments, since the range of interest for the development of capillaries structures 
is preserved [29, 264].  
For further experiments, the geometry 25K-50K with the µCh width of 26 µm and 
µCh spacing of 22 µm was chosen. This choice results from the fact that the overall 
width of the µCh was identical for the three types of geometry but, the SiM MICRO-
L-25K-50K allows to produce more µCh per unit of surface compared to the other 
two types, resulting in a higher surface area where capillary-like structures can be 
developed. From now on, polycarbonate material with this geometry will be simply 
indicated as PC-µCh. 
2. PART II: Biofunctionalization  
2.1. Layer-by-layer biofunctionalization 
To immobilize peptides on the various polycarbonate surfaces, we firstly 
deposited a polyelectrolyte multilayered film using the well-known layer-by-layer 
(LbL) deposition technique. Hyaluronic acid (HA) and chitosan (CHI) were chosen as 
polyelectrolytes based on their biocompatibility, their net charge at the working pH 
and the availability of free carboxylic groups to further graft the peptides of interest. 
First, the build-up of the LbL made of HA and CHI was followed by ellipsometry. 
One of the peculiarities of ellipsometry measurements is the requirement of a 
smooth surface, to limit the scattering of the laser beam during the measurements. 
Therefore, the ellipsometry study using PC films spin-coated on a 1x1 cm2 silicon 
wafer. Different concentrations of PC solution were prepared and spin-coated in 
order to determine which one would provide a homogeneous, thin and smooth 
layer. Concentrations of 0.5 g/L, 1 g/L, and 2 g/L were tested (Figure IV. 2 A), and the 
layer thickness was calculated based on the fitting of the simulation resulting in 4.4 
± 0.03, 6.1 ± 0.08 and 10.3 ± 0.3 nm, respectively (Figure IV. 2 B). 
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Figure IV. 2 - Ellipsometry measurements for PC-spin coated on the silicon wafer.(A) the Psy 
and delta values are given by the ellipsometer for 0.5, 1 and 2 g/L spin-coated PC with also 
the simulation curve of the material’s characteristics. (B) XY plot with linear regression to 
evaluate the correlation between PC film thickness and PC solution concentration. Detail of 
the R2 and equation of the line used. 
Figure IV. 2B shows that the resulting PC film thickness is linearly correlated with 
the concentration of the PC starting solution. To investigate polyelectrolytes growth 
by ellipsometry, we used the 6 nm thick PC layer obtained from the 1g/L PC solution 
for the spin-coating step. 
Prior to the deposition of HA/CHI bilayers, a first anchoring PEI layer was 
deposited onto the PC spin-coated film based on previous investigations [308]. When 
the precursor layer of PEI is adsorbed on the material surfaces, it enhances the 
polyelectrolytes multilayer film thickness and the amount of adsorbed polymer, 
regardless the materials’ substrate [308]. Since the first layer works as anchoring 
precursor for the further LbL deposition, the type of polymer used to anchor plays 
an important role, affecting the stability of the whole film [308]. The general 
architecture of the grown multilayers can be represented in this form: PC-
PEI(HA/CHI)n , with n indicating the number of deposited HA/CHI polyelectrolytes 
bilayers. (HA/CHI)n multilayer with n ranging between 4 and 24 bilayers were grown. 
All samples were freshly prepared and crosslinked with carbodiimide chemistry prior 
to each measurement, in order to preserve their stability. The LbL thickness with n= 
4, 8, 12, 16, 20, and 24 bilayers result in 16.8 ± 0.1, 43.2 ± 0.2, 112.0 ± 0.8, 159.0 ± 
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0.9, 260.2 ± 0.4, 373.8 ± 0.6 nm thick multilayers, respectively (Figure IV. 3 A). The 
final architecture is schematically represented in Figure IV. 3 B, with the particular 
interest in the repetitive alternation of CHI and HA typical of the LbL approach. The 
thickness of the final PC-PEI(HA/CHI)12.5 architecture in liquid conditions was 
measured after sample immersion in PBS/rhodamine red solution overnight, 
recording the fluorescence signal (Chapter II.1.4.6) resulting in 6 ± 1 µm thickness. 
The thickness of the final polyelectrolytes film depends, as previously investigated, 
on several parameters such as the salt concentration, the pH of the solution, the 
temperature, the nature of the polyelectrolytes, and the time of swelling [118, 119]. 
 
Figure IV. 3 - Layer-by-layer deposition characterization.(A) Polyelectrolytes growth while 
increasing the number of deposited bilayers measured in dry conditions using ellipsometer. 
(B) Schematic representation of the final PC-PEI(HA/CHI)12.5 architecture, named from now 
on PC-LbL (or PC-µCh-LbL). (C) CLSM cross-section view of LbL swelling in wet conditions 
using rhodamine red fluorescence. Measurements were performed after 16h incubation in 
PBS/rhodamine red solution at 4˚C. 
LbL is an attractive method for surface modification since it can be potentially 
applied to any type of substrate and provides support and multiple signals for cell 
adhesion and interactions [309]. In the present work, HA and CHI were used as 
natural polyelectrolytes for the build-up of the LbL coating onto PC substrates. The 
salt concentration of 0.15 M NaCl and pH 6 were chosen as build-up conditions, 
according to a previous publication showing that HA solubility decreases with 
increasing salt concentration [119]. The evolution of (HA/CHI)n coating thickness in 
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terms of the number of deposited bilayers, presented in Figure IV. 3, proofs that the 
LbL assembly of HA and CHI was successful under these conditions and that, as 
previously reported that the growth mechanism follows an exponential curve [119]. 
Richert et al. investigate the buildup process of hyaluronic acid/poly(L-lysine) 
(HA/PLL) multilayers formed by electrostatic self-assembly. This polyelectrolyte film 
constitutes one of the best known exponential growth system, where the thickness 
increases exponentially with the number of deposited layers. This exponential 
growth regime was shown to result from an ‘in’ and ‘out’ diffusion of PLL chains 
through the film during the buildup process. PLL diffuses throughout the film down 
to the substrate after each new PLL deposition and out of the film after each rinsing 
step and further after each HA deposition. As PLL reaches the outer layer of the film, 
it interacts with the incoming negatively charged HA, forming a new PLL/HA layer. 
Consequently, the thickness of the new formed PLL/HA layer is proportional to the 
amount of PLL that diffuses out of the film during the buildup step, which explains 
the exponential growth regime [119]. 
Covalent cross-link within the film was made in order to create covalent amide 
bonds between the carboxyl groups of the HA with the amine groups of the CHI. This 
protocol was taken from previous publications [119, 310] since it was applied already 
on CHI/HA LbL and characterized in terms of mechanical properties and film adhesive 
properties. It was also investigated how one micrometer thick films are sufficiently 
thick to do not allow cells to experience the underlying material [311].  
For all further experiments, the architecture PC-PEI(HA/CHI)12.5, corresponding to 
a coating thickness of about 120 nm, was used and, labeled as PC-LbL when applied 
on PC films, or PC-µCh-LbL when applied to PC with µCh (Figure IV. 3 B). We focus on 
the PC-PEI(HA/CHI)12.5 architecture for two main reasons: 12 deposition cycles were 
chosen according to previous investigations in which was shown how 120nm of 
CHI/HA bilayers develop a uniform film on the materials’ surface [119]. HA was used 
as the last layer in order to have a top surface richer in carboxylic acid groups to 
further perform peptides grafting using carbodiimide chemistry. 
After the determination of the thickness dry conditions, using ellipsometry, we 
focused on the swelling degree of the LbL when exposed to salt conditions, which 
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better mimic the real environment experienced during biological test analysis. In 
these wet conditions, the PC-LbL thickness measured by CLSM was 6 µm (Figure IV. 
3 C). This means that the multilayer swells by a factor of about 60 when going from 
the dry to the wet conditions. The swelling of the LbL was homogeneous without any 
small islets that would be characteristic of inhomogeneous polyelectrolytes build up 
[119]. The high degree of swelling observed in our work indicates that the degree of 
crosslinking remains rather low and that, consequently, not all the carboxylic groups 
of HA are involved in linking with amine groups of CHI but some are still available for 
the further grafting of peptides We, therefore, decided to maintain the 
functionalization focus on this architecture for the further chemical-immobilization 
studies and the biological investigations. 
2.2. Immobilization and penetration of peptides on 
materials’ surface 
The next step was the immobilization of adhesive and angiogenic peptides on the 
newly deposited PC-LbL surface. First, the amount of available carboxylic groups was 
determined using toluidine blue (TBO) test, reading the absorbance at 633 nm with 
a spectrometer. Results show a high concentration of carboxylic groups, on the PC-
LbL sample with 73 ± 4 pmol/mm2. 
In order to investigate whether the peptides were physically adsorbed on the LbL 
cushion or covalently grafted on it using carbodiimide chemistry, a test with different 
washing sonication steps was performed after the grafting steps of RGD-FITC 
peptide. Three materials’ chemistry were used and, for each of them, three different 
sonication exposition time were tested (0, 30, and 60 min) (Figure IV. 4 A). (1) PC 
films without biofunctionalization and without EDC/sulfo-NHS activation step 
(Chapter II.1.3.2) were immersed in RGD-FITC solution. Later, physically adsorbed 
peptide concentration was evaluated resulting in 0.9 ± 0.3 pmol/mm2, corresponding 
to 0 min sonication time. After the first wash time of 30 min, concentration results 
in 0.1 ± 0.05 pmol/mm2. Finally, after 60 min of sonication time, the concentration 
results in 0.4 ± 0.1 pmol/mm2. After the statistical analysis, no significant differences 
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were found for the PC material (Figure IV. 4 A). (2) PC films coated with HA/CHI LbL 
multilayer without the addition of the activating EDC/sulfo-NHS compound, named 
PC-LbL (Chapter II.1.3.2) were immersed in RGD-FITC solution. Physically adsorbed 
peptide concentration (0 min sonication) was evaluated resulting in 7 ± 2 pmol/mm2. 
After the first wash time of 30 min concentration result in 0.7 ± 0.1 pmol/mm2. 
Finally, after 60 min of sonication time, the concentration results in 0.9 ± 0.1 
pmol/mm2. Using this material PC-LbL, the statistical analysis identifies a significant 
difference (*) between the 0 min sonication and each of the two other sonication 
step of 30 and 60 min (Figure IV. 4 A(3) PC films coated with HA/CHI LbL multilayer 
with addition of the activating EDC/sulfo-NHS compound, named PC-RGD (Chapter 
II.1.3.2) were immersed in RGD-FITC solution. Physically adsorbed peptide 
concentration (0 min sonication) was evaluated resulting in 18 ± 3 pmol/mm2. After 
the first wash time of 30 min, concentration results in 18 ± 2 pmol/mm2. Finally, after 
60 min of sonication time, the concentration results in 21 ± 2 pmol/mm2. After the 
statistical analysis, no significant differences were found for the PC-RGD material 
(Figure IV. 4 A). 
Another important investigation was performed to evaluate the efficiency of 
peptides penetration into the LbL cushion (Figure IV. 4 B). In this case, RGD-FITC 
peptide was grafted as reported in the previous section (Chapter II.1.3.2) and 
analyzed at the CLSM (Chapter II.1.4.6) resulting in a 6 ± 1 µm (Figure IV. 4 B). To 
efficiently evaluate if the penetration of peptide corresponds to the whole LbL 
cushion thickness, we merge the signal with the Rhodamine red test (Figure IV. 3 C) 
resulting in a complete overlap (Figure IV. 4 C). 
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Figure IV. 4 - Characterization of immobilized-peptides.(A) Fluorescence quantification of 
peptides physically adsorbed on PC and on PC-LbL before and after sonication steps, as well 
as quantification of immobilized peptides on PC-RGD before and after sonication steps. (B) 
CLSM cross-section of RGD-FITC peptides penetration and (C) comparison with the LbL 
thickness shown in Figure IV. 3 C resulting in a merge of the fluorescent signal. 
Measurements were performed after 16h incubation in PBS solution at 4˚C. 
Peptides were chosen to induce adhesion and induce angiogenesis/tube-like 
formation. In the specific case of RGD sequence, this peptide is already largely 
investigated in tissue engineering application to improve cell adhesion even after 
immobilization onto materials’ surfaces [1, 312]. However, in order to determine the 
number of peptides that were covalently immobilized on the PC substrates and to 
verify that our protocol of washing the physically adsorbed peptides was efficient, a 
quantification was performed at different sonication times. 
In order to determine the number of peptides that were covalently immobilized 
on the PC substrates, and to verify that our protocol of washing the physically 
adsorbed peptides was efficient, a quantification was performed at different 
sonication times.  
Only the PC-LbL presents a significant difference of immobilized peptide density 
before and after sonication (Figure IV. 4 A). As previously reported for PLL/PGA LbL 
composition [313], our PC-LbL material based on CHI/HA is expected to adsorb 
peptides in the LbL cushion. The removal of physically adsorbed peptides was 
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successfully proven by the difference in fluorescence intensity between the 
untreated sample and sonicated sample for 30 min, considering equal signal 
acquisition method per each measure. This result, justify perfectly the effectiveness 
of the sonication step for the adsorbed peptides removal. In addition, the constant 
level of fluorescence intensity after 60 min of sonication, compared to the 30 min of 
sonication, proofs how all the physically adsorbed peptides were already efficiently 
removed after the initial first 30 min of sonication, and therefore this time was 
selected for the further experiments. 
On the contrary, on the virgin PC film between 0 and 30 min sonication time, 
there are no significant differences in fluorescence intensity, since the absence of a 
LbL cushion does not allow the adsorption of a high amount of peptides on the 
surface. In addition to this point, we can conclude that the sonication step does not 
affect the stability of the LbL cushion, resulting in an efficient and non-destructive 
method to remove only the physically adsorbed peptides and not affecting the bi-
layer architecture. As a proof of what was just discussed, the high-intensity signal 
found in the sample treated with carbodiimide chemistry, PC-RGD, persists both 
before and after the two sonication steps, without any significant difference in the 
quantification of the fluorescent signal. From this, we can evince how the 
immobilization of the peptide was successful and not altered by the sonication steps, 
even during the longest exposition time. 
Another key point of the in materials’ surface characterization is to deeply 
understand the distribution of the immobilized molecules in it. In fact, 
immobilization of peptides could be superficial, following a gradient of penetration 
or being homogeneously dispersed. In order to understand how our peptide would 
be immobilized on the LbL cushion, two tests were performed. RGD-FITC penetration 
after immobilization in the LbL was characterized in 0.15M NaCl ph6.0 using confocal 
laser scanning microscopy (CLSM) (Figure IV. 4 B). We compared the thickness, 
resulting from the penetration of the peptide, with the total thickness of the swelled 
LbL previously investigated with Rhodamine red at point 1.2 of this chapter and 
showed in Figure IV. 3 C. It results how the signal from peptide penetration and LbL 
thickness is perfectly overlapping, indicating that the peptides during the 
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immobilization step were able to penetrate completely into the entire LbL thickness, 
resulting in a total thickness of 6 ± 1 µm (Figure IV. 4 C). From this important result, 
we conclude that the impact of the peptides on the cells would be determined only 
by the homogenous immobilization of them, and not by a gradient in the LbL cushion.  
2.3. Quantification of RGD, SVV and QK peptides on PC-
LbL 
Peptides are potent small molecules which can specifically trigger intracellular 
signaling, affecting the cellular activity and morphology [158, 230-232, 234, 238, 241-
243, 246, 248]. In our work three main fluorescent-peptides are used (Chapter II.1.1.) 
to quantify their concentration after immobilization: RGD-FITC, SVV-FITC, and QK-
FITC.  
Considering that our system has a third dimension in space which is the not-
negligible thickness of the LbL, it would have been more appropriate to report the 
peptide concentration in volume units (cm3 or mm3) instead of the surface units (cm2 
or mm2). However, as we did not find any reported peptide grafting density per unit 
of volume in the literature that would allow comparisons, we also reported the 
peptide grating per unit of surface area. 
The immobilized peptide density was quantified using the corresponding 
calibration curve for each peptide used (Figure IV. 5). Data are presented in Table IV. 
1. The lowest grafted peptide density results from PC-RGD sequence immobilization 
(18 pmol/mm2), followed by PC-SVV sequence immobilization which results in an 
intermediate density (34 pmol/mm2), and the highest grafting density was obtained 
with PC-QK sequence immobilization (55 pmol/ mm2). 
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Figure IV. 5 - Calibration curve of fluorescent RGD, SVV and QK.Curves of RGD-FITC in blue, 
SVV-FITC in red and QK-FITC in green. For each curve are also represented the goodness of 
fit (R2) and their equation are also presented. 
Table IV. 1 – Quantification of immobilized peptides Peptide density for RGD-FITC, SVV-FITC, 
and QK-FITC. The density is measured in the different type of units to allow a comparison 
with the different resources found in the literature. 
 Mean ± standard 
error 
Mean ± standard 
error 
Mean ± standard 
error 
Concentration nmol/cm2 pmol/cm2 molecules/nm2 
RGD-FITC 1.8 ± 0.3 1800 ± 310 11 ± 2 
SVV-FITC 3.4 ± 0.4 3400 ± 370 20 ± 2 
QK-FITC 5.5 ± 0.2 5500 ± 150 33 ± 1 
 
In order to predict the effect of the second functionalization with peptides 
immobilization, we compared some previously published works in which the focus 
was based on the immobilization of the same peptide sequences, but on different 
material. RGD is the most known and used peptide which improve cellular adhesion, 
especially when immobilized on surfaces. Previous work demonstrated how cells 
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require a density as low as 1 fmol/mm2 to adhere and spread on glass surface [314]. 
In other works using polyethylene terephthalate (PET) [171] or titanium [315] RGD 
density was reported as 1.8 and 6 pmol/mm2 respectively. In a previous work of 
Gribova et al. the amount of RGD grafted onto an LbL of (PGA/PLL)6.5 was evaluated 
3 pmol/mm2 [316]. Chua PH et al., instead quantify the amount of RGD grafted on 
Ti-(HA/CHI)5 as high as 0.15 pmol/mm2. Laslie-Barbick et al. were able to immobilize 
RGD peptide PEG hydrogels at peptide density of 80 pmol/mm2 [317]. 
In the present work, the RGD (GRGDS sequence) grafting density is evaluated to 
be 18 ± 3 pmol/mm2. This value lies in between the one reported by Gribova et al. 
(CGPKGDRGDAGPKGA sequence) [316] and the one reported by Laslie-Barbick et al. 
(RGDS sequence) [317] and is much higher than the minimum RGD density required 
for cell adhesion reported by Massia. et al. [314]. Our results also demonstrate that 
the RGD-FITC peptide penetrates into the entire swollen LbL in wet conditions. As 
among the different tested peptides, RGD-FITC showed the lower grafting density 
but a complete penetration into the LbL film, it is highly probable that the other two 
peptides SVV-FITC and QK-FITC, which present a higher grafting density, also fully 
penetrate into the LbL cushion. 
Concerning angiogenesis and capillary-like formation, SVV and QK peptides were 
used in our work based on literature reviews of previous works. SVV peptide was 
already used as a potent angiogenic factor with a similar impact as VEGF in solution 
inducing the formation of capillaries [318], however, when grafted onto a surface 
material it was able to acquire both cell adhesion properties and promote 
neovascularization in artificial bone marrow scaffold [165-167, 242]. SVV peptide 
was already successfully grafted onto a modified gold substrate using EDC/NHS 
chemistry resulting in 1.6 ± 0.2 pmol/mm2 [319], and on PET surface using same 
chemistry resulting in 20 pmol/mm2 [167].  
Regarding the PC-SVV, our SVV peptide density results in 34 ± 4 pmol/mm2 which 
is, as for the case of PC-RGD higher than previously investigated. Therefore, we 
expect to have a significant impact of immobilized SVV peptide when grafted to the 
LbL cushion in the development of tubular-like structures. In addition, also, in this 
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case, the consideration of a three-dimensional substrate where peptide was 
successfully grafter is still valid. 
QK peptide, the most used VEGF-mimetic peptide, is largely studied when used 
in solution in vitro for activation of VEGF receptors (VEGFRs) [248] and in vivo to 
enhance neovascularization of burn wounds in mice [247, 249]. Even after 
immobilization, it was shown how QK peptide preserve the bioactive properties in 
terms of angiogenetic protentional [317, 320] [321]. Chan et al. demonstrate a local 
increase of HUVEC tubulogenesis and increased endothelial sprouting with 
immobilized QK peptide of 55 pmol/mm2 onto 2D collagen substrate [320]. Laslie-
Barbick et al. demonstrate how covalently immobilized QK increased in vitro HUVECs 
migration and tubulogenesis and in vivo angiogenesis. In their studies 23 pmol/mm2 
of QK were immobilized on PEG hydrogels [317]. 
Concerning PC-QK material, our peptide density results in 55 pmol/mm2 which is 
equal with the density achieved by Chan et al. and comparable with the range 
investigate in the PEG hydrogels by Laslie-Barbick et al. Therefore, like in the case of 
SVV, we expect to have a significant impact of immobilized QK peptide when grafted 
to the LbL cushion in the development of tubular-like structures. 
Further studies should be performed in order to investigate exactly the ratio 
between the grafting of peptide combinations (like in the case of RGD+SVV and 
RGD+QK). It would indeed be interesting to evaluate, how the presence of one 
peptide would influence the grafting of the other peptide and in which ratio the two 
peptides would coexist on the materials’ surfaces. It is surprising how the longest 
peptides used, QK, presents as well the highest concentration after grafting, while 
the intermediate SVV peptide presents an intermediate concentration, and finally, 
the shortest sequence of RGD presents also the smallest concentration after grafting. 
Logically, one would have expected that the shortest peptide RGD presents the 
highest concentration, thanks to better diffusion into the LbL film. One potential 
explanation can be that the presence of large FITC molecule could influence the 
efficiency of the formation of amide bonds during the grafting due to charges or 
steric hindrance. 
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2.4. Preserving a selective functionalization into µCh 
To selectively preserve the functionalization only inside the µCh of the sample, a 
scratch test was performed on half of the materials’ surface using a metal blade on 
LbL-RGD-FITC samples. Fluorescence microscopy was used in order to measure 
differences in fluorescence intensity between the half materials’ surface scratched 
and the half not scratched (Figure IV. 6). The signal differences were evaluated 
between the top part of the material with scratch and without the scratch, as well 
as between the bottom part of the material inside the µCh with scratch and without 
the scratch. The signal from the top of the not-scratched region differs significantly 
with the region scratched with p < 0.0001 (****). In the case of the bottom of the 
µCh, the signal in the region not-scratched and the one scratched do not present any 
significant difference (Figure IV. 6 E). 
 
Figure IV. 6 - Selective functionalization of micro-channels. (A) Schematic representation of 
a half scratched sample of PC-µCh-LbL-RGD-FITC with a particular focus on the green region 
(FITC) or light blue region (PC). (B) In the region not scratched the brighter region represent 
the spacing (s) between channels (w) which are less bright. (C) In the region where the 
scratch started spacing non-scratched (s), spacing scratched (s’), channel not scratched (w), 
and channel scratched (w’) can be identified. (D) In this region spacing (s’) and channel (w’) 
fully scratched can be identified. (E) The t-test for spacing results significantly different in 
the fluorescence intensity, compared to the non-significant difference between the 
channels regions. 
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The region of PC-µCh-RGD-FITC sample not scratched shows a stronger signal 
between the micro-channels, in the spacing region (s), this is due to the type of focus 
used for the image acquisition, which results in a larger light component coming from 
the top part of the sample, compared to the region deep inside the micro-channels 
(w). The resulting fluorescent signal is homogeneous between the spacing region and 
is homogenous also between the channel regions, but they do not correspond to the 
same signal intensity between themselves (Figure IV. 6 B, E). In the region, half-
scratched (Figure IV. 6 C), large differences are observed between the spacing which 
underwent a scratch (s) and the one which did not (s’). This difference is confirmed 
by the quantification and it results in a significantly strong difference (Figure IV. 6 C, 
E). Regarding the signal change between the channel which underwent scratching 
(w) and the one which did not (w’), there is no evidence of a statistical difference 
(Figure IV. 6 E). Finally, the region fully-scratched present a very low signal on the 
spacing area (s’) compared to the micro-channels area (w’) which do not show the 
higher intensity in the overall picture (Figure IV. 6 E). It is important to notice how 
the micro-channel signal results in a homogenous surface, without any trace of 
scratch or peptide removal. 
Therefore, we can conclude from the scratching assay that it is possible to get a 
selective removal of the LbL-RGD-FITC cushion only in the upper part of the sample 
where the spacing between channel exists, without affecting the functionalization 
inside the channels, which is the region of interest for the future biological 
evaluations in the development of capillary-like structures. 
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3. PART III: Capillaries development 
3.1. Sterilization protocol for HUVEC adhesion 
In order to successfully seed HUVECs cells on the material, and on the tissue 
control plate (TCP) as control, two sterilization process of the material have to be 
optimized (Chapter III.1.3.3.). The first approach, named approach A was chosen 
according to the previously investigated sterilization method with PET material 
(Figure IV. 7) [166, 167]. Preliminary results using HUVECs on PC materials, identify 
a consistent cellular death in both; the functionalized materials, and the surrounding 
TCP without the biofunctionalized materials. The second approach investigates 
named approach B, is a variation of the first one, with modifications in the exposition 
time to ethanol and the drying plus washing steps (Figure IV. 7). Using the second 
approach, no cellular death was identified in neither the samples or the surrounding 
TCP. 
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Figure IV. 7 - Two sterilization approaches. Approach A uses an overnight immersion in 
ethanol 70% followed by 1 hour of drying step and three washing steps of 10 min each with 
PBS. After HUVECs seeding and 24h incubation a massive cell death was found. Approach B 
use 15 min immersion in ethanol 70% followed by 45 min of drying step and three washing 
steps 2 min each with PBS. After HUVECs seeding and 24h incubation, cells were alive and 
adhered on the TCP material. 
The model which we used to explain the initial cell death involved the 
evaporation and diffusion of the ethanol entrapped into the PC film which is released 
after incubation at 37˚C (Figure IV. 7). The sterilization with approach A result in a 
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toxic condition for the surrounding HUVECs, leading to massive cell death due to the 
evaporation of the ethanol entrapped into the polymer when exposed for a long time 
at 37˚C in the cell incubator. In fact, it is known that ethanol is absorbed by PC up to 
0.08 g/g of polymer [322] Considering the small diffusion coefficient of ethanol in 
glassy PC of 10-12 cm2/sec [323], we can estimate that it would probably take the 
same time (overnight) to remove completely the ethanol inside the PC than for the 
immersion in ethanol. Therefore the exposition time to ethanol and the drying step 
were changed. 
The optimized sterilization approach, approach B (Figure IV. 7), do not present 
any toxicity, and in addition, no contaminations were reported in the tested samples, 
indicating both the successful sterilization of the materials and the non-toxicity 
linked to ethanol entrapment. Therefore, the approach B was used for all the future 
cellular experiments. 
3.2. Counting of HUVEC. Malassez vs Pico green 
(sonication tests also) 
In order to properly quantify the number of cells adhering both on the 
biofunctionalized materials or the TCP, a precise and reliable method has to be used. 
Two main techniques were investigated in this work, preliminary on TCP material: 
Malassez chamber counting (Chapter III.2.1.2.) and Pico Green assay (Chapter 
III.3.2.). A preliminary result, to investigate which technique is the most precise, 
HUVECs cells were let adhere on the TCP material for 24h, detached, counted and 
compared with the initial amount of HUVECs seeded.  
The first technique, based on trypsin detachment and brightfield microscopy 
counting with Malassez chamber, corresponds to the most common method used. 
In our case on TCP, after 24h of seeding 100’000 HUVECs only 49’632 ± 1’757 cells 
were effectively counted under the microscope. For 50’000 HUVECs seeded, only 
33’169 ± 1’602 cells were counted and for 25’000 HUVECs seeded, 27’280 ± 1’016 
cells were counted (Figure IV. 8 A). 
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The second technique is based on a selective interaction between a fluorescent-
DNA-intercalant and fluorescent quantification signal, later converted in cell number 
(Figure IV. 8 B). Using this technique, the dsDNA extraction is the crucial step, and 
therefore to optimize the amount of extracted dsDNA three power-mode were 
selected, according to the ultra-sonicator characteristics: power 3 (P3), power 4 (P4) 
and power 5 (P5) (Figure IV. 8 B). To help in visualizing the theoretical value of cells 
counted per each seeding concentration, three different dash-lines are represented 
in Figure IV. 8, indicating 100’000, 50’000, and 25’000 cells in blue, red and green 
respectively. The DNA quantification, converted in cell number, is summarized in 
Table IV. 2 indicating the amount of cell counted per each power-mode selected. 
 
Table IV. 2 – Correlation of HUVECs count and sonication power used. Number of HUVECs 
counted using different ultra-sonication power after 24h seeding in 48-well plate. 
HUVECs 
seeding 
Power 3: 
# HUVECS ± SEM 
Power 4: 
# HUVECS ± SEM 
Power 5: 
# HUVECS ± SEM 
100’000 66’348 ± 3’169 70’628 ± 1’688 90’012 ± 3’062 
50’000 43’301 ± 337 39’569 ± 2’175 50’710 ± 2’546 
25’000 20’112 ± 494 19’210 ± 1’211 23’130 ± 2’031 
 
 
Figure IV. 8 - Number of HUVECs counted after 24h seeding using two techniques. (A) 
Counting with Malassez chamber under the microscope, according to three different initial 
seeding concentrations. (B) Quantification with Pico Green assay after ultra-sonication step 
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at three different power mode. Also, in this case, three different initial seeding 
concentration were tested. Blue-dash line report the maximum confluent value for the 48-
well plate used, reported to be 95’000 cells. The red-dash line indicates 50’000 cells level. 
Green-dash line indicates 25’000 cells level. 
Determine with precision the number of cells is crucial in biological investigations 
such as adhesion studies or metabolic activity studies. Therefore a precise protocol 
needs to be defined to determine whether one sample contains more cells than 
another one. Firstly, the common approach of detaching adhesive cells using trypsin-
EDTA was used counting the cells with the Malassez chamber. However, the large 
difference between the cell-seeded originally, and the cells detached after 24h of 
incubation was too large to be considered reliable for the further biological 
investigations. The difference is significantly evident for the highest cell seeding 
condition with p < 0.0001 (****), showing a 48% reduction between the theoretical 
value of cell confluency 95’000 cells and the cells counted. As well, the second 
seeding condition presents a strong statistical difference with p < 0.0001 (****) and 
decrees of 34% from the initial seeding of 50’000 cells. Contrariwise, the lowest 
concentration does not present any difference between the cell initially seeded and 
the one counted after 24h. 
This might indicate that at high cellular density, trypsin does not work efficiently 
with highly confluent cells, to allow a complete detachment from the 48-well tissue 
culture plate (TCP). 
To overcome the problem, another approach was used, lysing the cells directly 
on the well plate, without a need for a detachment step. In this case, three 
instrumental setting were tested increasing the power of the ultra-sonicator. There 
is a significant difference between the power used to lysate the cells, and the 
quantification of cells, through their DNA. In fact, we can notice how the P3 and P4 
set-up give a significantly lower number of counted cells, compared to the expected 
one for all the three seedings’ concentration used. However, the P5 set-up shows no 
significant difference versus the relative theoretical cell density, per each used 
condition, resulting in the most reliable approach for an accurate count of cells. 
Therefore, considering an equal cellular adhesion in each sample, at the different 
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seeding concentration, the efficiency of dsDNA extraction using the ultra-sonication 
with power 5, is much higher than the other two. And as result, the number of 
HUVECs counted correspond to the number of HUVECs initially seeded. 
3.3. Metabolic activity of HUVECs 
Metabolic activity was measured after 18 hours using XTT kit on HUVECs cells, 
seeded on flat PC, flat PC-LbL and flat PC-LbL functionalized with RGD (PC-RGD), SVV 
(PC-SVV), QK (PC-QK) peptides and their combinations, as well as in the 48-well plate 
(TCP) as control (Figure IV. 9 A). The first investigation reports how the cells grown 
on TCP show the highest signal, significantly different against all the others with p < 
0.0001 (****) in each case. The second highest signal comes from PC-RGD sample 
presenting a strong statistical difference against PC-LbL and the other single-peptide 
materials PC-SVV and PC-QK, with p < 0.0001 (****). Then the samples containing a 
combination of peptides PC-RGD+SVV and PC-RGD+QK present a similar signal 
compared with PC-RGD sample, with significant difference against the single-peptide 
samples PC-SVV and PC-QK with p < 0.01 (**) and p < 0.05 (*) respectively (Figure IV. 
9 A). 
Then the second analysis reveals the number of cells present in each sample, 
using the PicoGreen assay developed previously. In this case, the highest cell density 
was found in the TCP with a strong significant difference compared with all the other 
samples with p < 0.0001 (****). Then sample PC-RGD shower the second highest 
concentration with strong significant difference against all the other samples with p 
< 0.0001 (****). All the other samples do not present a significant difference 
between each other (Figure IV. 9 B). 
The last analysis, results in the adjustment of the metabolic activity signal, against 
the number of counted cells per each material condition. We define this new value 
as corrected absorbance. In this case, the signal from TCP sample reduced 
considerably being not different from PC-LBL or PC-RGD. However, the samples with 
peptide combination PC-RGD+SVV and PC-RGD+QK show a significant increment, 
resulting as the two highest conditions tested with a significant difference against all 
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the other samples presenting only one peptide PC-RGD, PC-SVV, and PC-QK (Figure 
IV. 9 C). 
 
Figure IV. 9 - Biological evaluation on metabolic activity. (A) The absorbance recorded 
directly after XTT test. (B) The number of cells counted in each sample using PicoGreen assay 
(power P5). (C) Metabolic activity of HUVECs after the correction for the relative cell number 
per each sample. 
In our studies, cells were seeded into a serum-free medium for the initial 4h of 
incubation in the case of XTT metabolic activity. This removes any possibility of the 
presence of adsorbed proteins which would enhance cell adhesion, and allow us to 
ensure a specific interaction between the cells' receptors and the peptides used. 
HUVECs are largely used for angiogenesis study and formation of vessel-like 
structures in vascular tissue engineering [324-326]. The studies on metabolic activity, 
after correction, showed a higher metabolism for peptide combination of RGD+QK 
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or RGD+SVV compared to each single-peptide version (Figure IV. 9 C). Further 
experiments are needed to fully understand the impact of the double peptide 
combination, however, some previous studies have been investigated the effect of 
co-immobilized RGD with VEGF [327] bFGF [328] and insulin [329] proving a 
synergistic effect on endothelial cells’ adhesion and proliferation compared to only 
RGD immobilization. Also, the crosstalk between the receptor 2 for VEGF and RGD-
binding integrins have been previously investigated [330-333] leading to a possible 
synergistic effect between the two in terms of cellular adhesion (Chapter I.4.2.1.), 
focal adhesion order, integrin activation, and migration speed. Le Saux et al. in a 
previous work reported an enhanced endothelial cells response depending on the 
grafting density of RGD [331]. Noel et al. reported a successful grafting of RGD 
peptide (1nmol/cm2) and VEGF protein (50fmol/cm2) showing a clear evidence of the 
additive effect of their combination [327]. 
Based on our investigations, would be interesting to answer the question about 
how deep cells’ receptors would be capable of binding the peptides entrapped into 
the LbL film. In fact, investigating how much of the LbL-peptides would be “visible” 
by HUVECs would help to investigate also the minimum thickness of LbL-peptides, in 
order to trigger the desired development of capillaries structures, with the minimum 
waste of polysaccharides and peptides to efficiently move the application to a closer 
clinical approach. However, more sophisticated studies would be required to answer 
this question, and therefore for the lack of time, it was not possible to study deeper 
this aspect. 
3.4. Centrifuge-based seeding approach of HUVECs 
In order to specifically seed HUVECs inside the micro-channels of polycarbonate, 
a centrifugation approach was developed and investigated. After HUVECs seeding, 
centrifugation was applied resulting in a perpendicular force which forces the 
HUVECs on the spacing between channels, to fall into the channels (Figure IV. 10 A). 
This allows both to selectively focus the work inside the micro-channels and at the 
same time, increase the density of HUVECs into them to increase the number of 
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tube-like structures. To effectively prove that the approach was working efficiently, 
a bright field image was acquired immediately after centrifugation (Figure IV. 10 B). 
Three important regions can be identified in the Figure IV. 10 B which are the border 
of the sample, without channels (red arrow), the spacing between channels (blue 
arrow) and the micro-channels (green arrow). We can clearly appreciate how there 
are no HUVECs laying in the spacing region between channels, while all the HUVECs 
are laying inside the micro-channels. 
 
Figure IV. 10 - Investigation of centrifugation seeding approach. (A) Schematic 
representation of the seeding approach showing the initial condition of HUVECs after their 
seeding on the materials, the forces applied on the cells during the centrifugation step, and 
their new localization at the end of the centrifugation step. (B) Bright field image of HUVECs 
seeded uniquely inside the micro-channels after the centrifugation step. Green arrow 
indicate the micro-channels, blue arrow indicate the space between two channels and the 
red arrow indicate the flat region, without channel at the edge of the sample. 
Raghavan et al. developed a microchannel structure in PDMS and seeded HUVECs 
cells into the channels using a similar approach to ours [65]. They reported that after 
the microchannels development, the material was immersed in liquid collagen and 
later, HUVECs resuspended in liquid collagen were seeded on the material surface 
and centrifugated to drive them into the channels (Figure I. 20) [65]. 
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3.5. Time lapse epi- fluorescence microscopy 
The very first evaluation of tube formation using HUVECs in PC-µCh 
functionalized materials was performed using the fluorescent microscope (LEICA 
DM5500B), equipped with the cell-culture chamber to maintain the proper 
temperature and CO2 level constant. Lei et al. developed a time-lapse acquisition for 
12 hours to investigate the development of capillary-like structures on flat-patterned 
PET material [166]. In this work the aim was to follow the evolution of the capillary 
formation in two-dimensional conditions, investigating the optimal time for the 
development of capillaries. However, in our experiment, an epifluorescence 
microscopy does not have enough resolution to visualize the complex three-
dimensional structure developed inside the micro-channels of the PC. In addition to 
this, it is impossible in our case to define a priori one single focal plane to follow the 
three-dimensional evolution of the capillaries during the entire time of the 
experiment. On top of those limitations, the microscopy presents a focus drift which 
generates a shift in the imaged focal plane, altering the initial parameters selected 
to follow the capillary formation and making impossible to perform a precise 
analysis. For all those reasons, CLSM with higher resolution (Chapter III.3.3.1.) in the 
cross-view reconstruction and reduced focal drift was chosen for the further 
experiments. 
3.6. Time-lapse confocal microscopy 
In order to obtain a better resolution for the image analysis, CLSM (Chapter 
III.3.3.1.) was performed with a setup for long-term cell culture (Figure IV. 11). The 
setup consists of a temperature controller to maintain 37˚C, and a 5% CO2 supplier. 
A time-lapse acquisition was performed on multiple PC-QK biomaterials and on 
multiple micro-channels of the same sample from 10 minutes after cell seeding, to 
840 min after cell seeding (Figure IV. 11). Our work wanted to follow the evolution 
of HUVECs during the development of capillaries structure, like in a previous work of 
Moon et al., which report a time-lapse confocal video-microscopy of HUVECs alone 
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or HUVECs and 10T1/2 cells encapsulated in PEG-hydrogels to follow endothelial 
tubule formation for about 70 hours [91]. 
 
Figure IV. 11 – Time-lapse acquisition of HUVECs on PC-µCh-QK. Scheme of HUVECs seeded 
into PC- µCh-QK (first left) and CLSM images of time-lapse acquisition showing the cross 
section and top views at different time-points from 10 min after seeding up to 840 min after 
seeding. 
Two different conclusions we can report from this analysis. The first one is 
concerning the auto-focus adjustment, in fact, no focus drift was detected during 
more than 13 hours of exposition resulting in a reliable method to maintain a stable 
acquisition.  
The second conclusion is that cells are not moving during the entire time-set of 
acquisition, a clear indication of cell death from the beginning of the experiment. 
Therefore, even after implementing the set-up for the time-lapse acquisition in 
collaboration with the Bordeaux Imaging Center, it was not possible to reproduce 
experiments in a reliable way with this approach. 
Two main causes can be identified. First, the transfer of cells between our cell 
culture facility and the facility of Bordeaux Imaging Center which resulted in a 
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stressful condition, due to long transfer without temperature and CO2 supply. This 
leads to cell death even before starting the experiment. Second, even though a 
culture performed in-loco, cells underwent a rapid death and detachment within 30 
min after the beginning of the experiment, indicating that some of the 
environmental parameters like temperature or the level of CO2 were not adequately 
precise to ensure a long-lasting time-lapse experiment. Unfortunately, the 
insufficient time did not allow us to solve the problems linked to the culture 
transport and the environmental controls. However, the experiment was repeated 
using fixed time-points instead of a time-lapse, explained in the next section of this 
same chapter. 
3.7. HUVECs on functionalized PC-µCh: late time-point 
investigation 
In order to assess the proper time-point in which HUVECs would develop a tube-
like structure, several samples were fixed at different times from 18 hours to 26 
hours in the sample PC-µCh-RGD+QK. As result, HUVECs cells are able to grow both 
inside the micro-channels region (Figure IV. 12 brown arrows) and between two 
channels, in the upper space (Figure IV. 12 green arrows). However, the percentage 
of HUVECs growing between two channels is higher than the percentage of HUVECs 
growing inside the micro-channels. In fact, there seems to be a driving force for the 
HUVECs to migrate from the bottom of the channels, in which they were originally 
seeded through centrifugation approach, to the top of the channel spacing. This 
effect might be due to constriction of the small size of the channels or simply a 
migration effect from a higher concentrated region to a lower concentrated region 
and the fact that micro-channels were left open, inevitably allow to HUVECs a free 
degree of freedom to migrate. 
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Figure IV. 12 – Fixed HUVECs cultured on PC-µCh-RGD+QK. CLSM images of HUVECs culture 
growing on PC-µCh-RGD+QK sample and fixed each 2 hours starting from 18h, ending at 26h 
after seeding. Brown arrows represent the micro-channel region, green arrows indicate the 
regions between two micro-channels. Nuclei colored in blue, and cytoskeleton in red. 
After image analysis, no tubular-like structures were found both inside the micro-
channels, nor in the spacing between channels, indicating that the following range 
of time-points would not suit for the development of those structures. A previous 
publication, however, showed how the initial formation of tubes around 21 hours 
was visualized when HUVECs are embedded into PEG-hydrogels [91] and after 24 
hours for HUVECs embedded into collagen matrix and seed inside micro-channel 
structure of PDMS [65]. 
3.8. HUVECs on functionalized PC-µCh: wide time-point 
investigation 
After the previous analysis with 5 time-points in the sample PC-µCH-RGD+QK, a 
new experiment was performed to investigate a more broad range of possible time-
points and evaluate the formation of tube-like structures in the different sample PC-
µCh-RGD+SVV. Therefore, 11 time-points were acquired and analyzed using CLSM 
and Fiji software (Chapter III.4.1) in order to evaluate the spatial organization of cells 
inside and outside the micro-channels. HUVECs initially lay only inside the micro-
channels (Figure IV. 13 4 h) both at the bottom and at the side of them, later they 
start to slowly migrate more on the side of the channels (Figure IV. 13 6 h, 8 h, 10 h) 
until they reach the upper part of the sample, in the interspace between two 
channels (Figure IV. 13 12 h). Starting from this point HUVECs start to be less present 
Results and Discussion 
 161 
inside the micro-channels and more present in the spacing region (Figure IV. 13 14 
h, 16 h, 18 h), until the moment in which there is almost a complete migration of 
cells in the spacing between channels (Figure IV. 13 20 h, 22 h, 24 h). 
 
Figure IV. 13 - Fixed HUVECs cultured on PC-µCh-RGD+SVV. CLSM of HUVECs growing and 
migrating in PC-µCh-RGD+SVV sample. Indicated fixed samples from 4 hours after seeding 
up to 24 hours after seeding. Per each time-point, the upper rectangular image represent 
the cross-section view, while the square image represent the top-view of the sample. The 
white rectangles drown upon each image represent the region with PC while micro-channels 
are indicated using their abbreviation (µCh). HUVECs were stained with red-cell tracker and 
the nucleus with DAPI. 
The wide time-points analysis, unfortunately, did not show the expected 
formation of tube-like structures in any of the analyzed samples. However, a more 
clear understanding of cell migration was achieved following the general trend of 
HUVECs. In fact, HUVECs move from the bottom of the channels, which are originally 
confined thanks to the centrifugation seeding, to the side, and then the top part of 
the sample. Surprisingly, even if the spacing area between channels was previously 
scratched to remove the LbL and the immobilized peptides, seems that HUVECs 
found the way to interact with that material and migrate consequently. 
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3.9. HUVECs on functionalized PC-µCh: early time-point 
investigation 
CLSM was performed on HUVECs cells, fixed each hour for 5 hours respectively 
to observe the formation of tubular structures with the empty lumen in the middle 
(Figure IV. 14 white arrows details). From the first sample, functionalized with RGD 
and QK peptides after 1 hour of HUVECs incubation cells just started the adhesion 
process inside the microchannels, as can be seen by their morphological shape which 
is still mostly round but with the presence of adhesion sites. In addition, all the cells 
are localized inside the channels, preferentially at the bottom of the channels (Figure 
IV. 14 A, 1h). After 2 hours HUVECs are already able to migrate from the bottom of 
the channels to the side and close the structure in a tubular-like morphology (Figure 
IV. 14 A, 2h white arrow). From the top view, the location of the tubular-like 
structure is indicated with a white dash line. After 3 hours HUVECs maintain their 
characteristic tubular-like structure (Figure IV. 14 A, 3h white arrow) but also they 
start to migrate between two channels in the inter-distance space region (Figure IV. 
14 A, 3h). After 4 hours the presence of tubular-like structure is maintained (Figure 
IV. 14 A, 4h) and more HUVECs are migrating between two channels (Figure IV. 14 
4h). After 5 hours all the HUVECs show the same morphology spreading both inside 
and outside the micro-channels, without the presence of tubular-like structure 
(Figure IV. 14 T5h). 
The sample functionalized with RGD and SVV peptides after 1 hour of HUVECs 
incubation cells just started the adhesion process like in the previous material, 
mostly inside the microchannels (Figure IV. 14 1h). After 2 hours, HUVECs show the 
same morphological tubular-like structure as in the previous sample (Figure IV. 14 
2h white arrow). After 3 hours HUVECs lose their capability to maintain the tubular-
like structure and adhere on the materials’ microchannels both on the bottom and 
the two sides (Figure IV. 14 3h white arrow) showing a reduced migration effect 
between the channels. After 4 hours HUVECs spread more outside of the channels, 
migrating from the channels to the top of the material (Figure IV. 14 B, 4h). After 5 
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hours all the HUVECs show an indiscriminate growth both inside and outside of the 
channels without the presence of tubular-like structure (Figure IV. 14 B, 5h). 
The sample which is functionalized with LbL but without any adhesion nor 
angiogenetic peptide, the formation of the tubular-like structure is completely 
absent during all the time points (Figure IV. 14 C). In all the time points analyzed, 
HUVECs preserve their round-shape morphology, showing a very limited capability 
of adhesion or migration from the bottom of the channels (Figure IV. 14 C, 1h-5h). 
Even at the last time point, HUVECs did not migrate between the channels, as shown 
for the other two materials. 
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Figure IV. 14 – Tube-like structure formation on functionalized biomaterials. CLSM of 
HUVECs grown in three functionalized PC-µCh for 1 to 5 hours to evaluate the formation of 
tube-like structures. (A) PC-µCh-RGD+QK material induces the formation of tube-like 
structures (white arrows) after 2, 3 and 4 hours. (B) PC-µCh-RGD+SVV material induces the 
formation of tube-like structures after only 2 hours. (C) The PC-LbL material does not induce 
the formation of any tube-like structure. The little triangle indicate where micro-channels 
are located in the images. 
HUVECs cells have been already investigated within micro-channels for 
transendothelial studies after reaching confluency [334]. In addition, Mori et al. 
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developed an interesting system of perfusable channels to supplement a skin-
equivalent graft by seeding HUVECs in channels made of collagen of about 500 µm 
width [335]. Tocchio A et al. developed a perfusable micro-channels system using 
sacrificial templates fabrication and 2-hydroxyethyl methacrylate (HEMA), agarose 
and gelatin methacrylate (GelMA) seeded with HUVECs [336]. Those studies 
investigate the formation of microvasculature using larger channel size about 300µm 
width, while our work focus on the smallest limit of a capillary vessel which present 
vessel diameter between 10 and 15 µm [29]. 
Thanks to the preparation of the proper size microchannels and functionalization 
with LbL and peptide the capillary tubes formation test was performed on three 
chemical conditions, using the same micro-channels structure size. Compared to the 
PC-LbL material, the peptides combinations largely improve HUVECs behave in term 
of adhesion onto the surface in the bottom but also sides of the micro-channels. In 
addition, with the time is clearly noticeable a migration effect of HUVECs through 
the side of the channels to the top of the sample, after 5h incubations. The formation 
of the tubular-like structure was more prominent after 2h incubation for both 
samples contains peptides, but only the PC-RGD+QK material allows the formation 
of the tubular-like structure for longer time-up to 4h after incubation. 
In their previous investigation, Tsvirkun et al. reported a complete 
endothelialization of their PDMS micro-channels of 30-40 µm diameter. They used a 
microfluidic approach to seed HUVECs over two days and later incubate them for 
two weeks to see the complete coverage of the micro-channel lumen with 
endothelial cells [72]. Zheng et al. used a similar approach developing a complete 
endothelialized surface of their 200 µm micro-channels after 1 week of culture. Their 
approach involved the usage of collagen type I to favor the cellular adhesion and 
obtain a complete coverage of HUVECs in a shorter time [68]. Sivarapatna et al. used 
a microfluidic chip fabricated with PDMS with micro-channels of 200 µm, to seed 
HUVECs cells embedded in Collagen type I enriched with VEGF to obtain capillary 
structures after only 4 days of incubation under a constant flow [66]. Finally, 
Raghavan et al. used micro-channels of about 50 µm in size developed in PDMS. They 
embedded HUVECs in collagen type I, later seeded by centrifugation approach inside 
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the channels and they were able to observe the formation of capillary structures 
after only 24h of incubation using enriched media with bFGF and VEGF [65]. In our 
work, we substitute the VEGF factor with the more stable approach of mimetic 
peptide immobilization on a biofunctionalized layer-by-layer of Chitosan and 
Hyaluronic acid. In addition, we reduced the size of the microchannel and seed 
HUVECs non-embedded directly into the micro-channels using centrifugation 
approach. As result, the development of the first tube-like structure was observed 
after only 2 hours of HUVECs seeding. Therefore, the combination of 
biofunctionalization with LbL approach and peptide functionalization, together with 
the geometry and size of micro-channels seems an optimal substrate where HUVECs 
can change their morphology to develop a tube-like structure. 
4. PART IV: Capillaries stabilization 
4.1. HUVECs and hPC-PL stabilize tube-like structures 
Co-culture experiments of HUVECs with hPC-PL were performed on PC-µCh-LbL-
RGD+SVV samples and CLSM was performed on fixed cells to evaluate the formation 
and stabilization of tube-like structures during 2, 3 and 4 hours (Figure IV. 15). In this 
experiment, we focus on the interest in the cells located inside the µCh and we 
analyze the cross-section of each image to identify the tube-like structures. After 2 
hours of monoculture with HUVECs, the formation of the tube-like structure with 
lumen component was observed (Figure IV. 15 upper image dash circle). When only 
HUVECs are present in the µCh, no lumen formation was observed at 3 and 4 hours 
(Figure IV. 15 left images). Once hPC-PL are introduced in the culture, the formation 
of lumen structure was observed both at 3 and 4 hours of incubation (Figure IV. 15 
right images). However, no pericytes were found lying above HUVECs in the region 
presenting lumen, but they were located in a more distant place. 
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Figure IV. 15 – Tube-like structure stabilization by co-culture. CLSM of co-culture with 
HUVECs and hPC-PL. Mono-culture (left) and co-culture (right) were performed to compare 
the potential of stabilizing tube-like structures in the presence of pericytes. Blue marking 
with DAPI for cell nuclei, red marking for HUVECs cytoplasm with CMTPX and green marking 
for hPC-PL cytoplasm with CMFDA. 
Co-culture systems, combining HUVECs with multiple cell lines have been already 
investigated for the stabilization of capillary-like structures [337]. In literature, the 
approaches which involve co-culture system between HUVECs and PCs are 
numerous and different. Therefore there is not a real agreement in the ratio 
between the two cells types, nor in the timing of seeding. Few examples can be 
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reported among the vast number of existing works. Tourovskaia et al. performed co-
culture with HUVECS and PCs in ratio 3:1 into a microfluidic device which allows a 
constant perfusion [88]. Their approach involves an initial HUVECs seeding for 30 min 
followed by 4 days perfusion. After, PC were seeded and let adhere for 15 min before 
reconnecting to the perfusion system again. They report a successful angiogenesis in 
which PCs were recruited to the ECs vessels in presence of VEGF gradient with 
increasing sprout length (Figure I. 25 D). In another work, Morin et al. performed a 
co-culture with HUVECS and PCs in ratio 5:1 encapsulating both cell types at the 
same time in fibrin gel and culturing the system for 3 days [89]. The results reported 
in their work demonstrated the ability of HUVECs and PCs to form fully 
interconnected microvascular networks in fibrin gel developing longer structures 
with longer average length. In addition, the type of media used influence significantly 
the recruitment of PCs (Figure I. 27). Kim et al. used a microfluidic chip with different 
channels to investigate angiogenetic sprout of HUVECS in the presence or not of hPC-
PL [90]. Firstly, HUVECs were seeded for 30 min in the lateral micro-channels 
resuspended in their media, later hPC-PL were resuspended in fibrinogen-thrombin 
solution and injected into the central channel at ratio 10:1 [90]. They reported how 
after 4 days of co-culture, PCs were frequently found adjacent to the capillaries 
vessels with stretched morphology to cover the abluminal surface of endothelium. 
Particular detail also in the pericytes attachment to the endothelial-derived collagen 
IV basement membrane (Figure I. 28). 
In our work, in order to prolong the tube-like structure in the PC-SVV+QK material 
for longer than 2 hours, a co-culture system of HUVECs and hPC-PL was developed. 
Analyzed samples show indeed the presence of tube-like structures only when the 
co-culture system is used, compared with HUVECs alone up to 4 hours after HUVECs 
incubation. This is an evidence on the formation of the tube-like structure after 2 
hours of HUVECs culture, which persists up to 4 hours only when hPC-PL are added 
to the culture. The mechanism of stabilization in our case remains unclear, however, 
samples with tube-like structured did not require hPC-PL to be physically in contact 
with HUVECs, instead, they were located in a distal position than the tube, probably 
stabilizing the tube-like structure with released factors. It was indeed already proven 
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how HUVECs and pericytes communicate through the release of several factors such 
as angiopoietin1 and 2 through the TIE2 receptor [338]. In the work of Zhang et al. 
presented in Chapter I, the AngioChip represent an elegant experiment in which the 
contact between HUVECs and pericytes was prevented, but not their interaction 
through the released factors [94]. 
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V. Conclusion and 
Perspectives 
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1. Conclusions 
In this study, we fabricated micro-channels functionalized with adhesive peptide 
RGD, and angiogenic peptides SVV and QK, using an LbL assembled-thin film of 
naturally-derived polyelectrolytes hyaluronic acid and chitosan as anchoring layer. A 
variety of techniques were used to characterize the surface thickness, the molecular 
density, the physical and chemical topography of materials’ surfaces for both flat and 
micro-channel biofunctionalized materials. Human umbilical vein endothelial cells 
(HUVECs) were cultured on flat and micro-channels biofunctionalized materials with 
and without peptides for various time points and the formation of tubular-like 
structures was observed. Specifically, we evaluated the metabolic activity of the 
cells, their organization in the material surface and their three-dimensional 
rearrangement inside the micro-environment. In addition, human pericytes derived 
from placenta (hPC-PL) were used to stabilize the tubular-like structures in order to 
improve the original approach and perform longer-term experiments. The general 
conclusions are as follow. 
1.1. Regarding materials preparation and surface 
functionalization 
Through the development of surface micropatterns and the functionalization 
method, we demonstrated that large-area surfaces of ordered arrays of 
microchannels can be fabricated on polycarbonate substrates using hot-embossing. 
Specifically, we succeeded in the development of three types of micro-channels 
geometry: (1) width of 22 µm, spacing of 100 µm and depth of 28 µm, (2) width of 
22 µm, spacing of 50 µm and depth of 27 µm, and (3) width of 26 µm, spacing of 
22,40 µm and depth of 25,86 µm. All those three geometries can be produced in a 
rapid and highly reproducible way. The current state-of-the-art in micro-vasculature 
focused most on the development of three-dimensional structure as small as 40 µm 
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and as large as 200 µm [65, 66, 72]. However, those structures differ from the size 
of capillaries in vivo and therefore can be classified as giant capillaries [69-71]. In this 
work, we succeeded to produce as small as 26 µm micro-channels, to better mimic 
the physiological conditions in vivo for capillaries size, representing therefore an 
original progress in the micro-vasculature development. 
 In addition, the homogeneous film of polysaccharides can be achieved on the PC 
substrate through layer-by-layer deposition. In fact, LbL films including a different 
number of hyaluronic acid and chitosan bilayers (4, 8, 12, 16, 20, and 24 bilayers) 
were successfully built up resulting in multilayered films with thickness ranging from 
17 to 374 nm. Moreover, we investigated more deeply the LbL thickness for the 
architecture PC-PEI(HA/CHI)12.5, used for the further biofunctionalization 
experiments. We showed that in liquid conditions, the 12.5 bi-layers swelled over 50 
times, reaching a thickness of 6 µm. Taken together, these results confirm the 
previously investigated CHI/HA coating and the final thickness of the LbL cushion, 
demonstrating a reliable reproducibility of the technique for surface 
biofunctionalization [119]. Next, peptides of varying lengths were successfully 
grafted onto the layer-by-layer cushion using carbodiimide chemistry reaction. 
Firstly, the grafting conditions were optimized for the RGD sequence. Later, SVV and 
QK peptides were also immobilized and their grafted amount was quantified. 
Quantification of peptide grafting in the LbL would be more adequately represented 
as peptide/cm3 or mm3 instead of peptide/cm2 or mm2, due to the non-negligible 
thickness of the LbL. However, as we did not find any reported peptide grafting 
density per unit of volume in the literature that would allow comparisons, we also 
reported the peptide grafting per unit of surface area. In the present work, the RGD 
grafting density was evaluated to be 18 ± 3 pmol/mm2 (11 molecules/nm2), between 
the one reported by Gribova et al. [316] and Leslie-Barbick et al. [317]. The SVV 
grafting density was evaluated to be 34 ± 4 pmol/mm2 (21 molecules/nm2) which 
was higher than previously investigated by Le Saux et al. [319] and Zouani et al. [170]. 
Finally, the QK grafting density was evaluated to be 55 pmol/mm2 (33 
molecules/nm2) which was equal with the density achieved by Chan et al. [320] and 
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comparable with the range investigate in the PEG hydrogels by Leslie-Barbick et al. 
[317]. 
 Finally, the selective functionalization into the microchannels, through the 
removal of the LbL from the inter-channel space was proven by the difference of the 
fluorescence signal from the scratched region and the non-scratched region of the 
same sample. 
Hence, the successful fabrication of micro-channels and their 
biofunctionalization, allow proceeding for the biological investigations in terms of 
HUVECs adhesion and capillary tube-like formation and stabilization. 
1.2. Regarding mono-culture on functionalized PC 
materials 
In terms of culture on materials without micro-channels, HUVECs were cultured 
on PC-LbL, PC-RGD, PC-SVV, PC-QK, PC-RGD+SVV, PC-RGD+QK in order to evaluate 
which material would give a higher cell metabolism as well as which material would 
allow an higher cell adhesion. More HUVECs adhere initially on PC-RGD surface, 
compared to the other grafted peptides or without peptides, and therefore the 
overall metabolic activity of the sample result higher. Once the metabolic activity is 
corrected for the cell number per each sample, a clear evidence of higher material’s 
impact result for peptides combination of RGS+SVV and RGS+QK. A definitive 
conclusion that this material would be the best condition for our experiment cannot 
be taken at this step, however, this preliminary result helps us to focus on the 
peptides-combination materials conditions for the further experiments. 
HUVECs were cultured on three PC-µCh functionalized materials: LbL, RGD+SVV, 
and RGD+QK. Formations of tubular-like structures were observed only in the 
samples containing the peptides and only during the early stage of seeding. 
Specifically, monoculture condition in RGD+QK allows the formation of tube-like 
structure starting from 2h, up to 4h after HUVECs seeding. The material condition 
with RGD+SVV peptide showed a similar tube-like formation at 2h after seeding but 
not further in the time-points. Therefore, in terms of material functionalization, for 
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the monoculture condition, the combination of peptides RGD+QK provide a stronger 
stabilization of the tubular structure for a longer time than the other tested 
conditions. This exciting result introduces new possibility of functionalization to 
obtain a rapid development of tubular-like structures after just 2 hours of cell 
seeding, compared to the previously investigated approach in which lumen 
formation was observed only later than 12 hours [65, 66, 68, 72] We expected to 
have a positive formation of tubular structure using QK, as previously reported in 
literature, however, the very rapid development found in our work provides an 
original appealing strategy to further develop a more stable system. 
1.3. Regarding co-culture on functionalized PC materials 
In terms of co-culture condition with HUVECs and hPC-PL, the material PC-µCh-
RGD+SVV was tested in order to evaluate a stabilization of the tube-like structures 
with the time. Firstly, the formation of the tube-like structure was newly evaluated 
for monoculture condition with only HUVECs as the negative control for tube like-
formation later than 2h. After this proof, co-culture was tested seeding HUVECs first, 
and after 2h the hPC-PL for other 2h. Compared with previous works [90, 91, 93] we 
reported for the first time an early development of capillary structure and 
persistence at very early time-point of the investigation. In fact, the formation of the 
tube-like structure was found both after 3h and 4h after HUVECs seeding, indicating 
an effective stabilization operated by the second cell line. However, in the previously 
reported work, the tube-like structures were investigated also for late-time point, as 
long as 69 hours [91], which we could not achieve in our case for equipment and 
time limitations. In our studies, the confocal images reveal how the pericytes are not 
strictly required to be in contact with the tube-like structure in order to stabilize it, 
and therefore a mechanism which involves soluble factors is likely to happen. 
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2. Perspectives and future work 
2.1. Comparison with single-peptide functionalization 
We plan to perform the same experiments of mono- and co-culture previously 
explained, using the material PC-RGD in order to assess if the absence of angiogenic 
peptides would lead to the formation of capillaries, even if unlikely possible since 
RGD is well known in processes of cellular adhesion and not for angiogenetic 
properties. In addition, the materials PC-SVV, and PC-QK could be tested to evaluate 
if the angiogenic effect of the peptides, even in the absence of a strong adhesion 
normally enhanced by RGD sequence, would be sufficient to induce the formation of 
tube-like structures. 
 
2.2. Investigate genetic pathways involved in 
angiogenesis 
We also originally planned to perform real-time quantitative polymerase chain 
reaction (RT-qPCR) together with the tube-like observation at the CLSM, 
investigating pathways involved in angiogenesis. This would assess if the 
combination of geometry and chemistry would trigger the activation of angiogenetic 
pathways such as Vascular Endothelial Growth Factor Receptor 2 (KDR) [200], 
Vascular Endothelial Growth Factor Receptor 1 (FLT1) [200, 339], Angiopoietin-1 
Receptor (TEK) [339], Fibroblast Growth Factor 2 (FGF2) [194], Platelet And 
Endothelial Cell Adhesion Molecule 1 (PECAM1) [340], and Tyrosine Kinase With 
Immunoglobulin-Like And EGF Like Domains 1 (TIE1) [339]. The process of 
angiogenesis is controlled by a complex expression of proteins which directly 
influences and guide cellular signals through the interaction of their receptors. VEGF 
and FGF-2 have been utilized frequently to develop new capillary vessels, as well as 
the angiopoietins family. Therefore, the gene expression of the receptors capable of 
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recognizing and triggering the intracellular signal is fundamental to complete our 
studies of tube-like development, performed with CLSM. 
2.3. Time-lapse analysis for tube-like formation 
Once the best conditions for mono- and co-culture would be confirmed by the 
combination of CLSM and RT-qPCR, a deep investigation of the formation of the 
tube-like structure can be performed using time-lapse CLSM. We already started the 
preliminary experiments to define the optimal parameters in order to perform the 
experiment, however, the cell survival was not sufficient to allow a stable culture. 
The problem of cell death was most probably caused by two different conditions: 
first, the transfer of the biofunctionalized material with the cell culture between the 
biological laboratory to the Bordeaux Imaging Center facility for time-lapse 
acquisition, inevitably induced cell stress due to lack of constant temperature and 
CO2 level. Second, the cell-culture chamber mounted on the CLSM was probably not 
precisely adjusted at the 37˚C and 5% CO2 level, fundamental for a long-lasting cell 
culture incubation. Therefore, performing the cell-seeding in the same facility as the 
CLSM, and improving the cell-culture chamber conditions at the CLSM would lead to 
a successful acquisition of time-lapse video to follow the development of the 
capillary-like structures inside the biofunctionalized micro-channels. 
 
2.4. Choice of cell line for the endothelial line and 
supporting cells 
Primary endothelial cells are constantly used for the purpose of investigating and 
reproducing vascularization. However, the final choice of which type of endothelial 
cell can differ, depending on the aim of the experiments [26]. HUVECs are in fact the 
most commonly used for in vitro studies and fundamental studies. Another 
possibility is the use of human adipose microvascular endothelial cells (HAMECs) 
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which are mature primary endothelial cells easily isolated from adults (and therefore 
practical for autologous procedures). In addition, they showed impressive 
angiogenic and vasculogenesis capacities, both in vitro and in vivo [26, 341]. 
Endothelial progenitor cells (EPCs) constitute another promising source of 
endothelial cells, in fact, it is possible to isolate them directly from the peripheral 
blood [342] with high angiogenic capacities [26]. There are two main sub-population 
of EPCs named early EPCs and outgrowth endothelial cells (OECs) [343]. 
Apart from the endothelial cells, all types of vessels also include supporting mural 
cells such as pericytes. In order to create in vitro long-lasting, stable blood vessels, 
endothelial cells must be co-cultured with mural cell [26]. Therefore, pericytes have 
been largely used, but not exclusively. In fact, fibroblasts [344] and smooth muscle 
cells [345] were used as well together with other mesenchymal stem cells [341]. 
However, there is not yet an agreement on which supporting mural cell would be the 
best for a stable vascular structure in vitro or in vivo [26]. 
2.5. Application of microfluidic system 
The creation of a microfluidic chip of Polycarbonate could push forward the 
research for a stable development of functional capillary vessels, under constant 
flow conditions to mimic more accurately the physiological environment of the 
human body, such as the shear stress. In fact, several studies in literature prove how 
the shear stress triggers specific mechano-receptors on the endothelial cell’s surface, 
improving their alignment, change in morphology, migration, development of 
capillary structure and finally the stabilization of such structures [54, 61, 66, 76]. A 
microfluidic chip is a pattern of microchannels molded or engraved in which at least 
two output holes are built through the chip and serve as inlet and outlet for the flow 
of the liquid [346]. Microfluidic chips can easily handle fluids no matter the area of 
application. The design of the microchannels network must be adapted to meet the 
requirements, thus, the materials for microfluidic chips employed should also be 
adequate and present the appropriate properties. In our case PC have been used to 
successfully produce micro-channels with hot-embossing techniques. Although 
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some scientists successfully built PC chips, they used thermal bonding procedures 
which are unfortunately known to be a process that doesn’t provide good bonds 
even when the temperature is slightly too low [346]. Moreover, thermal bonding 
also significantly alters the geometry of the channels when the temperature is high 
enough to ensure bonding [346]. Therefore, optimizations are firstly required to 
properly develop a microfluidic chip in the PC. 
Through the microfluidic approach, it would be possible to bio-functionalize 
selectively the microchannels with the LbL of Chitosan/hyaluronic acid and in 
addition immobilize the adhesive RGD peptide and the angiogenetic SVV and QK 
peptides. Finally, HUVECs can be seeded and let adhere for some time, before 
applying the constant physiological flow. In addition, co-culture could be performed 
seeding hPC-PL together with the HUVECs or in a second moment, investigating 
which procedure would allow a faster and more stable formation of capillary vessels. 
2.6. Moving towards clinical application 
Our novel approach is not yet properly optimized to be transferred to a clinical 
approach. However, some considerations can be already done for a possible future 
perspective approach in clinics. 
The model material used in this study, Polycarbonate, is biocompatible but not 
biodegradable and therefore, a proper substitute should be investigated to not-
implant directly this material in vivo, even if, nowadays, the best candidate has not 
been found yet. 
To work efficiently, immediately after implantation, the micro-vasculature 
should be surgically connected to the macro vasculature of the patient. This is 
nowadays not possible due to technical and surgical limitations. However, in the 
future, the possibility to develop a more complex vascular network composed of 
both capillaries, arterioles, and arteries, would allow the surgeon to micro-surgically 
join the own patient’s blood vessels with the newly implanted vessel network. 
Another interesting approach would be to properly remove the develop capillary 
vessels from the three-dimensional micro-channels, without compromising their 
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structure or function. Two main approaches can be used to achieve this goal: the 
peeling out of the capillaries using a solution collagen after crosslinking, as previously 
reported in the work of Raghavan et al. [65]. Alternatively, the usage of the thermo-
responsive system can be used, such as poly(N-isopropylacrylamide). This interesting 
polymer has been already used to harvest cell sheets, briefly, above its lower critical 
solution temperature (LCST) cells are capable of adhesion and growth. But below the 
LCST, the polymer undergoes a structural transition changing from the hydrophobic 
to the hydrophilic state, allowing an efficient cell detachment [347]. We could 
transfer this technology into the microchannel and modify the temperature of the 
system to efficiently release the capillaries when mature. 
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1. Appendix 1: Scientific communication 
Scientific publications 
❖ Bruno Aor, Irfan Khan, Karine Glinel, Alain M. Jonas, Sophie Demoustier-
Champagne, Marie-Christine Durrieu. Microchannel Molding and Layer-
by-layer Approach for the Formation of 3D Tube-like Structures by 
Endothelial Cells. Under submission to BIOMATERIALS journal. 
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Glinel, Alain M. Jonas, Sophie Demoustier-Champagne, Marie-Christine 
Durrieu. EJD-FunMat training school 2016, Bordeaux – France, March 
13th-18th 2016.  
➢ Engineering micro-channels for vascularization in bone tissue 
enginnering (Poster session), Bruno Aor, Laurent Plawinski, Karine 
Glinel, Alain M. Jonas, Sophie Demoustier-Champagne, Marie-Christine 
Durrieu. 2nd Workshop of Regenerative Medicine in Bordeaux, 
Bordeaux – France, October 24th - 26th 2016. 
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Durrieu. EJD-FunMat training school 2017, Aveiro - Portugal. 
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2017. 
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enginnering (Oral communication), Bruno Aor, Laurent Plawinski, Karine 
Glinel, Alain M. Jonas, Sophie Demoustier-Champagne, Marie-Christine 
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Cedex – France, May 17th 2017. 
➢ Engineering micro-channels for vascularization in bone tissue 
enginnering (Flash-Poster session), Bruno Aor, Laurent Plawinski, Karine 
Glinel, Alain M. Jonas, Sophie Demoustier-Champagne, Marie-Christine 
Durrieu. Journée Scientifique de la FR TecSan, Bordeaux – France, June 
22nd 2017. 
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Plawinski, Karine Glinel, Alain M. Jonas, Sophie Demoustier-Champagne, 
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Sophie Demoustier-Champagne, Marie-Christine Durrieu. 28th annual 
conference of the european society for biomaterials, Athens, Greece, 4-
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Titre: Synthèse de microcanaux bioactifs pour la vascularization 
Résumé: In vitro, la formation de structures de type tubulaire avec des cellules 
endothéliales de veine ombilicale humaine (HUVEC) a été étudiée en combinant la 
fonctionnalisation de la chimie des matériaux et le développement de la géométrie 
tridimensionnelle. Le polycarbonate (PC) a été utilisé comme modèle pour le 
développement de l'échafaud. Le film de polysaccharide naturel, basé sur un dépôt 
alternatif couche par couche (LbL) d’acide hyaluronique (HA) et de chitosane (CHI), 
a d’abord été appliqué sur une surface PC et caractérisé en termes de croissance 
d’épaisseur microscopie à balayage lascar (CLSM). Cette première fonctionnalisation 
se traduit par un revêtement complet de la couche PC. Une biofonctionnalisation 
supplémentaire avec un peptide adhésif (RGD) et deux peptides angiogénétiques 
(SVV et QK) a été étudiée, immobilisant ces peptides sur le groupe carboxylique de 
HA précédemment déposé, en utilisant la chimie bien connue du carbodiimide. La 
version marquée de chaque peptide a été utilisée pour caractériser l’immobilisation 
et la pénétration des peptides dans les couches de polyélectrolytes, aboutissant à 
une greffe réussie avec une pénétration complète dans toute l’épaisseur du LbL. Des 
tests in vitro ont été effectués à l'aide de cellules HUVEC pour évaluer leur efficacité 
d'adhésion et leur activité métabolique sur la LbL avec et sans immobilisation de 
peptides, ce qui a permis d'améliorer l'activité préliminaire lorsque des 
combinaisons de peptides sont utilisées. Enfin, les micro-canaux PC (µCh) ont été 
développés et caractérisés pour la première fois, et les autres expériences ont été 
réalisées sur un micromètre de 25 µm de largeur, fonctionnalisé avec une 
architecture (HA / CHI) 12,5 (PC-LbL) avec des peptides RGD et QK -RGD + QK) ou 
avec des peptides RGD et SVV (PC-RGD + SVV). Notre première expérience de 
tubulogénèse a montré de manière surprenante la formation de structures de type 
tubulaire déjà après 2h d'incubation en utilisant la combinaison double-peptides, 
mais uniquement avec PC-RGD + QK. Les tubes étaient également présents après 3 
et 4 heures de culture. L'expérience de co-culture avec des péricytes humains dérivés 
du placenta (hPC-PL) montre comment la stabilisation des tubes a été améliorée 
après 3 et 4 heures également pour l'échantillon de PC-RGD + SVV. Globalement, 
notre matériel bio-fonctionnel avec les peptides PC-RGD + QK et PC-RGD + SVV 
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permet la formation d'une structure de type tubulaire à la fois dans une expérience 
de monoculture et de co-culture. 
Mots clés: estampage à chaud, fonctionnalisation de surface, microcanaux, 
dépôt couche par couche, bioactivité, cellules endothéliales de la veine ombilicale 
humaine, péricytes humains, peptides, structure capillaire. 
 
 
Title: Engineered microchannels for vascularization in bone tissue engineering 
Abstract: In vitro, tubular-like structures formation with human umbilical vein 
endothelial cells (HUVECs) was investigated by combining material chemistry 
functionalization and three-dimensional geometry development. Polycarbonate (PC) 
was used as a template for the development of the scaffold. Natural polysaccharide’s 
film based on alternate layer-by-layer (LbL) deposition of hyaluronic acid (HA) and 
chitosan (CHI), was first applied to PC surface and characterized in terms of thickness 
growth both, in dry conditions using ellipsometry, and confocal lascar scanning 
microscopy (CLSM). This first functionalization results in a complete coating of the 
PC layer. Further biofunctionalization with one adhesive peptide (RGD) and two 
angiogenetic peptides (SVV and QK) was investigated, immobilizing those peptides 
on the carboxylic group of HA previously deposited, using the well-known 
carbodiimide chemistry. The labeled version of each peptide was used to 
characterize the peptides’ immobilization and penetration into the polyelectrolytes 
layers, resulting in a successful grafting with complete penetration through the 
entire thickness of the LbL. In vitro tests were performed using HUVECs to assess 
their adhesion efficiency and their metabolic activity on the LbL with and without 
peptide immobilization, resulting in a preliminary improved activity when peptide-
combinations is used. Finally, PC micro-channels (µCh) were first developed and 
characterized, and the rest of the experiments were performed on µCh of 25µm 
width, functionalized with (HA/CHI)12.5 architecture (PC-LbL) with RGD and QK 
peptides (PC-RGD+QK) or with RGD and SVV peptides (PC-RGD+SVV). Our first 
tubulogenesis experiment surprisingly showed the formation of tubular-like 
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structures already after 2h of incubation using the double-peptides combination but 
only using PC-RGD+QK the tubes were present also after 3 and 4 hours of culture. 
The co-culture experiment with human pericytes derived from placenta (hPC-PL) 
demonstrates how the stabilization of the tubes was improved after 3 and 4 hours 
also for the PC-RGD+SVV sample. Globally our bio-functional material with PC-
RGD+QK and PC-RGD+SVV peptides allow the formation of tubular-like structure in 
both mono and co-culture experiment. 
 
Keywords: hot-embossing, surface functionalization, micro-channels, layer-by-
layer, bioactivity, human umbilical vein endothelial cells, human pericytes, peptides, 
capillary structure. 
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